Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ABHD14A-ACY1		ENSG00000114786	"ABHD14A-ACY1 readthrough"		3	51974706-51989183	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.4;HUVEC TERT2: 4.1;SH-SY5Y: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA036174, HPA036175, HPA038153"	Approved		Uncertain	Vesicles				Vesicles		"HPA036174: , HPA036175: , HPA038153: "	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.90e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.11e-4)"	2.7	2.9	3.5	2.6	8.2	2.0	2.3	8.3	15.1	3.7	3.5	3.2	1.9	4.8	2.5	3.2	2.0	3.3	3.5	4.8	3.2	4.1	5.8	8.4	3.0	1.9	2.7	7.2	2.7	4.6	1.4	3.7	1.7	5.6	2.8	1.6	8.2	4.1	2.2	8.0	2.0	10.5	2.0	3.9	3.3	2.6	2.2	1.3	0.9	4.7	1.8	2.8	2.3	2.7	2.4	5.2	1.2	4.0	4.7	4.1	2.7	0.0	0.0	0.3	0.5	2.0	1.1	0.2	0.0	2.0	0.4	0.4	1.9	3.4	0.8	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	2.1	0.0	0.0	0.0	2.6	1.0	0.0	0.0	4.1	2.1	0.0	0.0	0.0	2.0	1.5	1.2	1.8	0.5	0.0	0.2	0.0	0.0	0.3	3.3	0.0	2.4	0.0	0.8	0.0	0.0	0.9	0.0	2.1	0.0	0.0	0.0	2.0	1.6	0.0	0.0	0.2	1.7	1.2	4.1	4.0	2.4	2.4	2.3	4.1	5.2	1.7	2.1	2.7	0.0	4.7	2.0	2.4	2.5	2.7	3.5	8.2	8.3	15.1	3.2	4.1	2.7	7.2	5.6	1.3
AC011455.2		ENSG00000269547			19	38915404-38949855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.6;ovary: 3.0"	"Cell line enhanced"	"Detected in some"		"A-431: 3.7;A549: 5.1;T-47d: 4.3;U-251 MG: 6.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA052730, HPA056957"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Mitochondria				"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: , HPA056957: "										"unprognostic (6.10e-2)"			"unprognostic (3.79e-2)"					1.3	2.6	0.3	1.7	0.3	0.0	0.1	0.4	1.1	0.3	0.1			0.0	1.2	0.5	0.1	0.4	0.8	1.1	0.1	0.1	1.6	1.1	0.2	0.0	0.2		3.0	0.6	0.0	0.1	0.5		0.2	0.0		0.1	0.0	0.2	0.2	0.2	0.0	0.3	0.1	0.1	0.5			0.1		0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.1	0.0	2.8	0.9	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.5	0.3	1.1	0.5	1.1	0.3	1.9	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.3	0.2	0.0	1.4	1.3	0.0	6.3	0.0	0.5	0.0	2.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC091057.5		ENSG00000284906	"Rho GTPase-activating protein 11B "	Q3KRB8	15	30624548-30685606	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;lymphoid tissue: 14.4;testis: 5.8"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA064479	Uncertain		Uncertain	Vesicles				Vesicles		"HPA064479: "																		0.2	0.1	0.8	10.3	1.8	7.1	0.5	0.7	0.9	0.1	5.1	0.6	0.0	1.1	0.8	0.2	1.8	0.2	0.3	0.2	1.0		0.0	0.1	0.9	2.8	0.1	0.0	0.1	0.0	0.0	0.4	0.7	0.6	0.0	1.2	0.3	0.1	0.1	0.4	0.9	1.5	0.8	1.9	1.4	1.0	5.8	2.1	14.4	0.0	1.4	5.7	0.5	0.0	1.0	1.0	1.6	0.3	0.0	0.8	0.0	4.3	2.9	5.0	2.5	0.1	0.6	2.8	4.6	1.8	3.2	3.7	3.0	3.7	2.8	1.8	1.9	4.0	2.5	1.6	2.8	6.1	3.0	7.4	9.9	1.3	0.0	4.7	5.3	0.2	0.2	2.1	1.6	2.2	4.4	8.6	2.2	2.1	3.6	4.0	1.5	1.5	5.1	5.1	1.3	0.9	2.8	2.4	2.2	5.4	2.0	1.0	2.5	2.4	2.5	5.0	4.2	2.4	3.9	3.0	3.2	6.1	1.7	5.3	4.0	1.6	0.3	0.2	0.4	0.0	0.0	0.6	0.8	0.6	0.1	1.0	0.1	0.1	0.1	0.0	0.1	1.0	0.6	0.0										
ACSM5	FLJ20581	ENSG00000183549	"Acyl-CoA synthetase medium chain family member 5"	Q6NUN0	16	20409534-20441336	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 94.6"	"Group enriched"	"Detected in some"	5	"ASC diff: 5.6;ASC TERT1: 12.3;HSkMC: 14.6;U-87 MG: 9.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 20.5;renal cancer: 9.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.2;monocytes: 2.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041435	Uncertain		Uncertain	Vesicles				Vesicles		"HPA041435: AB_10961121"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.57e-1)"	11.1	1.1	1.9	0.7	2.1	0.4	3.2	1.3	1.6	1.0	1.0	2.9	0.0	0.5	0.3	2.8	0.5	0.6	1.0	0.9	3.0	1.9	8.9	94.6	0.9	1.6	2.9	2.1	0.4	1.4	0.4	0.1	0.7	2.0	0.4	0.6	0.5	0.5	0.5	4.4	0.6	0.6	0.5	2.9	1.7	0.9	1.0	3.0	0.1	1.7	0.6	0.4	0.5	0.7	0.3	3.2	0.3	2.8	0.0	0.3	0.5	0.0	0.0	0.1	0.1	5.6	12.3	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.0	14.6	0.0	0.8	0.1	0.0	0.1	0.6	1.7	0.0	0.0	0.3	0.2	0.0	0.0	0.1	2.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	9.0	0.1	0.0	0.3	2.8	0.1	0.1	1.9	0.1	0.1	0.3	0.2	3.2	0.3	0.2	0.3	0.1	0.0	1.3	0.1	0.0	0.5	1.9	2.1	1.3	1.6	3.0	1.9	2.9	2.1	2.0	3.0
ADAM15	MDC15	ENSG00000143537	"ADAM metallopeptidase domain 15"	Q13444	1	155050566-155062775	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 63.6;RPMI-8226: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.2;intermediate monocyte: 12.0;myeloid DC: 28.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 28.7;monocytes: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011633, HPA072878"	Uncertain		Uncertain	Vesicles			13000	Vesicles		"HPA011633: AB_1844574, HPA072878: "	"unprognostic (6.35e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavourable (5.83e-5)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (5.64e-9)"	"unprognostic (3.35e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.40e-2)"	32.7	8.3	7.3	13.3	8.9	19.3	47.9	7.8	13.9	19.9	21.2	22.2	11.9	10.7	20.4	16.2	36.0	19.3	30.3	42.3	8.0	7.7	12.4	12.8	29.2	23.3	10.8	8.3	15.7	17.5	18.9	6.9	25.5	13.9	17.8	15.9	15.4	20.4	12.1	13.6	45.8	20.3	25.6	13.6	16.0	19.6	8.3	7.4	2.7	14.6	41.5	19.7	13.4	26.5	1.1	28.7	0.7	17.2	0.7	4.5	8.1	20.7	6.6	1.3	29.6	10.9	9.1	12.8	9.2	11.7	11.7	8.0	4.8	11.9	5.8	41.3	12.0	26.0	6.6	28.2	3.1	2.6	8.6	1.4	13.1	4.7	19.1	11.7	1.5	9.7	29.9	11.8	17.0	52.9	2.1	24.2	8.7	11.3	0.1	8.6	4.1	63.6	1.8	4.0	67.0	8.5	5.4	4.0	8.7	20.1	25.3	7.9	37.4	7.3	39.0	11.5	4.9	11.4	10.1	2.7	2.1	2.5	8.4	8.9	12.5	0.0	17.2	0.3	4.5	12.0	3.1	1.0	2.3	2.6	28.7	1.1	1.0	1.2	0.7	0.7	2.8	2.3	3.8	8.1	7.3	8.9	7.8	13.9	8.0	7.7	10.8	8.3	13.9	7.4
ADGRE2	"CD312, EMR2"	ENSG00000127507	"Adhesion G protein-coupled receptor E2"	Q9UHX3	19	14732393-14778541	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Cell adhesion, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;lymphoid tissue: 38.9"	"Cell line enhanced"	"Detected in some"		"HEL: 10.1;HMC-1: 16.3;NB-4: 9.8;RPMI-8226: 7.2;U-937: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 24.2;monocytes: 28.7"									HPA055200			Uncertain	Vesicles,Cytosol				Vesicles	Cytosol	"HPA055200: "	"unprognostic (2.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (4.35e-6)"	"unprognostic (1.46e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.01e-1)"	6.3	3.1	1.7	22.9	1.9	7.2	4.4	1.0	1.3	14.9	8.1	2.5	0.9	2.4	12.0	1.0	1.9	2.3	3.3	7.3	2.0	1.8	3.4	4.3	15.6	37.4	2.2	0.0	5.3	3.5	0.7	1.6	10.9	2.4	3.8	2.5	3.2	2.4	3.9	3.5	3.0	3.0	2.0	3.1	38.9	2.0	2.2	1.4	2.8	3.4	5.2	2.8	7.5	2.1	0.1	3.1	24.2	28.7	1.2	0.0	1.8	0.2	1.0	0.1	0.2	0.1	0.3	1.1	0.8	1.1	0.0	0.0	0.2	0.2	0.2	0.1	0.6	1.7	0.3	0.1	0.0	0.2	0.2	10.1	3.2	0.2	0.5	3.7	16.3	0.8	1.4	3.6	0.6	0.1	2.3	0.4	1.2	0.5	1.3	9.8	0.4	0.2	0.1	1.4	7.2	0.0	0.3	0.1	0.2	2.1	1.7	0.4	0.3	4.7	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.2	1.0	12.9	0.5	19.6	4.4	24.2	0.0	15.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	19.1	1.2	28.7	0.6	0.0	1.8	1.7	1.9	1.0	1.3	2.0	1.8	2.2	0.0	2.4	1.4
AGMO	"FLJ16237, TMEM195"	ENSG00000187546	"Alkylglycerol monooxygenase"	Q6ZNB7	7	15200318-15562015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 41.9;liver: 57.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 4.0;Karpas-707: 8.5;NTERA-2: 3.8;SCLC-21H: 3.6;TIME: 4.3;WM-115: 16.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 15.7"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 3.6;neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057900			Uncertain	Vesicles				Vesicles		"HPA057900: "	"unprognostic (2.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	6.8	0.2	0.8	1.0	1.2	0.1	3.7	0.3	0.5	0.3	16.5	1.1	0.1	4.6	0.3	7.3	0.3	0.3	4.7	0.9	0.7	0.6	5.3	57.9	0.4	0.5	1.1	0.8	0.3	0.3	0.0	0.7	0.4	0.7	0.4	0.3	0.0	0.4	0.1	0.5	0.5	41.9	0.1	1.1	0.3	0.3	1.8	2.0	0.0	0.7	0.1	0.1	1.0	0.4	0.2	0.1	3.6	0.1	0.6	0.1	0.0	0.0	2.4	0.0	2.1	0.2	3.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	1.2	0.0	0.7	3.6	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.5	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	16.8	3.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	3.1	0.6	0.0	0.1	0.0	0.0	0.8	1.2	0.3	0.4	0.7	0.6	1.1	0.8	0.7	2.0
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 29.6;placenta: 44.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 62.9;ASC TERT1: 8.8;BJ hTERT+ SV40 Large T+: 12.0;HBF TERT88: 18.9;HSkMC: 11.4"	"Group enriched"	"Detected in many"	8	"breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA003596	Enhanced		Uncertain	Vesicles				Vesicles		"HPA003596: AB_1845163"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.48e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.41e-3)"	18.8	11.6	0.0	0.1	0.0	0.0	10.8	0.0	0.0	0.8	5.5			0.0	0.6	0.5	0.5	2.2	1.6	3.1	0.0	0.1	5.7	29.6	2.6	0.0	0.9		0.8	0.6	0.6	0.8	44.9		1.3	1.0		1.0	1.0	2.9	4.4	0.7	1.1	0.0	2.3	1.7	0.2			4.1		0.0	4.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	62.9	8.8	0.0	0.0	1.3	12.0	6.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	1.1	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AL049629.2		ENSG00000284969	"CD59 glycoprotein "		11	33698261-33722467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	16	"placenta: 65.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.0;HUVEC TERT2: 24.4;TIME: 29.9;U-2197: 25.5"									"Group enriched"	"Detected in some"	6	"memory CD8 T-cell: 1.6;T-reg: 2.5"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.5"									HPA026494	Uncertain		Uncertain	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA026494: AB_1846321"																		3.2	0.4	0.3	2.8	0.5	1.2	2.2	0.4	2.6	0.7	0.5	0.1	0.9	1.5	1.3	2.3	1.5	0.3	2.6	2.4	1.6		2.0	0.6	1.9	2.0	0.9	1.0	0.4	1.3	0.1	0.2	65.2	0.9	0.4	0.4	0.5	3.1	1.3	3.9	0.0	0.1	1.4	0.7	0.4	3.6	1.0	0.5	0.2	1.0	1.4	1.4	0.8	2.9	0.0	0.3	0.0	0.0	0.0	2.5	0.2	0.5	1.5	0.1	1.0	1.6	3.7	0.0	8.2	3.7	1.1	1.0	0.0	4.2	0.0	0.9	5.6	0.9	0.1	19.0	1.8	0.8	0.1	0.1	3.3	0.3	0.4	0.2	0.5	1.3	1.3	0.4	6.7	24.4	0.2	3.2	7.0	0.4	0.7	0.3	0.2	11.2	0.2	0.7	0.5	2.2	0.9	0.0	0.1	0.9	1.5	2.7	0.4	0.0	29.9	3.1	1.2	25.5	3.2	1.7	1.5	0.1	7.2	0.0	7.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2										
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: "	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favourable (6.70e-4)"	"prognostic favourable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	21.6	12.7	11.8	12.6	13.2	20.6	22.0	18.2	14.1	17.5	27.4	14.3	13.2	42.0	17.9	12.4	19.8	10.4	16.7	10.5	12.3	15.2	22.2	10.5	13.6	10.7	17.3	12.3	12.7	14.4	18.6	14.4	17.5	19.4	10.7	24.4	18.6	23.1	19.5	11.3	24.6	52.9	19.9	23.6	9.4	11.1	9.1	8.8	5.5	17.7	15.8	13.9	13.7	17.0	2.0	8.5	22.4	12.5	6.3	4.6	4.3	8.8	7.1	7.9	8.3	32.2	17.3	9.7	26.2	43.6	13.4	17.1	4.8	8.3	1.0	8.4	34.5	4.9	6.2	14.3	16.3	9.9	4.4	11.6	9.6	5.2	14.1	2.0	9.5	16.1	11.4	16.5	22.5	31.3	8.7	7.6	29.6	6.3	2.2	1.5	9.4	8.3	1.8	5.7	3.0	26.4	9.4	1.9	5.8	10.3	8.5	6.0	18.1	4.3	25.4	20.4	7.6	21.4	11.9	4.9	6.4	0.3	18.6	4.4	13.4	4.4	12.5	0.9	4.6	7.1	2.7	1.9	3.2	3.1	8.5	2.0	2.8	4.3	22.4	6.3	7.7	1.5	3.5	4.3	11.8	13.2	18.2	14.1	12.3	15.2	17.3	12.3	19.4	8.8
ANTXR1	"ATR, FLJ10601, FLJ21776, TEM8"	ENSG00000169604	"Anthrax toxin receptor 1"	Q9H6X2	2	69013178-69249327	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	Hypotrichosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 72.6;RH-30: 39.4;TIME: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054785			Uncertain	Vesicles	"Intracellular and membrane"		4100000	Vesicles		"HPA054785: "	"unprognostic (1.44e-1)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.26e-3)"	"unprognostic (9.84e-2)"	"prognostic unfavourable (1.22e-5)"	"unprognostic (2.09e-2)"	27.5	25.8	10.0	10.1	14.9	0.1	21.1	11.0	9.6	33.4	14.2	23.6	8.5	4.9	35.7	13.5	14.0	20.7	51.5	18.8	17.0	10.1	6.1	3.1	20.1	4.4	19.4	6.5	45.5	3.1	30.5	10.4	32.3	23.6	21.7	8.8	37.2	13.8	23.0	12.4	17.9	8.9	30.4	21.4	11.7	7.4	6.6	16.7	2.6	17.5	10.4	6.7	29.1	24.5	0.0	0.1	0.1	0.0	0.2	0.4	0.0	6.8	8.6	7.6	4.8	35.4	17.3	0.1	11.2	23.0	12.0	9.6	0.0	0.6	0.0	6.6	29.7	6.5	5.3	6.7	11.3	0.0	4.3	1.8	19.2	2.2	15.7	1.5	1.0	28.1	2.7	11.8	7.4	3.3	1.1	0.0	72.6	3.1	4.2	0.1	7.2	5.6	0.0	39.4	0.1	2.9	6.0	4.3	19.4	21.9	0.1	7.7	2.2	0.4	49.3	15.2	12.8	15.3	11.9	0.0	0.0	0.0	7.9	1.3	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	10.0	14.9	11.0	9.0	17.0	10.1	19.4	6.5	23.6	16.7
ARHGAP11B		ENSG00000285077	"Rho GTPase activating protein 11B"	Q3KRB8	15	30624494-30638805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 2.6;intestine: 2.7;stomach 1: 1.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 17.6"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA064479	Uncertain		Uncertain	Vesicles				Vesicles		"HPA064479: "																		0.2	0.0		0.0		0.3	0.0		0.0	0.0	1.1			1.1	0.0	0.0	2.6	0.1	0.0	0.0			0.0	0.1	0.1	1.6			0.0	0.0	0.0		1.0		0.0	2.7		0.0	0.0	0.0	0.3	0.1	0.0		0.3	1.9	0.4			0.0		0.9	0.3		1.0	0.8	0.0	0.0	0.0	1.3	0.0	2.8	0.4	0.0	1.7	0.6	0.6	1.6	0.2	1.0	1.3	0.5	4.6	3.0	0.0	1.4	1.0	5.2	4.1	0.1	2.4	4.0	0.4	0.0	17.6	1.4	0.4	0.8	0.2	0.4	0.1	0.5	1.1	1.5	1.3	7.6	3.8	0.2	2.4	0.6	0.9	0.2	0.8	1.8	1.1	1.3	4.5	2.7	1.0	1.1	1.3	0.6	1.5	3.3	1.3	4.7	2.6	0.1	3.0	2.9	2.1	1.4	1.1	3.6	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.3	0.9	0.8	1.0	0.3	0.6	0.0	0.0	0.0	0.3	0.2	0.0										
ARHGAP15	BM046	ENSG00000075884	"Rho GTPase activating protein 15"	Q53QZ3	2	143091362-143768352	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 52.0;bone marrow: 33.5;lymphoid tissue: 94.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.0;HEL: 25.0;HL-60: 35.3;MOLT-4: 23.3;NB-4: 27.3;THP-1: 37.2;U-698: 28.0;U-937: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA032125			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA032125: AB_10671370"	"unprognostic (1.59e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.62e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (6.95e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.94e-2)"	5.5	2.7	3.6	36.6	4.6	33.5	3.7	0.6	2.9	2.4	4.3	1.5	2.1	2.7	2.1	4.3	3.6	2.4	4.9	5.0	3.8	2.1	4.5	4.8	9.1	36.9	7.8	1.7	1.5	1.2	0.4	1.3	1.6	4.6	3.9	3.3	1.0	8.1	2.2	1.1	1.7	12.2	1.6	11.3	51.8	3.0	3.5	5.9	94.4	4.2	2.2	21.7	6.0	3.9	25.2	14.5	52.0	9.6	28.7	46.0	23.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	25.0	0.1	0.0	0.0	35.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	23.3	27.3	0.1	0.0	13.1	0.1	6.6	0.0	0.0	0.1	0.1	0.1	0.0	0.2	1.2	37.2	0.1	0.1	0.8	0.0	0.0	0.3	0.1	28.0	0.2	18.7	1.0	38.6	8.6	34.9	26.6	8.8	42.3	25.2	46.0	33.3	14.5	22.5	33.9	28.4	52.0	28.7	9.6	14.4	36.5	23.2	3.6	4.6	0.6	2.9	3.8	2.1	7.8	1.7	4.6	5.9
ARNTL	"bHLHe5, BMAL1, JAP3, MOP3, PASD3"	ENSG00000133794	"Aryl hydrocarbon receptor nuclear translocator like"	O00327	11	13276652-13387266	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045962, HPA050938"	Supported		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"			Nucleoplasm	Vesicles	"CAB045962: AB_11124144, HPA050938: "	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.08e-2)"	12.3	28.5	13.4	10.3	13.3	13.4	18.2	24.4	25.2	16.4	10.3	5.7	10.6	11.8	10.4	6.5	9.3	9.7	9.4	8.1	11.5	7.5	11.1	17.3	12.1	15.0	6.7	13.1	21.1	9.8	6.1	17.8	9.2	9.3	7.5	8.9	8.6	11.2	8.2	19.2	27.2	10.9	11.7	9.6	10.4	9.6	16.2	9.3	29.2	17.6	0.7	12.2	8.1	17.0	2.8	6.1	20.0	7.8	9.8	19.7	7.3	6.8	6.6	6.1	4.1	11.8	7.6	4.8	6.9	7.4	6.8	8.0	3.3	10.0	0.1	2.2	5.2	2.6	4.8	8.2	5.9	11.7	5.0	3.1	5.4	1.7	21.1	1.4	13.0	9.4	21.7	2.5	18.2	4.8	1.8	12.2	6.8	3.7	3.2	0.7	1.7	3.6	4.2	7.7	3.3	6.6	1.6	1.3	11.9	5.7	2.0	6.6	4.4	5.8	9.3	7.1	5.5	16.7	3.9	3.5	9.4	0.0	7.0	3.6	6.1	4.4	6.7	13.7	14.3	6.9	19.7	2.4	13.4	12.9	6.1	2.8	7.8	9.1	20.0	9.8	7.8	1.1	8.5	7.3	13.4	13.3	24.4	25.2	11.5	7.5	6.7	13.1	9.3	9.3
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101360417-101383519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 128.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.1;CACO-2: 3.4;Hep G2: 2.4"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles			470000	Vesicles		"HPA021251: AB_1845247, HPA021330: "	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favourable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.0	0.1	0.1	0.2	128.4	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.1	0.1	6.1	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.3	3.4	0.1	0.6	0.2	0.0	0.3	0.1	0.2	0.5	0.3	0.1	0.5	0.2	2.4	0.0	0.9	0.3	0.0	1.0	0.1	0.0	0.0	0.7	0.4	0.5	0.1	0.2	0.3	1.0	0.7	0.2	1.1	0.2	0.6	0.2	0.3	0.4	0.4	0.2	0.5	0.0	0.2	0.1	0.6	0.6	0.2	0.4	0.4	0.6	0.5	0.5	0.2	0.6	0.3	0.2	0.0	0.7	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 139.4;liver: 39.3"	"Group enriched"	"Detected in some"	5	"hTCEpi: 15.9;RPTEC TERT1: 9.8"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"			25000	Vesicles	"Actin filaments"	"HPA007600: AB_1845284, HPA027823: AB_10602394"	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavourable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	0.9	0.5	9.2	0.5	7.1	0.5	8.2	3.9	7.5	1.5	0.6	4.9	0.1	0.5	0.6	3.6	5.7	3.8	3.6	0.5	7.9	6.3	139.4	39.3	0.6	0.6	10.9	4.3	0.5	0.8	0.5	8.3	1.3	9.2	0.7	0.5	0.0	2.2	2.0	0.6	16.4	0.5	0.5	7.1	0.5	0.6	0.6	5.8	0.0	8.9	1.6	0.7	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.0	15.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	7.1	3.9	7.5	7.9	6.3	10.9	4.3	9.2	5.8
BTN3A1	"BT3.1, BTF5, BTN3.1, CD277"	ENSG00000026950	"Butyrophilin subfamily 3 member A1"	O00481	6	26402237-26415216	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA012565	Approved		Uncertain	Vesicles				Vesicles		"HPA012565: AB_1845494"	"unprognostic (2.82e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (4.15e-5)"	"unprognostic (2.45e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-2)"	"prognostic favourable (4.81e-4)"	11.3	14.3	6.7	33.5	5.4	10.3	10.2	10.7	5.9	18.5	14.9	10.0	10.1	11.5	22.3	14.1	13.1	9.6	16.5	9.0	5.3	6.1	9.7	11.4	29.9	24.1	7.1	5.4	15.5	9.4	5.6	11.2	8.5	7.8	17.9	12.1	12.3	16.7	10.0	4.8	9.7	20.6	10.2	9.0	45.2	12.5	4.9	6.7	16.5	8.5	9.8	32.9	11.6	12.9	9.8	4.4	17.4	5.9	18.4	23.4	12.1	3.7	3.2	4.7	4.8	13.6	14.5	0.5	3.0	12.0	6.9	20.3	0.1	8.1	9.7	10.6	5.5	2.5	1.5	4.8	4.0	9.5	3.3	5.1	3.9	2.2	6.1	4.7	4.7	7.8	2.7	6.0	2.8	9.7	1.2	12.7	2.8	0.3	8.5	2.9	0.5	1.0	11.8	2.1	22.0	4.2	4.7	2.5	5.0	1.7	3.6	6.8	3.3	1.9	2.4	5.3	1.3	1.5	2.9	21.7	22.1	3.5	8.1	10.6	4.1	17.4	5.3	13.5	23.4	5.7	20.9	9.8	14.6	21.7	4.4	5.3	12.7	16.8	11.9	18.4	5.9	2.1	16.9	12.1	6.7	5.4	10.7	5.9	5.3	6.1	7.1	5.4	7.8	6.7
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.7"	"Cell line enhanced"	"Detected in many"		"HEL: 16.1;RPTEC TERT1: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Uncertain	Nucleoplasm,Nucleoli,Vesicles			100000	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favourable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	2.6	2.6	2.0	1.9	3.1	0.5	2.9	2.4	2.4	3.2	18.2	0.8	0.0	14.2	1.8	1.7	6.7	1.4	25.6	5.8	1.6	1.9	10.4	17.1	9.5	2.4	2.0	0.1	2.2	1.6	9.3	6.5	1.0	5.7	2.6	3.7	1.9	7.0	1.0	1.9	7.1	56.7	1.9	5.2	2.2	7.0	0.9	0.9	0.4	10.3	3.9	5.6	2.9	5.2	0.8	2.1	3.2	2.5	0.5	0.5	1.0	0.3	0.4	0.9	0.1	0.6	0.7	0.4	1.1	1.1	0.1	3.1	7.5	5.8	0.4	0.5	1.3	2.4	2.3	3.0	0.2	1.6	1.0	16.1	2.1	6.9	1.6	0.2	0.7	2.4	0.5	0.2	1.3	1.7	4.1	3.2	2.7	0.1	0.3	0.2	0.5	0.5	0.2	2.4	0.2	8.7	0.3	0.3	0.1	0.5	0.0	1.6	0.6	0.8	1.6	3.0	4.3	0.1	1.6	1.3	0.6	2.0	6.3	2.3	2.8	3.2	2.5	1.3	0.4	0.7	0.2	0.2	0.2	0.1	2.1	0.8	0.3	0.5	0.9	0.5	0.8	0.9	0.1	1.0	2.0	3.1	2.4	2.4	1.6	1.9	2.0	0.1	5.7	0.9
CALN1	CABP8	ENSG00000183166	"Calneuron 1"	Q9BXU9	7	71779491-72447151	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0"	"Cell line enriched"	"Detected in some"	6	"Karpas-707: 30.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036278, HPA036708"	Approved		Uncertain	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA036278: AB_10673125, HPA036708: "	"unprognostic (6.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.67e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.72e-4)"	"unprognostic (2.99e-1)"	0.8	16.0	10.8	0.8	17.7	1.5	1.0	48.5	39.1	2.3	0.9	5.1	0.0	0.9	1.4	0.8	0.8	1.0	1.3	0.8	9.5	4.4	0.8	1.0	0.9	0.8	6.8	7.3	1.0	1.9	0.8	0.3	0.8	18.6	1.0	0.9	0.0	0.8	2.4	0.9	4.2	0.8	0.9	8.4	0.8	0.8	11.3	3.3	20.0	0.9	0.0	0.8	0.9	1.9	0.3	1.3	0.6	0.4	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	30.7	0.0	0.0	0.0	0.0	4.1	0.0	4.7	0.0	0.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	4.9	4.7	0.0	0.2	0.0	0.0	0.6	0.4	0.3	0.2	0.1	0.1	0.2	0.2	0.2	1.3	0.3	0.2	0.2	0.5	0.3	0.1	0.4	0.1	0.1	10.8	17.7	48.5	11.6	9.5	4.4	6.8	7.3	18.6	3.3
CATSPERB	"C14orf161, FLJ14298"	ENSG00000133962	"Cation channel sperm associated auxiliary subunit beta"	Q9H7T0	14	91580696-91780707	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;U-937: 3.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA035134	Uncertain		Uncertain	Vesicles				Vesicles		"HPA035134: AB_10671510"	"unprognostic (2.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.04e-3)"	"unprognostic (2.72e-5)"	"unprognostic (1.81e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.85e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.71e-3)"	0.6	0.1	0.0	0.6	0.0	0.0	1.4	0.0	0.2	0.4	0.9			0.3	0.4	0.4	0.6	0.7	1.2	0.6	0.0	0.0	0.3	0.2	0.9	1.1	0.0		0.2	15.1	1.0	0.3	0.0		0.9	0.7		3.7	0.0	1.7	4.2	1.2	0.1	0.0	0.8	2.0	2.0			0.9		0.6	0.5	0.3	0.4	0.2	1.1	0.2	0.7	1.6	0.4	0.6	0.0	0.7	1.7	0.0	0.0	1.9	0.3	0.3	0.0	0.0	2.4	3.9	1.2	0.9	0.0	0.7	0.0	0.5	0.7	1.4	2.1	0.4	1.3	2.3	0.0	1.7	0.8	0.6	0.7	0.4	0.5	0.0	0.5	0.2	0.5	2.3	0.6	0.7	0.2	0.5	0.3	0.0	0.0	0.4	0.9	1.7	0.1	0.0	0.8	1.6	0.4	2.2	0.9	0.2	0.2	0.0	0.3	0.9	0.9	0.3	0.2	3.8	1.0	1.1	0.2	0.6	1.1	0.0	1.5	0.4	1.6	1.0	0.0	0.2	1.1	1.4	0.4	0.7	0.2	0.2	0.0	0.4										
CCDC169-SOHLH2	C13orf38-SOHLH2	ENSG00000250709	"CCDC169-SOHLH2 readthrough"		13	36168794-36297842	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"testis: 42.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEL: 2.3;HL-60: 6.1;LHCN-M2: 2.3;NB-4: 3.5;U-937: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029182			Uncertain	Vesicles				Vesicles		"HPA029182: AB_10602409"					"unprognostic (5.56e-2)"			"unprognostic (3.93e-1)"		"unprognostic (3.60e-2)"		"unprognostic (4.66e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.84e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.43e-2)"	0.4	0.5	0.5	0.2	1.8	0.2	0.4	0.4	1.4	0.5	0.8	0.3	4.9	0.2	1.0	2.0	0.3	0.4	0.3	1.1	0.5	0.6	0.7	0.3	0.3	0.2	0.5	1.3	0.4	0.4	0.3	0.3	3.3	1.1	0.6	0.3	0.5	0.4	9.1	0.5	0.3	0.4	3.0	1.0	0.3	0.6	42.2	0.0	0.0	0.4	0.0	0.2	1.6	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	3.3	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.3	6.1	0.0	0.1	0.0	0.8	0.0	0.8	0.1	0.0	2.3	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	1.7	0.0	0.1	0.0	0.1	1.1	0.6	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.1	5.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.4	1.4	0.5	0.6	0.5	1.3	1.1	0.0
CCDC74A	FLJ40345	ENSG00000163040	"Coiled-coil domain containing 74A"	Q96AQ1	2	131527675-131533666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.1;testis: 41.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 19.0;SCLC-21H: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 3.3"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 3.3"									HPA060727			Uncertain	Vesicles				Vesicles		"HPA060727: "	"prognostic favourable (5.11e-4)"	"unprognostic (2.89e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (1.70e-7)"	"unprognostic (7.28e-3)"	"prognostic favourable (4.92e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.53e-2)"	1.3	12.8	5.8	2.7	6.5	0.2	6.8	1.1	4.4	5.6	1.9	3.2	4.7	0.9	7.1	7.1	1.9	26.1	5.1	2.2	5.1	6.8	3.0	0.5	3.0	0.9	2.2	4.1	7.1	1.5	13.3	14.1	0.9	13.6	5.2	1.3	2.4	1.8	5.1	0.9	3.5	0.8	5.9	3.0	1.0	1.0	41.2	1.9	2.2	2.6	0.9	1.2	4.5	2.7	0.0	3.3	0.0	0.1	0.0	0.8	0.2	0.0	3.9	4.0	0.2	5.7	13.9	0.3	3.3	5.6	3.1	2.3	0.1	5.9	1.5	2.1	5.1	3.0	1.7	1.0	1.2	3.9	7.4	0.0	3.7	0.1	0.7	0.1	0.3	4.5	0.4	3.0	0.0	1.2	2.1	4.3	2.7	2.4	8.4	2.3	19.0	2.5	4.0	0.0	1.7	7.8	0.0	15.6	11.4	0.4	0.5	0.5	5.4	0.8	1.2	0.9	2.9	12.0	2.5	0.9	0.7	0.5	12.9	0.3	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	3.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	5.8	6.5	1.1	4.4	5.1	6.8	2.2	4.1	13.6	1.9
CCDC74B	DKFZp434E2321	ENSG00000152076	"Coiled-coil domain containing 74B"	Q96LY2	2	130139287-130145134	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 12.4;testis: 22.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.4;SH-SY5Y: 14.8"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060727			Uncertain	Vesicles				Vesicles		"HPA060727: "	"prognostic favourable (4.46e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.43e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-4)"	"unprognostic (8.31e-3)"	"unprognostic (9.94e-3)"	0.0	1.4	2.8	0.1	2.4	0.0	0.4	0.0	2.2	8.3	0.1			0.0	3.5	0.6	0.1	12.4	1.1	0.1	3.0	4.0	1.0	0.0	1.0	0.1	0.9		2.1	0.2	7.5	7.7	0.0		2.7	0.0		0.2	2.5	0.0	0.1	0.0	1.0	1.4	0.0	0.0	22.7			3.7		0.0	0.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.8	2.8	0.1	2.6	5.7	0.6	2.2	1.1	0.3	0.5	0.8	0.7	0.0	3.6	2.0	1.0	0.2	0.3	0.4	1.9	5.4	0.0	6.7	0.1	0.3	0.1	0.2	1.2	0.0	0.9	0.0	0.1	0.1	1.7	0.8	2.0	0.0	0.0	5.8	5.8	4.4	0.0	3.1	1.7	0.0	10.4	14.8	1.6	0.1	0.2	5.9	0.6	0.4	1.1	4.9	5.9	0.5	0.1	0.2	0.0	6.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5										
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541108-74546143	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 46.8"	"Cell line enhanced"	"Detected in some"		"HEL: 5.2;HMC-1: 25.6;THP-1: 4.8;U-937: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 32.5;monocytes: 46.8"									"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"				"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavourable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	9.8	2.8	3.6	9.0	4.6	10.9	1.8	0.4	2.9	1.2	1.7	2.9	0.0	1.5	1.4	1.9	1.0	1.9	2.8	3.4	2.0	1.7	1.9	2.1	11.2	12.3	5.3	1.3	1.1	1.3	0.5	1.2	3.8	3.9	1.9	1.8	1.8	1.8	0.7	1.1	0.9	2.3	4.1	7.1	14.2	1.6	0.9	2.7	0.1	1.6	0.1	1.4	3.5	1.1	0.4	32.5	8.4	46.8	8.6	0.1	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	2.4	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	12.1	0.0	8.4	28.6	1.4	0.1	46.8	0.1	0.4	0.0	0.0	32.5	0.3	0.0	0.0	1.0	8.6	46.4	2.1	0.0	10.7	3.6	4.6	0.4	2.9	2.0	1.7	5.3	1.3	3.9	2.7
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736491	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 285.5"	"Cell line enhanced"	"Detected in many"		"TIME: 213.3;U-2197: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		98000000	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favourable (1.39e-10)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	96.7	41.0	36.7	26.3	44.3	23.8	76.0	25.9	32.7	44.8	36.9	24.0	57.9	16.5	45.4	132.8	68.4	53.2	67.6	90.5	35.6	38.4	100.0	61.0	86.4	39.8	39.7	25.8	39.3	52.3	60.6	48.0	285.5	68.7	47.4	37.7	51.4	114.8	62.6	70.6	43.4	25.0	52.4	32.9	26.2	54.7	28.1	23.1	16.1	85.9	57.7	40.0	51.2	63.4	13.5	20.5	42.8	4.8	17.7	60.4	11.1	16.5	15.5	4.6	13.5	107.8	84.5	2.7	94.2	105.1	23.6	27.7	7.2	49.8	1.2	16.8	101.4	18.7	8.5	93.9	33.2	26.3	12.9	1.7	54.9	10.8	29.4	9.9	5.7	39.2	23.8	20.0	96.4	144.0	11.6	38.3	148.6	15.1	4.6	4.1	2.5	80.9	1.7	14.4	13.3	71.3	28.3	3.2	4.3	32.8	15.2	17.3	11.6	1.0	213.3	54.3	13.0	176.7	32.6	17.0	33.2	1.6	46.7	0.0	94.3	30.5	4.8	42.8	11.3	1.6	14.4	13.5	24.0	12.7	20.5	10.6	15.7	9.3	28.4	17.7	0.9	10.5	60.4	11.1	36.7	44.3	25.9	32.7	35.6	38.4	39.7	25.8	68.7	23.1
CDH12	"Br-cadherin, CDHB"	ENSG00000154162	"Cadherin 12"	P55289	5	21750673-22853622	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.5;PC-3: 5.1;SCLC-21H: 7.4;U-2 OS: 3.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029325	Uncertain		Uncertain	Vesicles				Vesicles		"HPA029325: "	"unprognostic (2.38e-1)"	"unprognostic (3.21e-1)"		"unprognostic (4.95e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.31e-2)"		"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.25e-4)"	"unprognostic (7.35e-2)"	"unprognostic (3.48e-2)"		"unprognostic (5.19e-2)"	0.5	5.2	5.8	0.3	17.7	0.4	1.7	2.0	13.8	9.3	0.5	0.0	0.0	0.5	1.3	1.0	0.4	6.7	0.3	0.5	6.3	3.4	0.7	0.5	0.8	0.3	1.4	4.8	0.5	0.5	0.6	8.6	0.7	4.2	0.5	0.6	1.4	3.1	0.9	0.5	2.5	0.4	0.9	2.5	0.3	0.4	2.9	0.5	0.0	0.4	0.0	0.5	1.5	0.2	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.0	1.0	0.4	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.1	0.2	0.0	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	5.8	17.7	2.0	13.8	6.3	3.4	1.4	4.8	4.2	0.5
CDKAL1	FLJ20342	ENSG00000145996	"CDK5 regulatory subunit associated protein 1 like 1"	Q5VV42	6	20534457-21232404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"tRNA processing"	Transferase	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SCLC-21H: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057474			Uncertain	Vesicles				Vesicles		"HPA057474: "	"unprognostic (9.64e-2)"	"unprognostic (7.23e-3)"	"unprognostic (8.40e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.72e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	18.5	9.8	10.9	18.0	12.2	14.7	13.9	24.1	10.6	16.6	11.4	14.6	9.6	8.1	19.4	12.1	12.1	13.5	11.4	10.8	9.0	7.8	10.8	9.7	11.9	13.4	12.4	7.7	16.6	14.1	12.0	29.9	12.6	11.2	10.8	12.0	14.3	15.7	11.0	22.2	15.0	11.4	13.7	13.4	13.9	11.7	11.4	13.8	22.9	17.1	13.6	19.4	13.2	12.6	8.1	5.4	3.3	11.2	12.0	9.7	3.6	2.9	1.8	4.2	5.4	2.4	3.2	4.4	3.0	2.8	4.5	6.0	3.3	2.6	6.9	7.7	2.6	2.9	5.6	3.1	6.1	12.4	3.1	5.9	3.1	4.4	3.1	5.8	4.1	2.9	3.3	4.3	4.0	4.1	7.6	2.8	3.3	2.4	7.3	6.9	2.9	2.0	4.3	5.6	6.5	5.8	3.3	66.0	3.9	3.4	5.5	4.4	4.0	2.9	4.0	5.3	3.7	2.1	5.6	4.5	11.9	6.1	1.9	3.3	8.9	1.5	3.6	3.3	7.8	5.9	6.5	8.1	7.7	7.7	4.9	7.8	9.7	8.6	1.9	12.0	11.2	5.4	8.2	3.6	10.9	12.2	24.1	10.6	9.0	7.8	12.4	7.7	11.2	13.8
CDKL3	NKIAMRE	ENSG00000006837	"Cyclin dependent kinase like 3"	Q8IVW4	5	134286350-134371047	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA027751			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA027751: AB_10601256"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.47e-4)"	"unprognostic (2.82e-1)"	"unprognostic (9.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.43e-3)"	2.5	2.7	7.0	2.2	7.1	1.6	2.5	7.0	8.5	2.6	2.4	5.9	5.5	2.3	3.9	5.3	2.6	3.7	2.6	6.6	6.1	6.5	4.5	2.8	2.2	2.5	8.0	4.3	3.0	2.4	3.2	6.5	2.2	8.6	2.8	2.6	3.9	2.0	3.2	7.5	2.7	2.5	4.6	8.4	2.7	2.2	33.4	9.3	1.3	3.9	2.1	3.0	2.8	2.2	1.5	2.7	1.0	1.1	1.4	4.0	1.3	1.0	2.2	3.3	2.2	5.6	4.8	1.4	3.0	2.7	1.4	3.3	2.0	1.5	2.8	1.9	1.9	0.9	2.7	1.9	2.7	3.0	2.1	1.5	2.4	3.4	3.4	0.6	1.0	2.2	4.9	4.1	1.3	1.3	1.5	1.2	3.6	1.1	2.1	8.3	2.2	1.0	3.6	1.4	0.8	1.8	1.0	5.0	1.5	2.2	0.6	3.6	1.9	1.7	1.0	2.7	0.6	3.6	1.0	3.4	4.5	5.4	4.1	2.2	2.1	0.0	0.9	1.0	0.9	1.1	4.0	1.5	1.4	2.5	2.7	1.0	3.8	3.8	0.2	1.4	0.4	1.6	2.3	1.3	7.0	7.1	7.0	8.5	6.1	6.5	8.0	4.3	8.6	9.3
CFDP1	"BCNT, CENP-29, CP27, p97, SWC5, Yeti"	ENSG00000153774	"Craniofacial development protein 1"	Q9UEE9	16	75293698-75433485	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041316, HPA048242"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA041316: AB_10794371, HPA048242: "	"unprognostic (1.45e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (9.63e-5)"	"unprognostic (5.81e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.25e-1)"	21.3	33.0	38.3	23.3	32.9	18.7	28.5	31.8	35.4	35.6	24.3	19.5	24.6	18.9	37.4	40.9	21.3	36.1	18.8	19.2	33.7	40.5	40.2	26.6	20.6	16.9	33.6	28.4	54.5	26.9	20.9	53.0	38.5	32.7	28.4	25.8	21.1	23.8	25.6	25.9	20.8	22.2	33.8	38.6	18.0	19.1	38.5	29.7	27.2	28.7	12.6	21.4	26.0	41.1	20.1	28.2	33.7	27.6	15.1	37.8	15.0	16.4	12.2	41.7	15.4	38.0	42.5	12.5	16.5	19.2	21.9	31.7	21.0	22.5	15.8	24.5	20.3	18.5	32.0	26.2	44.0	6.8	15.2	16.5	11.8	44.7	26.2	17.3	14.4	26.4	22.5	26.4	32.3	23.8	22.9	7.4	24.4	37.4	25.4	38.3	20.4	6.4	46.1	17.1	27.3	24.3	9.1	25.0	21.1	27.6	5.8	22.6	24.0	30.8	14.1	15.7	17.0	16.5	10.4	14.4	22.4	59.4	15.7	23.0	13.8	28.7	27.3	33.7	19.4	27.6	27.3	19.8	26.7	21.3	28.2	20.1	24.5	23.1	22.4	15.1	25.0	28.1	37.8	15.0	38.3	32.9	31.8	35.4	33.7	40.5	33.6	28.4	32.7	29.7
CLDN14	DFNB29	ENSG00000159261	"Claudin 14"	O95500	21	36460621-36576569	"Disease related genes, Predicted membrane proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"kidney: 7.4;liver: 25.0"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 68.6"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054707			Uncertain	Vesicles				Vesicles		"HPA054707: "	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.43e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.54e-2)"	"prognostic favourable (1.53e-4)"	"unprognostic (3.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.87e-1)"	"unprognostic (7.44e-4)"	"unprognostic (2.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.71e-2)"	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.1	0.3	0.0	7.4	25.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.8	0.1	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.4	0.0	0.5	1.4	0.1	0.1	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.2	0.2	2.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	1.3	0.0	0.2	0.1	1.8	3.6	0.0	0.3	0.1	0.0	0.7	0.2	2.1	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.2	0.2	1.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0
CLN6	"FLJ20561, HsT18960, nclf"	ENSG00000128973	"CLN6, transmembrane ER protein"	Q9NWW5	15	68206992-68257211	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066046, HPA066759"	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum"	"Nucleoli, Vesicles"	"HPA066046: , HPA066759: "	"unprognostic (1.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (4.87e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.78e-2)"	21.2	17.8	11.6	16.5	11.8	29.8	13.9	14.9	20.7	14.4	20.2	13.2	11.6	17.1	11.7	14.3	16.7	12.0	17.1	10.4	11.7	10.8	22.0	29.5	18.8	27.0	11.1	12.2	12.4	19.7	11.7	11.5	18.6	14.3	13.4	18.0	28.6	16.0	17.9	16.3	17.0	18.5	12.4	11.6	26.5	15.7	13.8	9.7	27.7	14.5	18.2	21.7	11.0	10.9	2.9	4.6	9.4	13.4	1.8	4.1	2.7	11.4	28.7	7.5	10.5	4.6	3.8	18.1	11.0	5.3	13.5	11.1	22.1	18.7	17.9	5.4	6.5	21.4	21.5	10.6	5.4	11.8	26.3	25.7	20.9	16.4	9.5	28.9	18.4	6.7	3.5	10.8	7.5	9.0	16.9	36.3	10.3	31.4	13.1	20.7	17.9	12.2	12.8	22.9	24.3	11.3	30.0	15.4	6.3	12.3	19.3	10.5	10.3	28.9	5.9	15.2	18.1	11.2	38.7	26.6	28.9	14.6	9.5	35.2	14.7	0.0	7.3	0.4	2.8	11.5	3.8	2.9	2.1	4.1	4.6	2.3	2.7	1.2	9.4	1.8	13.4	3.8	1.9	2.7	11.6	11.8	14.9	20.7	11.7	10.8	11.1	12.2	14.3	9.7
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 10.9;lymphoid tissue: 10.8"	"Group enriched"	"Detected in some"	6	"HDLM-2: 9.0;U-937: 4.7"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles				Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.4	0.5	0.3	5.7	0.3	0.5	0.7	0.4	0.3	1.9	1.8	0.1	0.1	0.7	0.8	1.7	2.0	0.4	1.4	0.3	0.3	0.3	10.9	1.2	3.2	5.0	0.3	0.1	0.5	0.7	0.0	3.2	1.5	0.5	0.5	0.4	1.6	2.5	0.1	0.3	1.2	2.3	1.7	0.3	6.3	1.6	1.1	0.1	8.4	0.5	1.5	10.8	0.4	0.4	3.4	5.5	1.6	0.4	4.3	3.6	0.5	0.1	0.5	0.5	0.3	0.8	0.2	0.6	0.4	0.0	0.1	0.2	0.0	0.4	0.3	0.1	0.4	0.4	0.0	0.0	0.1	9.0	0.4	0.4	0.5	0.1	0.1	0.3	0.3	0.3	0.1	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.1	1.1	0.1	0.6	0.8	0.1	0.3	0.5	0.2	0.3	0.0	1.0	0.2	0.3	0.6	0.3	0.5	0.1	0.4	0.5	4.7	0.2	1.0	0.4	0.6	0.7	0.3	0.3	3.4	1.2	0.4	5.5	2.9	0.5	0.5	1.6	4.3	0.2	1.4	3.6	0.5	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.1	0.5	0.1
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;ovary: 59.4"	"Cell line enhanced"	"Detected in some"		"AF22: 5.7;SCLC-21H: 16.1;THP-1: 10.1"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"			9100	Vesicles	"Cytokinetic bridge"	"HPA031342: AB_10602800, HPA061800: "	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	14.2	5.0	4.9	1.0	9.8	0.8	8.5	1.5	19.7	4.1	1.8	2.4	0.3	1.2	5.2	1.8	1.6	3.6	2.6	5.9	15.4	4.0	4.5	1.5	1.7	2.8	4.1	14.3	59.4	2.0	1.5	1.3	1.5	23.7	5.4	1.4	3.0	1.6	1.8	1.9	2.1	1.5	6.6	1.4	0.8	1.4	1.9	0.5	0.0	2.9	0.5	1.0	1.9	4.7	0.3	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.1	5.7	0.0	2.5	0.6	0.1	0.7	0.0	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	2.3	0.0	0.0	0.0	2.4	10.1	0.0	1.2	0.5	1.6	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	4.9	9.8	1.5	19.7	15.4	4.0	4.1	14.3	23.7	0.5
CPLX1	CPX-I	ENSG00000168993	"Complexin 1"	O14810	4	784957-826198	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 98.8"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles				Vesicles		"HPA071191: , HPA074390: "	"unprognostic (9.21e-3)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.26e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.01e-2)"	"prognostic favourable (5.05e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.77e-2)"	7.8	6.5	13.1	2.9	40.7	1.5	2.4	26.3	98.8	2.2	2.5	3.9	0.0	2.8	4.2	1.5	1.6	2.3	1.9	3.0	16.9	7.6	2.4	2.4	2.8	2.4	16.3	18.3	2.4	3.0	3.4	1.7	1.8	52.8	4.4	1.7	3.8	4.4	2.5	4.5	3.0	2.8	2.0	5.4	5.6	3.2	4.9	4.2	0.0	1.8	0.0	1.6	1.7	1.7	0.2	2.3	0.1	0.0	0.0	0.8	0.0	2.7	0.2	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	8.0	0.8	2.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.2	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.1	1.1	0.0	1.3	1.3	0.0	0.0	0.7	0.0	0.2	42.0	5.8	0.2	2.7	0.0	4.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	2.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	13.1	40.7	26.3	98.8	16.9	7.6	16.3	18.3	52.8	4.2
CPLX2	"CPX-2, DKFZp547D155"	ENSG00000145920	"Complexin 2"	Q6PUV4	5	175796310-175884020	"Predicted intracellular proteins"	"Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.3;epididymis: 80.1"	"Group enriched"	"Detected in some"	22	"A549: 103.7;Hep G2: 62.5;SCLC-21H: 44.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles				Vesicles		"HPA071191: , HPA074390: "	"unprognostic (1.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"		"unprognostic (6.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.90e-5)"	"unprognostic (6.88e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	1.7	23.3	72.6	2.0	32.7	1.4	1.3	79.0	95.3	1.3	2.6	2.6	0.3	2.7	1.3	80.1	1.4	1.4	1.4	1.3	68.3	16.3	1.4	1.3	2.1	1.3	37.2	26.3	1.3	7.9	1.3	11.3	1.3	17.9	1.4	2.2	0.2	1.3	1.4	1.3	1.4	2.5	1.6	4.0	1.3	5.1	3.1	3.7	0.0	1.4	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	103.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	44.1	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	72.6	32.7	79.0	66.6	68.3	16.3	37.2	26.3	17.9	3.7
CPM		ENSG00000135678	"Carboxypeptidase M"	P14384	12	68842197-68971570	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.8;ASC TERT1: 20.5;HSkMC: 37.0;SiHa: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 15.5;myeloid DC: 11.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 11.9;monocytes: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002657, HPA077243"	Enhanced		Uncertain	Vesicles			5000000	Vesicles		"HPA002657: AB_1078398, HPA077243: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.00e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-1)"	56.1	6.6	3.8	5.4	7.0	1.1	37.2	1.2	4.9	6.5	12.9	13.2	0.9	1.6	10.7	6.1	4.1	6.4	6.5	2.9	5.3	3.0	22.1	11.6	24.1	13.0	10.9	4.3	7.5	7.8	3.2	1.0	27.9	5.5	6.2	10.8	2.7	3.2	1.7	8.2	13.0	3.7	2.5	6.7	11.4	5.9	5.8	9.3	1.1	5.1	3.5	4.5	4.4	4.4	2.8	11.9	1.3	15.5	0.3	1.3	4.7	0.0	1.5	0.0	0.0	28.8	20.5	0.3	3.8	0.4	0.6	0.9	1.2	1.6	0.2	3.8	0.5	0.0	0.5	1.0	1.6	0.0	1.0	0.0	6.2	0.1	0.1	0.4	0.7	37.0	0.2	0.4	0.8	0.0	0.0	0.0	2.9	0.6	0.0	0.2	0.6	2.0	1.1	0.2	0.0	2.9	2.2	0.1	0.0	27.1	4.2	3.2	0.4	10.1	0.1	0.5	3.1	0.2	0.0	0.1	0.1	4.9	1.7	5.1	2.3	0.3	15.5	0.1	0.1	10.2	0.0	1.4	1.2	0.0	11.9	2.8	0.7	0.1	1.3	0.3	4.7	0.8	1.3	4.7	3.8	7.0	1.2	4.9	5.3	3.0	10.9	4.3	5.5	9.3
CRB1	"LCA8, RP12"	ENSG00000134376	"Crumbs 1, cell polarity complex component"	P82279	1	197268204-197478455	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4"	"Cell line enriched"	"Detected in some"	8	"HeLa: 17.1"	"Cancer enriched"	"Detected in single"	12	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"basophil: 9.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA061250, HPA063127"	Approved		Uncertain	Vesicles	"Intracellular and membrane"			Vesicles		"HPA061250: , HPA063127: "	"unprognostic (1.96e-1)"	"unprognostic (5.38e-3)"		"unprognostic (2.92e-3)"	"unprognostic (1.50e-2)"	"unprognostic (5.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.96e-1)"	1.1	1.1	11.9	0.9	11.0	1.8	1.2	31.4	20.4	0.9	0.9	10.4	0.0	0.9	0.8	1.2	1.1	2.0	1.0	1.2	11.4	6.2	1.1	0.9	1.0	1.0	4.0	8.9	2.6	1.7	0.7	1.9	0.9	14.1	1.0	0.9	9.0	0.8	0.9	2.4	0.9	0.9	0.8	8.7	0.9	1.5	7.3	9.6	0.0	1.3	0.0	0.8	0.9	0.1	0.1	0.0	9.4	0.0	0.1	0.4	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	17.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.0	11.9	11.0	31.4	10.5	11.4	6.2	4.0	8.9	14.1	9.6
DERL3	"C22orf14, derlin-3, FLJ43842, IZP6, MGC71803"	ENSG00000099958	"Derlin 3"	Q96Q80	22	23834503-23839128	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;pancreas: 80.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 33.1;RPMI-8226: 19.4;U-266/70: 35.6;U-698: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 77.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 77.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037234, HPA049306"	Approved		Uncertain	Vesicles				Vesicles		"CAB037234: AB_1840802, HPA049306: "	"unprognostic (2.01e-3)"	"prognostic favourable (8.70e-5)"	"unprognostic (9.72e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.77e-3)"	"prognostic favourable (8.01e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (7.76e-13)"	"unprognostic (1.53e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-1)"	1.3	1.8	1.2	27.3	2.1	4.1	2.8	1.7	1.6	3.7	21.5	1.1	20.2	18.7	1.9	2.9	4.1	3.4	5.7	3.9	1.2	1.9	2.9	4.7	7.2	25.5	1.3	1.2	1.1	80.8	0.6	4.0	7.9	2.4	1.6	6.9	1.9	44.8	29.3	1.3	0.4	14.9	0.3	1.0	28.5	21.8	12.6	1.6	1.0	9.5	3.4	36.1	15.5	1.2	8.4	77.7	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.0	3.4	0.6	0.0	0.0	0.3	0.6	0.0	0.7	1.8	0.1	2.0	0.0	0.4	3.7	0.9	0.0	0.1	0.2	0.0	0.1	0.5	33.1	0.0	0.0	0.5	2.0	0.5	0.1	2.6	0.0	19.4	0.7	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.0	35.6	4.3	8.4	0.4	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	6.1	0.0	0.0	0.1	0.0	0.0	77.7	0.0	1.3	1.2	2.1	1.7	1.6	1.2	1.9	1.3	1.2	2.4	1.6
DHRS4L2	SDR25C3	ENSG00000187630	"Dehydrogenase/reductase 4 like 2"	Q6PKH6	14	23969874-24006408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023972	Uncertain		Uncertain	"Nuclear membrane,Vesicles"	"Secreted - unknown location"			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.41e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-3)"	"unprognostic (7.34e-2)"	"prognostic favourable (3.21e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.65e-2)"	6.3	11.2	6.9	12.8	7.9	3.0	11.4	14.6	9.6	7.2	9.9	3.4	2.6	12.1	5.6	10.4	25.5	5.4	4.3	8.9	5.0	4.1	42.0	33.0	16.7	7.2	4.6	2.4	7.1	28.4	6.0	5.2	3.1	7.6	8.3	9.5	5.4	14.2	10.9	18.7	9.8	14.9	6.4	5.6	8.1	7.1	28.2	4.5	13.8	5.9	32.8	14.5	5.3	7.1	10.4	22.3	3.2	27.2	7.9	11.5	14.7	8.5	12.8	2.2	10.9	21.3	22.3	0.2	7.7	15.2	11.2	8.4	3.7	10.1	5.5	5.3	15.4	9.3	9.9	12.8	9.4	18.1	5.9	1.3	11.1	22.9	15.7	7.1	22.1	23.0	16.3	7.3	10.8	13.1	4.3	19.8	12.0	26.7	17.6	7.3	4.4	14.2	27.8	9.0	17.3	16.1	11.3	11.9	7.2	10.5	9.7	6.4	11.8	10.6	9.2	5.9	6.2	7.0	3.8	11.6	9.1	1.6	5.1	10.3	8.4	2.3	27.2	3.2	10.1	22.5	10.4	10.4	10.8	11.5	22.3	8.2	11.1	10.1	1.3	7.9	13.2	18.3	10.3	14.7	6.9	7.9	14.6	9.6	5.0	4.1	4.6	2.4	7.6	4.5
DLG1	"dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97"	ENSG00000075711	"Discs large MAGUK scaffold protein 1"	Q12959	3	197042560-197299300	"Predicted intracellular proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016307, HPA069593"	Supported		Uncertain	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"CAB016307: AB_2092015, HPA069593: "	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.56e-3)"	"unprognostic (3.54e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-1)"	12.3	12.6	30.0	10.2	34.5	9.6	14.2	42.1	37.7	19.9	17.8	32.3	17.0	16.1	15.4	8.8	30.2	12.7	12.9	13.8	26.9	19.2	21.0	18.6	12.9	10.6	32.9	27.3	18.7	11.9	28.2	19.8	15.1	29.1	12.1	20.2	10.4	16.5	14.7	18.7	13.7	18.4	15.3	32.2	8.8	16.7	11.1	39.4	14.7	34.6	13.9	14.8	13.8	15.7	3.7	2.9	2.9	1.0	1.4	3.9	1.5	46.9	7.4	14.8	26.8	12.2	11.5	15.1	16.8	15.4	16.9	19.9	21.7	20.3	13.7	48.2	16.6	31.0	13.5	26.1	32.6	3.7	9.0	12.0	11.5	15.8	12.1	11.9	11.9	10.3	14.2	15.5	34.0	21.2	9.7	16.7	40.6	18.2	17.7	4.6	11.6	14.3	9.5	17.9	9.8	17.6	19.9	7.3	12.3	26.3	17.5	19.1	40.0	9.2	20.1	45.9	12.1	12.6	28.3	26.5	19.0	17.8	16.9	18.2	14.3	0.0	0.9	2.9	1.5	1.0	3.9	3.7	2.9	2.7	2.2	2.0	3.0	3.1	1.1	1.4	0.4	2.9	2.9	1.5	30.0	34.5	42.1	37.7	26.9	19.2	32.9	27.3	29.1	39.4
DOK4	FLJ10488	ENSG00000125170	"Docking protein 4"	Q8TEW6	16	57471922-57487327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.6;CACO-2: 29.1;SH-SY5Y: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"gdT-cell: 1.4;neutrophil: 4.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.3;T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055849	Supported		Uncertain	"Vesicles,Microtubules,Cytokinetic bridge"				Microtubules	"Vesicles, Cytokinetic bridge"	"HPA055849: "	"unprognostic (3.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.18e-3)"	5.0	4.6	7.8	9.5	4.5	0.7	13.6	15.6	6.9	14.2	29.2	2.0	17.7	24.4	9.9	11.8	15.5	8.1	21.0	7.3	5.0	6.9	27.1	25.8	12.3	1.9	3.4	4.7	12.8	14.8	7.2	10.1	6.6	5.2	12.9	16.9	8.4	7.5	15.0	3.1	22.7	51.5	9.6	2.1	5.1	19.9	8.4	2.9	1.9	8.6	12.9	6.3	8.8	14.1	0.5	0.1	4.3	0.0	0.1	1.4	0.2	2.7	25.6	4.1	7.4	5.8	6.5	4.6	4.8	6.4	3.4	1.0	29.1	14.5	0.2	21.1	10.0	5.7	2.5	1.3	1.5	0.7	1.9	5.9	7.5	16.7	8.3	0.0	0.6	4.5	3.9	4.5	0.5	5.2	1.9	1.2	4.1	2.6	0.3	1.1	2.6	1.1	2.3	2.1	0.3	18.0	1.0	20.5	67.0	3.9	1.7	1.2	1.5	1.1	5.5	0.6	4.3	1.7	0.2	0.8	1.0	0.2	1.9	1.2	2.5	0.0	0.0	0.0	1.4	0.0	0.6	0.1	0.3	0.2	0.1	0.5	0.4	0.3	4.3	0.1	0.0	0.0	0.1	0.2	7.8	4.5	15.6	6.9	5.0	6.9	3.4	4.7	5.2	2.9
EEF2KMT	"EFM3, FAM86A, MGC19636, SB153"	ENSG00000118894	"Eukaryotic elongation factor 2 lysine methyltransferase"	Q96G04	16	5084304-5097808	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA041610	Approved		Uncertain	Vesicles				Vesicles		"HPA041610: "	"unprognostic (4.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"prognostic unfavourable (8.85e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (2.35e-4)"	4.8	6.1	4.8	4.3	15.5	0.8	11.6	4.4	7.5	5.6	4.6	4.4	2.2	6.7	6.5	4.4	5.4	5.7	3.6	5.7	5.8	4.5	4.9	8.0	8.6	3.9	4.2	4.3	5.8	13.9	10.4	5.0	2.9	7.5	4.4	4.8	2.6	5.9	6.2	7.0	4.5	3.5	7.1	3.8	4.7	4.9	27.0	4.8	3.8	6.1	5.2	4.3	5.3	3.8	9.4	7.0	6.5	11.0	7.0	13.7	5.1	2.4	6.2	3.9	6.6	4.8	3.9	5.0	4.7	3.3	5.9	3.7	4.7	6.5	6.7	2.9	5.9	4.4	7.2	7.2	4.3	7.5	5.2	2.9	3.4	7.8	5.9	7.0	4.6	4.3	5.4	6.8	12.1	5.8	5.2	6.4	4.9	16.4	2.7	3.9	6.4	3.2	6.7	4.4	41.3	6.4	3.0	4.6	3.6	6.1	8.5	3.4	5.3	2.4	2.6	8.1	5.1	23.9	4.7	4.3	4.8	4.7	2.3	4.8	7.0	6.5	5.6	0.4	7.6	10.1	12.5	9.4	7.9	8.8	7.0	7.2	5.6	9.9	0.8	7.0	11.0	1.9	13.7	5.1	4.8	15.5	4.4	7.5	5.8	4.5	4.2	4.3	7.5	4.8
EGR3	PILOT	ENSG00000179388	"Early growth response 3"	Q06889	8	22687659-22693302	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.5;HMC-1: 7.3;MCF7: 23.9;SK-MEL-30: 16.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	10	"amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2"	"Group enriched"	"Detected in many"	9	"amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0"	"HPA006206, CAB009373"	Uncertain		Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB009373: AB_2097202, HPA006206: AB_10602491"	"prognostic favourable (1.83e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.44e-2)"	"prognostic favourable (4.78e-4)"	"unprognostic (3.48e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.07e-2)"	20.7	17.7	11.5	12.3	33.6	5.6	7.1	0.8	35.0	7.4	3.3	11.1	0.2	0.9	3.8	1.0	4.0	14.6	20.6	8.5	13.7	2.0	3.0	2.0	4.1	7.3	1.9	12.8	10.6	2.9	12.8	5.0	1.2	3.6	10.3	2.2	2.6	2.3	4.0	1.6	28.4	3.6	8.3	1.6	2.8	5.3	4.1	2.1	5.5	5.8	1.3	5.8	12.3	2.5	0.8	0.0	2.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	1.4	4.5	0.1	0.4	0.5	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.3	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.3	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.0	23.9	0.0	0.2	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.1	0.4	0.0	16.0	1.1	0.0	0.0	0.2	0.1	0.2	0.3	0.3	0.0	0.0	0.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	11.5	33.6	0.8	35.0	13.7	2.0	1.9	12.8	3.6	2.1
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.9;brain: 22.6;lymphoid tissue: 21.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.6;MCF7: 3.4;SCLC-21H: 6.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in some"	20	"cerebellum: 22.6"	"Group enriched"	"Detected in many"	7	"gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9"	"Group enriched"	"Detected in many"	102	"NK-cells: 17.9;T-cells: 16.5"	"Region enriched"	"Detected in some"	8	"olfactory region: 95.2"	"Group enriched"	"Detected in some"	13	"cerebellum: 44.2;olfactory region: 21.9"	"HPA028896, HPA077118"	Uncertain		Uncertain	Vesicles				Vesicles		"HPA028896: AB_10601370, HPA077118: "	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.4	0.7	0.5	6.8	0.4	1.6	1.6	22.6	0.4	1.8	0.8	0.0	0.0	0.3	3.2	0.9	1.4	0.6	5.0	0.7	0.4	0.7	1.0	4.9	10.1	15.6	0.5	0.3	1.3	0.9	0.0	0.6	1.6	1.1	2.1	0.9	3.3	2.2	0.1	0.4	0.4	1.8	0.7	0.9	21.4	1.4	0.5	0.0	1.8	1.1	0.9	11.2	3.3	0.8	0.0	0.0	0.1	0.0	17.9	16.5	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	2.2	0.0	11.6	1.7	0.0	0.1	0.9	0.0	1.4	0.0	0.1	1.4	0.0	1.6	0.0	0.3	0.0	0.0	3.4	3.1	0.0	0.4	1.4	2.1	0.0	0.0	1.1	0.0	6.5	0.0	0.0	0.0	1.3	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	10.0	0.0	16.5	0.0	1.9	12.0	0.0	0.0	0.1	7.5	0.1	17.9	0.0	0.0	0.0	1.4	0.5	0.4	22.6	0.4	0.4	0.7	0.5	0.3	1.1	0.0
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276547	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.7;skeletal muscle: 32.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.1;HEL: 17.1;HL-60: 16.9;NB-4: 26.6;THP-1: 23.8;U-937: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"			"Nucleoplasm, Vesicles"		"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favourable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favourable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	4.9	1.5	2.9	9.3	4.6	12.4	2.5	1.1	4.3	1.0	1.6	3.4	0.8	1.8	1.2	1.1	1.1	1.1	2.0	19.2	3.8	2.0	2.1	2.5	8.0	18.4	4.3	1.0	1.8	0.8	0.8	1.0	5.8	3.2	1.3	1.1	5.4	2.7	0.7	32.3	0.8	6.1	1.2	3.6	15.9	2.3	20.1	2.4	23.7	1.5	1.8	15.0	3.1	0.8	14.4	5.2	14.5	10.9	2.5	10.5	6.9	0.3	0.1	1.1	2.5	0.8	0.2	18.1	0.2	0.1	0.2	0.1	0.1	0.1	7.5	0.1	0.1	0.0	7.3	0.1	0.0	1.9	0.6	17.1	0.2	0.1	0.3	16.9	0.7	0.2	0.3	0.0	0.0	10.0	6.0	2.1	0.2	2.6	0.7	26.6	1.2	0.2	1.8	1.0	10.5	0.1	0.0	0.7	0.9	1.0	0.3	1.0	0.6	23.8	0.2	1.0	1.1	0.6	0.0	1.6	0.8	4.4	0.1	15.9	0.2	0.4	8.6	14.5	8.6	10.9	6.8	12.5	8.3	9.3	5.2	14.4	10.5	8.7	8.8	2.5	8.1	2.4	8.2	6.9	2.9	4.6	1.1	4.3	3.8	2.0	4.3	1.0	3.2	2.4
FAM86B1	MGC16279	ENSG00000186523	"Family with sequence similarity 86 member B1"	Q8N7N1	8	12182096-12194133	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 7.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 5.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041610, HPA055718"	Uncertain		Uncertain	Vesicles				Vesicles		"HPA041610: , HPA055718: "	"unprognostic (1.90e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.58e-2)"	0.9	2.0	3.2	1.0	6.9	1.2	0.7	4.8	7.5	0.8	0.5			2.2	4.0	1.3	1.2	2.8	1.3	1.1	3.3	4.1	1.3	0.1	1.2	0.7	2.8		5.0	0.9	2.0	5.4	0.3		2.6	0.0		2.4	1.0	2.0	3.0	0.7	0.1	2.3	1.4	0.3	0.6			2.6		0.0	0.8	1.1	0.2	0.6	0.9	0.1	0.0	0.8	0.2	0.5	2.8	0.0	5.7	0.0	0.7	2.4	4.6	0.3	1.0	0.7	1.6	1.3	1.0	0.2	0.2	4.8	0.9	0.8	0.8	0.5	0.7	0.2	0.7	0.8	3.0	1.9	2.1	0.3	0.4	0.5	1.3	0.2	1.6	1.6	0.2	2.6	0.0	1.3	1.8	0.4	1.5	0.9	0.7	0.3	1.3	4.7	0.9	0.9	0.5	0.6	2.1	0.0	0.0	1.0	0.9	3.9	1.6	0.6	1.3	0.6	0.8	0.1	0.7	0.8	0.1	0.7	0.1	0.0	0.7	0.2	0.8	0.5	0.3	0.0	0.6	0.7	0.9	0.0	0.0	0.6	0.4	0.2										
FAM86B2		ENSG00000145002	"Family with sequence similarity 86 member B2"	P0C5J1	8	12425614-12436343	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 4.6"	"Group enriched"	"Detected in some"	7	"hTERT-HME1: 6.2;RPMI-8226: 18.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA041610, HPA055718"	Uncertain		Uncertain	Vesicles				Vesicles		"HPA041610: , HPA055718: "	"unprognostic (3.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.04e-4)"	"unprognostic (9.37e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.13e-2)"	0.4	0.9	0.2	0.4	0.7	0.0	0.8	0.2	0.3	0.8	0.8			0.4	1.0	0.0	3.9	4.6	0.7	0.1	0.2	0.5	1.1	0.5	0.6	0.1	0.2		1.3	1.1	0.6	2.2	0.1		0.6	0.6		0.5	1.8	0.3	1.2	0.0	0.6	0.0	0.0	0.4	0.1			3.4		0.1	1.0	0.6	0.4	1.3	0.0	0.9	0.6	2.1	0.3	0.2	1.3	0.2	0.0	0.3	1.4	1.4	0.2	0.7	0.5	1.3	0.5	1.3	0.8	0.0	1.4	0.2	1.0	1.7	0.0	0.0	0.0	0.2	1.7	0.0	1.2	0.0	0.0	0.4	1.5	1.4	6.2	0.0	1.2	0.2	0.1	0.4	0.0	0.4	1.2	0.4	0.2	0.7	18.1	0.0	1.2	1.8	0.0	0.5	1.4	0.3	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.5	0.4	0.9	1.1	1.3	0.4	0.4	0.3	0.0	0.6	0.9	0.0	2.1	0.3										
FO393400.1		ENSG00000285382			20	32632183-32743567	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in single"	31	"HEL: 12.9"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA054119			Uncertain	Vesicles				Vesicles		"HPA054119: "																		3.3	2.9	2.8	2.4	3.0	3.1	3.3	3.8	5.1	2.2	2.2	2.6	4.2	1.9	3.3	4.4	2.4	3.6	2.5	4.4	2.2		3.7	4.6	3.2	2.1	1.4	4.2	3.5	4.3	2.6	1.6	5.4	2.3	3.0	2.0	3.2	3.5	3.1	3.1	3.9	2.6	4.0	0.8	2.5	3.0	3.3	2.0	1.3	6.5	2.0	2.9	3.9	1.7	1.0	0.8	1.6	0.3	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.3	0.8	0.4	0.2	0.3	0.4	0.3	0.3	0.1	1.0	0.3	0.6	0.5	0.6	0.2	0.8	0.5	0.2										
FOSB	"AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291"	ENSG00000125740	"FosB proto-oncogene, AP-1 transcription factor subunit"	P53539	19	45467995-45475179	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 14.6;hTCEpi: 9.1;Karpas-707: 7.5;SK-BR-3: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.1;basal ganglia: 4.2;cerebral cortex: 5.3;hippocampal formation: 4.5;olfactory region: 8.8"	"Low region specificity"	"Detected in many"			"CAB010267, HPA054663"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB010267: AB_640583, HPA054663: "	"unprognostic (7.22e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.72e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.04e-2)"	72.7	13.0	2.3	111.4	7.4	39.2	10.0	5.5	7.7	62.9	9.0	14.9	2.2	1.7	32.1	6.1	18.9	135.1	102.6	14.1	2.5	2.9	3.4	8.6	22.9	6.0	2.0	1.2	29.1	12.2	8.1	8.1	129.0	8.5	12.2	7.9	38.6	8.7	59.1	2.2	59.5	10.8	36.3	2.5	2.6	30.5	21.7	1.3	4.0	33.6	114.5	8.2	16.7	4.4	0.2	1.7	9.0	1.6	0.2	0.7	0.2	0.4	0.8	0.2	0.3	1.3	0.3	2.4	2.5	1.1	0.8	0.7	0.5	1.0	2.1	0.4	1.6	0.9	0.5	1.7	0.5	0.3	0.8	0.6	0.8	0.4	0.9	1.2	14.6	0.5	9.1	1.9	2.1	1.0	0.8	7.5	0.2	0.2	0.2	1.2	0.5	0.4	0.6	0.1	1.4	0.7	1.4	3.4	0.4	1.5	10.7	1.3	0.6	0.8	0.2	0.6	0.7	1.2	0.8	5.6	0.7	0.6	1.2	0.8	1.4	1.5	1.6	1.7	0.3	0.2	0.7	0.1	0.4	0.3	1.7	0.2	0.0	0.0	9.0	0.2	0.1	0.1	0.1	0.2	2.3	7.4	5.5	7.7	2.5	2.9	2.0	1.2	8.5	1.3
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109725	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 37.0;salivary gland: 12.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HaCaT: 1.4;MCF7: 5.3;SCLC-21H: 1.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	48	"eosinophil: 4.7"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Uncertain	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"HPA071469: "	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	37.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.3	0.0	0.0	12.4	3.7	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.4	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXK2	"ILF, ILF1"	ENSG00000141568	"Forkhead box K2"	Q01167	17	82519713-82644662	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027523, HPA073491"	Approved		Supported	Nucleoplasm,Vesicles,Mitochondria				Nucleoplasm	"Vesicles, Mitochondria"	"HPA027523: AB_10601013, HPA073491: "	"unprognostic (2.39e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.24e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	16.8	21.2	17.5	14.3	19.2	8.7	19.1	21.3	30.5	17.7	17.1	17.1	16.9	11.2	22.2	13.7	24.2	14.6	13.4	17.1	14.9	14.9	13.0	13.6	15.2	13.6	13.7	17.2	17.6	19.2	25.4	19.8	18.6	15.6	14.9	11.7	13.8	17.1	16.3	41.5	21.6	12.6	19.9	10.3	13.2	15.5	32.3	15.8	21.8	18.6	12.4	13.9	16.4	16.4	4.0	5.9	4.1	2.9	4.1	4.4	1.6	21.4	22.9	21.5	23.4	12.4	13.7	14.3	12.6	14.5	22.1	22.5	22.2	13.8	18.3	9.2	15.6	12.5	22.9	14.5	21.0	12.5	21.9	18.9	15.1	21.9	19.6	21.0	12.7	12.9	26.7	23.4	26.7	22.3	25.2	18.8	12.1	12.8	35.8	13.4	12.3	17.6	23.5	18.4	15.1	10.1	18.1	35.6	26.3	12.5	31.9	29.7	22.4	24.4	17.4	29.2	20.5	19.5	25.4	21.7	19.2	23.7	15.8	17.6	15.3	4.1	2.9	3.3	4.4	2.2	3.5	4.0	3.3	4.2	3.3	2.8	2.6	2.9	0.5	4.1	2.3	5.9	3.4	1.6	17.5	19.2	21.3	30.5	14.9	14.9	13.7	17.2	15.6	15.8
FPGT	GFPP	ENSG00000254685	"Fucose-1-phosphate guanylyltransferase"	O14772	1	74198212-74234086	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072331			Uncertain	Vesicles				Vesicles		"HPA072331: "	"unprognostic (1.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.18e-3)"	"unprognostic (4.32e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (1.86e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.91e-1)"	14.6	11.6	10.9	9.1	12.6	3.4	13.0	19.0	15.8	15.9	11.7	13.0	7.5	11.5	17.7	11.1	15.7	15.4	13.3	12.8	10.9	7.1	15.9	13.7	10.8	8.0	15.5	10.6	14.1	10.2	14.2	27.7	10.6	14.4	11.1	11.3	10.6	11.7	9.1	15.7	12.0	12.0	11.8	16.3	11.0	12.3	8.7	13.9	6.6	20.0	6.8	9.2	17.9	12.9	4.3	9.2	15.2	14.9	3.8	5.4	7.4	9.2	7.7	5.8	8.5	13.5	12.7	8.7	12.2	8.1	8.4	10.0	4.3	7.0	5.7	15.1	7.2	7.8	10.4	11.1	13.4	11.5	4.4	12.9	9.3	7.2	11.3	9.8	9.9	10.4	14.5	8.4	4.0	8.7	13.2	6.8	13.2	2.4	5.4	2.0	6.3	7.0	5.8	13.6	8.0	7.4	6.7	6.1	6.1	9.0	13.2	14.0	15.9	11.2	7.8	3.7	7.1	20.2	9.2	7.5	5.3	7.6	15.0	9.7	12.5	12.0	14.9	15.2	4.3	14.5	5.0	3.6	4.4	3.9	9.2	4.3	4.9	4.4	4.4	3.8	12.5	0.9	5.4	7.4	10.9	12.6	19.0	15.8	10.9	7.1	15.5	10.6	14.4	13.9
FTCDNL1	FONG	ENSG00000226124	"Formiminotransferase cyclodeaminase N-terminal like"	E5RQL4	2	199760544-199851173	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA065748			Uncertain	Vesicles	"Secreted in other tissues"			Vesicles		"HPA065748: "	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (9.86e-2)"	"prognostic favourable (3.31e-4)"	"unprognostic (3.92e-2)"	"unprognostic (4.63e-2)"	"prognostic unfavourable (5.74e-4)"	"unprognostic (1.21e-2)"	4.5	9.4	5.5	1.8	19.0	4.0	4.2	1.6	12.0	1.7	2.3	9.7	2.6	2.1	1.2	3.9	2.9	3.9	2.0	5.3	5.8	4.8	8.0	17.9	2.8	3.5	7.6	7.5	2.4	4.3	1.9	2.0	1.5	7.9	2.8	2.5	2.7	4.8	1.7	13.1	2.4	1.8	3.4	9.1	8.0	2.1	2.8	4.0	0.1	11.0	2.4	1.8	1.6	1.9	3.8	10.6	2.0	6.2	1.2	2.4	1.9	0.7	2.4	0.1	0.1	2.5	1.5	1.8	0.9	0.9	1.3	0.5	0.0	4.4	2.5	0.3	1.0	0.0	1.1	6.5	1.5	3.0	0.8	1.9	1.0	2.1	0.9	6.4	8.2	1.1	0.3	0.5	0.1	0.0	3.4	0.1	0.9	7.5	2.4	2.6	2.1	5.1	0.4	0.2	0.1	0.5	0.0	3.0	0.0	4.2	4.0	4.1	6.0	8.6	0.7	3.5	0.0	2.2	1.5	6.5	3.5	1.4	6.5	3.3	1.7	0.0	5.3	2.0	0.6	6.2	2.3	3.8	2.2	0.8	6.9	2.1	1.5	2.4	0.0	1.2	5.6	10.6	0.0	1.9	5.5	19.0	1.6	12.0	5.8	4.8	7.6	7.5	7.9	4.0
GABRD		ENSG00000187730	"Gamma-aminobutyric acid type A receptor delta subunit"	O14764	1	2019298-2030758	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"brain: 87.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;HMC-1: 2.5;MCF7: 8.2;NB-4: 5.2;SH-SY5Y: 3.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 87.0"	"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044371	Enhanced		Uncertain	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA044371: "	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-8)"	"unprognostic (6.34e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (4.12e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.16e-2)"	1.2	3.4	8.8	0.9	16.8	1.0	1.0	87.0	40.0	1.0	1.2	1.7	0.0	0.9	1.3	1.2	1.3	1.0	1.5	1.7	6.0	1.7	1.1	0.9	1.4	1.3	3.3	11.1	0.9	0.9	1.4	0.7	1.2	17.1	1.0	1.0	0.0	1.1	0.9	1.3	1.4	1.0	1.4	1.4	1.0	1.0	3.3	1.5	0.0	1.6	0.0	1.0	1.2	0.1	0.0	1.2	0.2	0.1	0.0	0.0	0.8	0.0	0.7	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	5.2	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.1	0.0	0.0	1.1	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.8	8.8	16.8	87.0	40.0	6.0	1.7	3.3	11.1	17.1	1.5
GFRA2	"GDNFRB, NTNRA, RETL2, TRNR2"	ENSG00000168546	"GDNF family receptor alpha 2"	O00451	8	21690403-21812357	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;thyroid gland: 17.4"	"Cell line enhanced"	"Detected in some"		"HEL: 8.8;HMC-1: 20.2;WM-115: 3.7"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 6.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 10.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.1;monocytes: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024704, CAB032791"	Uncertain		Uncertain	Vesicles	"Intracellular and membrane"		3300000	Vesicles		"CAB032791: AB_2110428, HPA024704: AB_1849629"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.48e-4)"	"unprognostic (2.87e-1)"	"unprognostic (6.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (2.11e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.68e-2)"	"unprognostic (9.63e-3)"	4.2	3.4	2.6	3.4	6.7	1.2	1.4	2.1	19.2	4.9	3.6	0.7	2.6	3.4	1.3	4.0	3.0	4.3	1.2	3.2	6.8	8.9	1.1	1.9	2.2	4.3	4.3	7.1	1.0	0.9	0.2	2.0	11.5	3.2	1.3	2.0	3.7	2.0	4.9	0.4	1.2	3.2	3.5	1.9	12.2	2.2	6.7	0.2	1.0	17.4	0.0	1.5	2.4	2.6	0.1	3.1	0.9	10.9	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.4	0.9	0.0	10.9	0.0	0.0	0.0	0.0	3.1	0.1	0.2	0.0	0.5	0.0	1.4	0.0	0.0	0.9	2.6	6.7	2.1	19.2	6.8	8.9	4.3	7.1	3.2	0.2
GLIPR2	"C9orf19, GAPR-1"	ENSG00000122694	"GLI pathogenesis related 2"	Q9H4G4	9	36136536-36163913	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.4;HDLM-2: 25.2;TIME: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029478	Approved		Uncertain	Vesicles,Microtubules			18000000	Vesicles	Microtubules	"HPA029478: AB_10670038"	"unprognostic (1.57e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavourable (6.54e-7)"	"unprognostic (6.57e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-2)"	28.5	10.8	8.1	25.5	12.1	32.5	15.6	5.7	11.2	19.9	32.4	23.3	9.1	7.5	40.3	16.8	16.3	18.7	13.0	11.7	9.4	7.1	4.9	3.5	31.2	26.5	14.7	6.5	13.4	2.8	0.4	2.9	4.7	12.3	20.1	17.1	11.6	7.9	21.3	4.8	6.1	14.9	35.5	21.8	21.1	13.8	5.0	13.2	10.1	10.6	7.4	9.4	19.2	14.2	3.3	28.8	92.9	48.6	15.8	24.8	45.5	1.2	1.0	7.5	7.9	26.4	12.6	0.8	12.0	7.2	2.8	5.1	0.4	0.1	0.0	3.7	10.8	0.0	2.7	0.4	1.7	25.2	2.3	3.0	2.4	0.1	10.5	1.9	10.3	8.5	0.3	16.1	2.8	22.2	0.1	1.8	6.4	2.8	9.4	5.2	7.2	3.8	6.5	15.9	0.3	0.6	0.6	2.0	4.1	1.5	0.7	1.2	0.8	8.3	44.7	3.9	9.1	3.5	9.7	2.8	0.7	4.3	4.0	12.2	0.9	30.1	48.6	71.9	24.8	22.3	13.1	3.2	17.2	15.8	28.8	3.3	7.3	11.5	92.9	15.8	16.2	2.5	17.6	45.5	8.1	12.1	5.7	9.8	9.4	7.1	14.7	6.5	12.3	13.2
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144663-79175315	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 73.8"	"Cell line enriched"	"Detected in some"	7	"MOLT-4: 41.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA041025	Enhanced		Uncertain	Vesicles				Vesicles		"HPA041025: AB_10794260"	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	2.2	0.5	0.4	20.3	0.4	2.6	1.3	0.3	0.4	2.4	5.1	0.0	0.5	2.1	1.6	0.9	2.6	0.9	1.9	1.0	0.4	0.4	1.9	1.7	8.2	16.6	0.5	0.0	1.0	0.7	0.0	1.1	0.3	0.2	1.7	2.0	1.6	3.8	0.1	0.5	0.7	9.1	0.2	1.0	21.0	2.2	0.5	0.0	73.8	2.5	1.6	28.1	5.1	1.8	4.0	1.8	6.0	9.1	6.5	8.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	41.8	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	6.0	0.0	4.7	5.7	3.4	1.7	4.0	7.5	8.6	0.1	3.9	6.1	6.8	0.4	6.5	9.1	1.8	7.6	2.7	0.4	0.4	0.3	0.4	0.4	0.4	0.5	0.0	0.2	0.0
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696585	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"intestine: 85.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.1;CAPAN-2: 4.5;SiHa: 4.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles				Vesicles		"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavourable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.2	0.1	0.2	3.4	0.2	0.0	0.2	0.2	0.2	0.2	38.8	0.2	0.2	28.0	0.3	0.2	0.4	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.2	17.5	0.2	0.5	0.2	0.2	1.0	85.1	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	4.3	0.7	2.7	1.7	0.0	0.0	0.6	1.1	0.1	0.0	3.7	0.0	0.0	2.2	0.1	0.0	0.0	0.0	3.1	4.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.5	4.2	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.1	1.3	0.8	1.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.5	0.0	4.3	0.0	0.0	0.7	2.3	0.0	0.0	2.7	0.0	0.0	0.7	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.8"	"Group enriched"	"Detected in some"	8	"HEL: 31.6;HMC-1: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol			170000	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	14.3	2.9	8.0	1.6	12.1	1.6	5.8	2.0	7.7	5.4	6.9	4.4	0.2	7.5	4.7	3.3	4.1	2.5	9.3	3.0	8.4	3.6	2.5	1.3	12.7	0.9	9.6	2.4	1.5	1.8	1.7	1.5	24.8	9.0	6.4	7.5	2.9	3.8	2.2	1.4	5.8	8.6	5.8	14.6	1.4	4.4	1.8	12.1	1.5	1.2	2.8	1.5	4.5	3.5	0.0	0.1	15.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	2.4	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	8.0	12.1	2.0	7.7	8.4	3.6	9.6	2.4	9.0	12.1
HSDL1	SDR12C3	ENSG00000103160	"Hydroxysteroid dehydrogenase like 1"	Q3SXM5	16	84122146-84145192	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045745			Approved	"Vesicles,Intermediate filaments,Mitochondria"				Mitochondria	"Vesicles, Intermediate filaments"	"HPA045745: "	"unprognostic (2.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (3.50e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.66e-1)"	"prognostic favourable (4.20e-7)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.14e-2)"	6.0	13.4	16.9	5.6	22.1	3.1	10.2	16.5	18.7	9.7	5.8	9.0	6.7	5.1	11.3	9.4	6.7	11.1	6.0	13.1	14.5	19.5	9.1	4.1	7.6	6.8	11.5	13.2	19.6	4.3	12.6	16.7	7.6	20.8	8.6	6.1	10.5	6.3	10.0	15.2	6.5	4.9	9.4	7.4	7.0	5.3	13.5	8.7	8.6	23.2	5.0	7.5	6.6	6.2	7.4	3.1	14.5	6.6	4.2	6.5	4.4	5.6	6.5	30.2	10.3	11.0	7.9	7.6	7.3	6.8	9.1	4.8	7.3	9.7	11.6	13.0	6.4	3.9	16.3	6.3	14.5	2.4	10.0	5.6	4.3	16.5	11.5	8.6	10.1	6.1	10.6	12.7	8.3	10.8	11.5	14.6	17.9	13.9	18.7	8.6	15.3	6.8	18.4	10.6	4.3	8.7	6.2	14.2	10.8	18.0	2.9	19.7	18.0	5.1	9.2	10.3	12.4	7.4	5.7	23.3	18.4	18.9	12.0	6.3	9.3	14.5	5.2	11.7	4.4	3.8	5.6	5.4	4.7	5.2	3.1	7.4	6.1	6.5	6.2	4.2	6.6	0.0	5.6	4.4	16.9	22.1	16.5	18.7	14.5	19.5	11.5	13.2	20.8	8.7
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;parathyroid gland: 16.6;placenta: 12.2"	"Group enriched"	"Detected in some"	5	"AF22: 42.5;CACO-2: 10.7;Hep G2: 33.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015713			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.2	0.6	3.5	0.4	2.1	0.2	1.7	10.8	4.6	1.0	0.5	3.3	0.0	0.3	1.6	0.4	0.2	1.4	0.4	0.4	3.2	2.6	0.6	0.2	0.3	0.2	2.5	1.7	1.7	0.3	16.6	2.9	12.2	2.6	0.5	0.3	0.6	0.2	0.5	0.5	0.4	0.3	0.6	2.2	0.3	0.4	4.7	2.7	3.7	1.7	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.7	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.1	10.8	4.6	3.2	2.6	2.5	1.7	2.6	2.7
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 30.3;HaCaT: 11.3;HBEC3-KT: 6.2;MCF7: 5.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"pons and medulla: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"pons and medulla: 1.9"	HPA064094			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.2	0.1	0.1	0.1	0.3	5.1	0.1	0.2	2.4	0.1	0.1	0.1	0.1	0.1	0.1	11.2	0.1	0.1	11.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	2.7	7.8	0.1	0.1	6.7	0.1	1.2	14.2	0.1	1.0	0.1	0.1	0.1	1.7	0.1	0.1	0.1	2.5	2.1	0.1	7.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.7	0.1
ITPR3	IP3R3	ENSG00000096433	"Inositol 1,4,5-trisphosphate receptor type 3"	Q14573	6	33620365-33696574	"Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"basophil: 1.8;gdT-cell: 2.8;MAIT T-cell: 2.1;memory B-cell: 1.5;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.0;naive B-cell: 2.0;naive CD4 T-cell: 1.4;naive CD8 T-cell: 1.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	10	"B-cells: 2.0;granulocytes: 1.8;T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003915, HPA064704"	Approved		Uncertain	Vesicles				Vesicles		"HPA003915: AB_1851845, HPA064704: "	"unprognostic (2.57e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.08e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-2)"	7.8	6.0	2.0	17.8	2.4	2.6	9.0	1.7	2.3	6.5	39.6	1.0	35.1	14.8	7.7	15.6	10.0	6.7	28.9	7.2	1.8	1.4	8.6	1.2	21.0	9.7	4.4	1.2	7.3	11.0	1.3	3.9	3.9	4.0	7.2	9.5	5.4	12.7	26.0	2.7	27.9	44.0	6.6	3.5	20.0	21.4	20.1	1.9	10.6	28.4	9.7	18.1	5.2	16.5	2.0	0.2	1.8	0.0	0.1	2.8	0.7	21.7	10.2	1.9	0.1	1.9	6.1	12.7	7.5	19.2	9.4	8.6	14.0	17.0	18.6	8.1	5.4	21.5	8.7	20.2	4.9	10.8	7.3	0.0	29.1	15.4	4.4	3.3	2.4	4.4	18.4	23.7	51.6	15.9	7.2	6.0	10.1	10.4	5.5	1.9	1.9	15.1	8.5	0.0	10.9	33.6	15.3	17.8	0.6	12.9	18.9	18.6	6.5	1.7	21.7	12.8	6.4	16.4	16.4	4.2	4.1	8.8	10.3	5.0	7.3	1.8	0.0	0.0	2.8	0.0	2.1	1.5	1.7	2.0	0.2	2.0	1.4	1.7	0.0	0.1	0.0	0.0	2.4	0.7	2.0	2.4	1.7	2.3	1.8	1.4	4.4	1.2	4.0	1.9
ITPRIP	"bA127L20.2, DANGER, KIAA1754"	ENSG00000148841	"Inositol 1,4,5-trisphosphate receptor interacting protein"	Q8IWB1	10	104309698-104338404	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 24.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.1"					"Low region specificity"	"Detected in all"			HPA043626			Uncertain	Vesicles				Vesicles		"HPA043626: AB_10963078"	"unprognostic (2.45e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.20e-1)"	"unprognostic (7.87e-2)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (9.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-3)"	23.7	5.8	3.5	7.4	3.8	81.5	20.8	0.5	4.3	13.5	5.5	4.5	6.8	1.6	8.5	6.0	29.5	5.6	9.8	33.8	3.0	1.5	6.9	7.2	20.2	9.8	4.4	1.5	19.9	4.4	4.4	7.3	24.4	4.7	8.6	2.5	21.7	6.7	7.3	7.6	26.4	3.8	8.4	3.4	8.8	5.6	8.4	5.2	12.9	14.0	14.6	14.2	13.6	17.3	2.4	4.4	24.1	5.7	3.2	3.4	9.7	2.3	5.8	7.0	3.1	12.3	11.9	4.0	13.0	27.6	9.5	11.9	0.4	1.0	4.1	2.9	8.0	7.6	2.3	6.3	9.9	3.5	2.9	2.4	9.2	1.7	24.3	5.4	4.6	11.0	38.2	19.8	15.9	17.7	10.2	7.8	11.6	0.9	1.1	6.0	5.2	6.8	5.1	3.7	2.4	3.9	1.0	4.0	2.6	2.4	2.8	5.7	0.2	4.1	30.6	19.3	5.1	12.7	12.3	3.0	3.5	2.7	14.1	9.9	9.0	3.5	5.7	9.9	3.4	4.1	3.3	1.9	1.9	1.9	4.4	2.4	2.3	2.0	24.1	3.2	3.7	3.1	1.5	9.7	3.5	3.8	0.5	4.3	3.0	1.5	4.4	1.5	4.7	5.2
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium voltage-gated channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4"	"Cell line enriched"	"Detected in some"	23	"RPTEC TERT1: 78.9"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles				Vesicles		"HPA059563: "	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (6.58e-4)"	"unprognostic (3.88e-1)"	0.4	0.3	4.1	0.3	4.4	0.4	1.5	22.6	6.1	0.3	0.4	1.7	12.6	0.4	0.4	6.4	0.3	2.0	6.5	0.4	6.0	7.2	96.5	0.9	0.5	0.4	8.3	3.4	0.4	15.8	59.4	0.8	0.5	25.5	1.0	0.3	0.0	4.1	14.3	0.4	0.5	1.2	0.2	7.5	1.1	7.4	0.8	5.3	0.0	60.4	0.0	0.2	0.3	0.3	1.1	0.5	5.1	0.2	0.9	1.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	78.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.6	0.9	0.1	1.2	1.0	1.0	0.5	0.1	1.1	0.7	0.6	5.1	0.9	0.1	0.5	1.1	0.3	4.1	4.4	22.6	6.1	6.0	7.2	8.3	3.4	25.5	5.3
KCNRG		ENSG00000198553	"Potassium channel regulator"	Q8N5I3	13	50015254-50020922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 27.7;ovary: 17.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001027			Uncertain	Vesicles				Vesicles		"HPA001027: "	"unprognostic (1.85e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-2)"	"prognostic favourable (2.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.16e-2)"	0.4	0.2	0.3	0.3	0.3	1.1	0.6	0.9	0.3	1.8	0.3	0.5	0.3	0.3	1.0	4.8	0.6	27.7	0.3	1.0	0.3	0.5	0.6	0.3	9.1	0.3	0.3	0.3	17.1	0.3	0.4	0.4	0.3	0.5	0.5	0.8	0.3	0.3	1.7	0.4	0.8	0.4	0.4	0.3	0.4	0.3	1.7	0.3	0.3	0.4	0.3	0.6	0.3	0.3	2.7	1.2	4.4	1.1	1.3	1.4	0.4	1.0	0.9	3.1	1.0	1.0	1.5	0.5	0.2	2.4	2.0	0.1	3.6	1.0	2.0	0.6	2.9	1.2	2.3	0.8	1.5	1.4	1.5	4.0	1.5	1.6	2.9	3.3	1.1	2.0	2.2	1.5	3.7	3.9	1.6	0.4	2.5	1.2	3.6	3.2	2.1	1.4	2.6	0.0	0.0	1.8	2.6	2.6	5.6	1.1	1.9	1.8	1.5	1.1	1.3	1.8	0.8	1.1	0.8	0.2	0.5	2.1	0.6	1.3	0.4	3.2	1.1	0.7	0.5	1.1	0.7	1.5	0.7	1.0	0.9	2.7	0.8	0.9	4.4	1.3	0.8	1.2	1.4	0.4	0.3	0.3	0.9	0.3	0.3	0.5	0.3	0.3	0.5	0.3
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077542	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 88.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.8;HaCaT: 34.2;HBEC3-KT: 29.8;hTCEpi: 42.6;RT4: 36.0;SiHa: 30.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 22.2"	"Cell type enriched"	"Detected in single"	18	"basophil: 16.3"	"Lineage enriched"	"Detected in single"	106	"granulocytes: 16.3"	"Group enriched"	"Detected in many"	4	"amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3"	"Low region specificity"	"Detected in many"			HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	2.3	1.5	4.1	24.3	22.2	12.9	8.1	0.7	1.2	19.6	74.4	0.4	4.3	28.7	4.8	3.7	88.4	8.3	48.4	1.3	1.4	1.2	3.9	1.2	12.8	0.1	0.9	1.1	5.0	3.5	0.0	7.3	22.8	4.3	17.6	32.9	1.8	26.4	5.4	10.0	59.4	88.1	4.1	2.4	0.8	17.9	12.2	1.4	3.0	20.7	64.4	61.8	23.4	34.1	0.0	0.0	16.3	0.0	0.0	0.1	0.0	5.7	8.1	0.0	0.1	0.3	0.4	9.2	3.4	7.9	1.5	1.9	7.4	29.8	0.1	18.1	3.0	34.2	10.4	29.8	2.4	0.2	2.7	0.1	17.0	0.7	2.1	2.7	0.5	2.2	42.6	0.4	16.7	0.0	0.4	0.6	6.8	2.0	0.5	0.2	0.3	11.5	0.5	7.6	0.6	23.6	36.0	0.7	0.3	30.4	4.9	2.1	0.6	0.6	0.0	2.1	6.2	0.0	1.4	0.9	0.4	1.0	2.9	0.5	2.5	16.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	22.2	0.7	1.2	1.4	1.2	0.9	1.1	4.3	1.4
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412312-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 28.5;brain: 9.7;lymphoid tissue: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.5;HEL: 2.2;HeLa: 11.8;HSkMC: 2.2;U-698: 3.2"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"					"Cell type enriched"	"Detected in some"	5	"NK-cell: 28.5"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 28.5"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles				Vesicles		"HPA039910: , HPA062570: "	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"		0.1	0.0	4.6	0.2	2.4	2.5	0.0	0.2	9.7	0.0	0.6			1.2	0.7	0.0	0.1	0.3	0.9	0.0	3.7	2.9	0.0	0.6	0.8	2.7	3.0		0.0	0.0	0.0	0.0	0.0		0.0	0.5		0.0	0.0	0.0	0.0	1.9	0.0	2.1	6.9	0.7	0.1			0.1		1.0	0.1	0.0	0.0	0.0	0.3	0.0	28.5	5.6	1.5	0.0	0.0	0.2	0.7	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	2.2	11.8	0.1	0.0	0.3	0.0	2.2	0.0	0.0	0.2	0.0	0.4	0.2	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	4.4	0.3	28.5	0.0	0.0	0.0	1.5										
KRIT1	"CAM, CCM1"	ENSG00000001631	"KRIT1, ankyrin repeat containing"	O00522	7	92198969-92246166	"Disease related genes, Predicted intracellular proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049606	Supported		Uncertain	Vesicles				Vesicles		"HPA049606: "	"unprognostic (8.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.04e-1)"	16.7	16.2	18.0	15.6	22.4	7.1	15.8	32.7	32.0	18.7	16.3	11.7	16.8	14.8	19.3	16.1	15.4	16.2	17.1	19.5	14.7	13.5	17.5	14.0	13.5	14.4	22.1	15.9	23.1	16.6	26.2	46.0	16.3	17.2	17.5	13.5	12.8	17.2	19.6	23.0	13.3	14.6	16.7	20.3	14.7	16.2	23.7	19.9	19.1	25.0	12.6	17.2	19.4	19.8	11.8	8.2	11.7	5.8	12.7	11.4	3.6	18.6	12.9	16.1	17.3	14.4	14.2	15.1	17.6	12.9	11.8	11.4	10.9	19.6	16.8	17.5	10.2	15.7	15.8	10.4	16.3	17.8	18.7	17.1	16.5	7.5	11.3	21.9	20.9	13.3	14.0	11.4	13.3	11.9	33.6	23.6	13.6	17.4	23.9	12.9	16.8	13.3	16.3	23.5	21.2	7.6	16.9	17.6	21.6	21.2	22.6	14.0	13.5	11.9	16.7	22.9	20.4	31.4	12.8	18.5	21.0	31.6	12.9	18.0	21.6	11.7	5.8	5.9	7.8	4.3	8.1	11.8	8.8	10.5	6.0	10.0	11.4	9.9	2.4	12.7	3.2	8.2	8.2	3.6	18.0	22.4	32.7	32.0	14.7	13.5	22.1	15.9	17.2	19.9
L3HYPDH	"C14orf149, FLJ25436"	ENSG00000126790	"Trans-L-3-hydroxyproline dehydratase"	Q96EM0	14	59460363-59484430	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056694	Approved		Uncertain	Vesicles			16000	Vesicles		"HPA056694: "	"unprognostic (3.39e-2)"	"unprognostic (5.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.24e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.60e-2)"	"prognostic unfavourable (1.72e-9)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.14e-1)"	17.9	15.4	13.5	13.5	17.1	4.9	22.8	10.4	16.5	12.6	9.9	18.5	10.9	12.3	17.6	10.3	9.8	16.3	13.2	15.9	13.6	7.2	20.2	17.4	11.5	18.5	22.7	9.6	20.1	12.8	23.1	22.5	11.9	18.2	15.5	12.0	12.9	13.6	15.5	8.7	11.0	13.7	14.0	18.4	14.3	11.0	18.9	17.4	6.6	17.9	9.9	15.0	12.7	18.7	2.3	7.9	0.8	7.0	7.0	5.1	2.5	6.1	16.6	3.6	8.5	7.8	20.7	5.1	16.6	13.2	9.6	9.4	3.3	11.1	2.1	7.0	9.2	16.7	5.8	8.9	9.5	3.5	7.5	5.7	14.5	12.0	8.9	5.0	4.1	14.9	6.1	9.6	14.9	11.7	7.4	9.8	9.9	7.3	1.9	8.3	5.8	15.0	2.8	5.9	8.4	15.4	3.5	3.7	5.3	15.6	6.5	5.9	6.8	3.3	16.3	11.3	13.7	8.7	19.4	2.5	1.1	2.0	19.4	4.3	21.9	0.0	5.0	0.8	5.1	7.0	3.4	2.3	2.5	3.0	7.9	2.2	3.9	1.4	0.0	7.0	3.2	4.3	1.1	2.5	13.5	17.1	10.4	16.5	13.6	7.2	22.7	9.6	18.2	17.4
LRMP	JAW1	ENSG00000118308	"Lymphoid restricted membrane protein"	Q12912	12	25004342-25108334	"Predicted intracellular proteins, Predicted membrane proteins"	"Fertilization, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;lymphoid tissue: 69.5"	"Group enriched"	"Detected in some"	6	"Daudi: 94.1;REH: 32.7;U-698: 107.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 51.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA002967, HPA018505"	Enhanced		Uncertain	Nucleoplasm,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Cytosol"	"HPA002967: AB_1079161, HPA018505: AB_1851988"	"unprognostic (3.78e-2)"	"unprognostic (2.59e-3)"	"unprognostic (7.54e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.97e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.59e-2)"	5.5	1.4	15.1	51.7	2.9	19.2	4.6	0.4	5.6	1.9	3.6	2.1	0.9	3.2	1.4	1.8	3.9	2.3	3.0	1.7	8.1	1.8	5.5	2.3	5.6	57.8	3.5	4.7	2.3	15.1	0.4	2.1	1.7	7.4	2.8	3.5	1.3	4.1	2.1	0.8	2.7	13.2	1.8	5.3	27.6	3.6	0.7	2.8	67.0	3.6	1.7	69.5	10.4	5.7	17.4	5.7	51.8	12.2	12.0	7.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.1	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	5.6	0.0	0.0	0.0	7.2	8.3	0.0	0.0	0.1	0.0	0.0	1.1	6.3	0.0	0.0	7.9	13.4	0.0	0.0	32.7	0.0	9.3	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	0.0	0.0	6.2	1.1	107.6	0.0	3.2	0.0	17.0	5.4	51.8	6.5	10.5	5.4	17.4	4.1	6.6	5.7	13.3	7.1	6.9	39.3	12.0	12.2	5.4	0.7	4.7	15.1	2.9	0.4	5.6	8.1	1.8	3.5	4.7	7.4	2.8
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464929-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"testis: 129.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles				Nucleoli	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favourable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	2.7	4.6	3.6	3.8	5.0	7.6	1.9	7.9	5.8	2.5	2.5	3.4	3.4	2.9	2.8	2.8	2.1	7.1	2.5	2.6	4.3	4.0	4.0	5.1	2.6	4.4	3.4	3.7	3.1	3.4	3.4	4.9	2.0	4.2	2.2	1.6	1.7	3.3	4.0	3.6	2.2	4.3	2.7	2.4	6.6	3.3	129.9	3.8	3.9	2.7	1.6	4.2	2.3	1.8	12.6	9.8	9.2	4.0	9.9	10.4	5.8	7.3	10.2	5.5	15.5	4.2	3.2	8.6	7.8	5.1	13.3	9.2	9.7	4.3	18.1	11.2	5.9	7.8	8.1	7.0	4.0	6.3	15.7	3.7	4.6	6.0	5.6	6.9	7.3	3.0	4.3	15.4	3.3	7.0	17.5	5.6	7.2	22.1	21.0	16.7	11.7	14.7	11.1	5.1	19.5	4.0	4.6	7.3	20.7	8.6	8.2	7.6	4.7	5.8	4.1	7.4	15.8	22.8	12.4	20.6	35.5	17.3	8.2	6.5	12.8	9.1	2.5	9.2	10.4	4.0	9.9	11.1	9.1	9.1	2.8	12.6	5.8	7.4	5.9	9.9	3.5	9.8	9.0	5.8	3.6	5.0	7.9	5.8	4.3	4.0	3.4	3.7	4.2	3.8
LUZP1	LUZP	ENSG00000169641	"Leucine zipper protein 1"	Q86V48	1	23084023-23177808	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028506, HPA028542"	Enhanced		Uncertain	"Vesicles,Actin filaments,Cytosol"				"Actin filaments"	"Vesicles, Cytosol"	"HPA028506: AB_10600083, HPA028542: AB_10601986"	"unprognostic (3.04e-2)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (7.35e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.46e-3)"	"unprognostic (9.77e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.50e-1)"	"prognostic favourable (1.46e-7)"	"unprognostic (4.49e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.33e-1)"	9.7	10.3	5.2	6.5	10.7	8.3	7.3	7.8	18.2	7.5	11.7	2.5	4.4	15.7	9.6	4.5	7.5	6.6	9.1	9.2	6.3	6.1	8.1	4.0	9.1	4.0	5.4	9.5	6.6	4.4	21.8	4.9	8.6	21.8	7.0	9.4	4.6	7.1	7.1	4.2	6.8	27.1	8.9	5.0	9.4	5.9	20.4	3.4	5.2	7.9	4.7	5.5	7.9	9.9	4.5	11.9	21.5	7.4	4.8	10.5	2.1	9.5	6.6	9.3	10.8	9.6	12.3	6.8	9.4	15.1	11.8	12.5	3.7	4.5	0.2	8.7	15.9	13.0	9.2	25.6	14.5	3.5	6.1	13.5	8.2	3.5	6.3	6.6	8.7	10.8	10.1	17.3	13.7	26.5	4.9	0.8	9.5	2.5	4.5	2.8	7.9	7.2	6.9	14.0	1.1	5.4	6.3	1.7	4.4	22.5	6.4	7.7	3.6	3.5	47.3	13.9	10.6	10.4	9.3	1.2	2.8	3.7	6.2	11.0	11.9	21.5	5.8	6.1	9.3	4.0	10.5	2.4	7.0	5.8	5.6	4.5	5.6	5.5	3.2	4.8	7.4	11.9	3.7	2.1	5.2	10.7	7.8	18.2	6.3	6.1	5.4	9.5	21.8	3.4
MAK16	"MAK16L, RBM13"	ENSG00000198042	"MAK16 homolog"	Q9BXY0	8	33484750-33501260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA044417, HPA050574"	Uncertain		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA044417: , HPA050574: AB_2681181"	"unprognostic (2.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.00e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.47e-1)"	22.3	11.0	10.6	14.9	15.3	13.5	15.2	11.5	17.6	13.2	11.5	12.5	8.3	9.1	20.8	9.1	15.2	13.6	11.3	13.1	10.5	13.4	17.9	20.0	10.5	17.3	11.4	10.3	24.8	15.7	10.4	19.2	13.1	19.2	14.2	11.3	8.9	10.6	10.3	25.2	12.4	10.8	19.7	13.1	17.3	11.9	9.5	7.1	20.3	14.8	14.3	17.4	16.8	11.3	3.8	4.0	0.9	9.4	5.7	6.2	3.3	5.9	8.4	5.9	13.5	7.0	8.4	8.8	10.8	7.1	11.8	11.1	12.5	5.3	21.1	10.7	9.5	7.9	19.7	12.0	15.9	4.5	5.5	19.9	6.0	11.0	10.4	8.0	12.2	8.7	11.1	15.3	18.0	8.6	24.7	12.3	9.8	7.0	28.5	9.7	31.2	5.9	10.2	8.9	9.5	10.0	10.2	15.1	12.0	6.6	9.4	13.0	6.5	8.5	7.6	11.1	8.7	14.3	12.3	6.1	6.7	21.8	6.9	17.2	11.8	0.0	3.2	0.9	4.8	6.8	5.4	3.2	4.7	4.1	3.9	3.8	6.0	6.2	0.7	5.7	9.4	4.0	3.6	3.3	10.6	15.3	11.5	17.6	10.5	13.4	11.4	10.3	19.2	7.1
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086927-137109187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051516	Approved		Uncertain	Vesicles			540000	Vesicles		"HPA051516: "	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	20.4	25.4	19.7	13.5	23.7	9.8	18.6	21.6	36.1	24.3	21.6	24.5	20.6	19.8	22.7	28.1	23.1	28.9	25.9	19.5	20.5	21.5	24.3	32.7	20.4	19.9	18.6	25.2	24.2	32.6	23.6	25.1	30.8	18.0	21.2	12.0	22.0	32.7	23.1	12.2	25.4	17.8	18.5	16.4	22.2	21.8	30.3	18.2	19.9	25.1	12.7	19.3	21.0	16.0	13.0	23.0	16.3	24.4	18.0	21.9	18.5	7.2	17.1	5.9	16.9	22.5	19.4	19.8	12.3	26.1	16.5	14.6	8.3	22.9	6.6	41.4	20.6	25.0	3.5	11.9	3.0	9.1	6.0	2.9	15.4	9.6	21.2	5.1	11.4	22.9	22.6	9.6	8.1	10.9	8.0	10.9	11.6	14.7	5.4	12.1	7.9	17.2	3.1	10.0	20.9	13.2	3.6	6.9	6.2	18.2	19.4	12.6	21.5	10.9	15.3	24.4	9.1	18.0	14.4	4.4	3.6	4.3	29.4	6.5	21.0	7.9	20.1	16.3	21.9	21.8	20.5	13.0	17.3	20.6	23.0	11.0	17.0	17.0	5.9	18.0	24.4	16.1	21.5	18.5	19.7	23.7	21.6	36.1	20.5	21.5	18.6	25.2	18.0	18.2
MAN1C1	HMIC	ENSG00000117643	"Mannosidase alpha class 1C member 1"	Q9NR34	1	25617468-25786207	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 12.5;HSkMC: 46.0;U-266/70: 13.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048352	Uncertain		Uncertain	Nucleoplasm,Vesicles			1200000	"Nucleoplasm, Vesicles"		"HPA048352: "	"unprognostic (2.75e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-2)"	"prognostic favourable (7.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"prognostic favourable (4.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.18e-2)"	4.6	4.5	4.2	3.0	3.8	0.0	2.2	9.9	8.8	8.6	3.6			1.2	6.6	2.5	2.4	3.9	7.3	3.4	5.2	3.2	10.3	12.1	3.2	4.0	4.2		7.1	0.7	4.4	7.8	8.3		7.2	1.2		1.8	7.5	0.9	2.7	1.9	8.0	6.0	7.0	3.1	1.0			10.7		3.2	4.3	4.0	1.0	0.6	1.1	1.6	0.8	8.3	1.1	0.0	0.1	12.5	2.6	9.3	7.3	3.6	0.1	2.4	0.6	0.2	0.2	0.0	0.1	0.1	0.9	0.1	1.1	0.1	0.2	3.9	0.5	0.2	0.1	0.0	1.1	2.1	5.2	46.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.0	2.3	3.2	0.0	0.2	7.7	0.2	0.1	0.2	7.3	0.2	0.3	1.9	0.6	1.0	1.5	0.0	0.0	0.7	8.4	0.3	13.7	0.0	0.0	1.9	4.4	0.6	0.4	1.6	0.7	0.6	1.0	0.8	0.4	3.6	1.6	0.6	1.0	8.3	4.8	1.1	0.8	1.3	0.4	0.8	1.1										
METAP1D	"MAP1D, Metap1l"	ENSG00000172878	"Methionyl aminopeptidase type 1D, mitochondrial"	Q6UB28	2	171999583-172082430	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030298, HPA030299"	Uncertain		Uncertain	Vesicles				Vesicles		"HPA030298: AB_2673419, HPA030299: AB_10602421"	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.44e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.92e-2)"	7.1	7.5	7.2	8.0	8.4	6.3	8.2	6.7	9.2	6.5	6.1	9.6	6.5	5.0	9.0	6.4	5.2	10.3	4.5	6.4	6.0	4.9	5.4	8.3	3.6	8.1	9.3	7.1	18.9	23.8	5.5	13.8	4.1	8.6	8.3	7.1	7.3	9.7	10.3	13.8	7.1	5.9	10.0	7.2	8.6	6.3	5.9	9.5	2.1	5.6	6.3	6.7	5.4	5.7	2.5	0.5	0.2	1.2	1.2	3.6	0.7	3.3	2.6	3.9	13.0	5.8	7.5	8.0	3.8	3.9	6.2	3.9	6.0	4.4	1.7	7.0	4.0	6.1	8.5	6.7	6.3	5.9	10.1	9.4	6.9	7.9	6.2	5.5	2.5	5.7	10.6	6.1	9.9	3.5	13.5	4.8	4.6	4.1	3.1	7.5	7.1	3.2	7.1	3.4	3.0	4.4	4.6	8.1	3.1	2.7	5.6	9.5	6.4	7.5	4.1	7.9	6.3	4.8	3.6	6.0	5.4	3.8	5.6	11.1	7.5	0.0	0.2	0.0	1.3	1.2	0.6	1.2	1.9	0.7	0.5	2.5	1.9	3.6	0.2	1.2	0.2	0.0	1.4	0.7	7.2	8.4	6.7	9.2	6.0	4.9	9.3	7.1	8.6	9.5
MSS51	"FLJ39565, ZMYND17"	ENSG00000166343	"MSS51 mitochondrial translational activator"	Q4VC12	10	73423579-73433561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	13	"parathyroid gland: 34.4;skeletal muscle: 66.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"cerebellum: 2.7"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038564			Uncertain	Vesicles,Cytosol				Vesicles	Cytosol	"HPA038564: AB_10674687"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.50e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-7)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-2)"	2.8	0.3	0.4	0.4	0.4	0.3	0.4	2.7	0.4	0.5	0.5	0.4	0.4	0.2	0.6	0.4	0.9	0.6	0.4	3.9	0.4	0.1	0.4	0.4	0.6	0.4	0.4	0.4	1.1	0.5	34.4	0.7	0.4	0.4	0.8	0.3	0.4	2.3	0.4	66.9	0.8	0.8	0.4	0.4	1.4	0.4	0.4	0.4	0.6	0.4	1.2	0.4	0.5	0.6	0.1	0.0	0.0	0.5	0.0	1.7	0.4	1.2	1.3	3.0	4.7	4.2	6.0	2.6	1.4	1.1	0.6	1.3	0.7	1.5	3.8	0.5	1.5	2.3	1.9	0.4	1.7	1.8	1.5	3.3	2.0	1.1	1.5	2.2	3.1	4.7	1.5	1.3	3.5	0.6	1.1	2.0	2.5	0.5	1.8	3.0	0.9	1.6	1.1	7.7	0.2	1.8	1.9	0.6	1.2	1.0	2.2	1.7	1.9	1.8	2.6	2.3	1.4	0.9	3.0	1.2	3.4	2.0	1.0	3.8	0.6	0.0	0.4	0.0	1.7	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.3	1.2	0.0	0.0	0.5	0.0	0.0	0.4	0.4	0.4	2.7	0.4	0.4	0.1	0.4	0.4	0.4	0.4
MTFR2	"DUFD1, FAM54A"	ENSG00000146410	"Mitochondrial fission regulator 2"	Q6P444	6	136231024-136250335	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029792, HPA029794"	Approved		Uncertain	Vesicles				Vesicles		"HPA029792: AB_10600210, HPA029794: AB_10600535"	"unprognostic (6.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (9.64e-4)"	"unprognostic (3.93e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.60e-6)"	"prognostic unfavourable (8.28e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.82e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.64e-2)"	1.7	0.9	0.6	5.1	1.5	15.2	0.9	0.9	1.1	0.8	2.9	0.8	0.4	2.8	0.7	0.9	4.5	0.5	1.7	1.0	0.6	0.6	2.5	0.7	1.5	6.4	0.8	0.4	0.9	0.7	0.0	0.7	3.2	1.2	0.7	4.1	0.6	1.3	0.4	1.4	1.9	3.2	0.9	1.1	3.8	1.9	13.5	0.4	16.8	0.4	3.2	5.8	1.1	1.4	1.6	3.0	0.1	2.9	0.0	2.6	1.1	7.1	5.6	4.8	8.9	0.8	1.4	8.6	9.5	6.6	11.3	15.9	9.9	5.9	18.7	5.8	3.8	11.2	10.8	7.0	16.9	10.4	8.3	14.7	4.1	9.0	0.5	26.9	13.9	1.1	1.5	12.6	8.1	6.1	15.8	14.6	8.4	9.6	15.1	22.6	4.8	6.9	13.9	7.7	9.4	4.8	5.6	3.8	3.8	6.0	10.6	5.4	4.4	18.6	3.3	5.6	5.9	19.8	14.5	5.5	13.0	12.4	3.2	18.4	8.6	0.0	0.6	0.0	1.2	2.9	0.4	1.6	1.6	2.6	3.0	1.3	0.2	1.3	0.1	0.0	2.3	2.2	2.2	1.1	0.6	1.5	0.9	1.1	0.6	0.6	0.8	0.4	1.2	0.4
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 45.9;TIME: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	39	"eosinophil: 20.4"	"Lineage enriched"	"Detected in single"	190	"granulocytes: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047992			Supported	Nucleoplasm,Vesicles			69000	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavourable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	37.3	3.1	4.1	4.4	6.3	1.1	27.5	3.0	7.7	16.2	8.4	1.5	5.2	3.1	14.5	9.4	14.4	6.8	9.1	17.2	5.1	4.2	6.9	11.1	24.1	4.9	5.8	1.9	8.2	2.5	3.4	2.7	17.4	6.6	8.8	5.3	8.3	4.0	3.7	14.2	4.8	5.5	10.8	5.4	39.4	4.6	7.7	5.2	0.6	12.5	11.0	2.8	17.0	12.3	0.1	0.0	20.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	45.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.2	0.2	0.5	0.0	0.4	0.0	5.7	0.0	0.0	0.0	0.4	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	4.1	6.3	3.0	7.7	5.1	4.2	5.8	1.9	6.6	5.2
NHLRC1	"bA204B7.2, EPM2B"	ENSG00000187566	"NHL repeat containing E3 ubiquitin protein ligase 1"	Q6VVB1	6	18120440-18122687	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 9.0;K-562: 7.6;SCLC-21H: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA066030			Uncertain	Vesicles				Vesicles		"HPA066030: "	"unprognostic (1.61e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (6.95e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-2)"	"prognostic favourable (5.30e-4)"	2.5	3.6	5.0	1.8	6.5	2.1	4.6	2.6	8.5	1.9	3.3	7.1	1.7	3.2	2.0	6.1	2.4	3.5	2.7	3.9	5.0	5.1	1.9	9.0	5.1	4.7	5.4	3.9	3.5	12.2	2.4	2.8	1.0	5.2	3.4	3.0	3.3	5.1	2.8	5.2	8.5	4.3	1.8	5.4	2.4	3.0	2.1	3.8	2.4	3.6	0.9	1.8	2.5	1.8	3.3	7.2	0.6	7.2	2.2	2.5	2.6	3.3	2.0	0.8	0.1	1.8	1.7	0.0	3.4	1.1	1.3	0.7	0.1	2.8	0.1	9.0	2.5	4.0	0.0	2.2	1.0	0.1	1.1	0.5	1.0	0.2	2.8	0.0	2.2	2.9	3.3	1.3	1.2	2.8	7.6	0.1	2.8	3.5	0.0	0.0	0.0	2.0	0.0	0.0	0.1	1.8	3.6	8.0	0.1	6.8	5.7	2.0	4.1	2.2	0.5	0.2	1.7	2.4	0.0	0.1	0.0	0.1	0.1	0.0	3.4	0.5	6.6	0.6	1.1	7.2	1.2	3.3	1.7	0.8	7.2	2.3	2.5	1.6	0.5	2.2	3.2	0.9	1.8	2.6	5.0	6.5	2.6	8.5	5.0	5.1	5.4	3.9	5.2	3.8
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"lung: 51.5;thyroid gland: 122.8"	"Cell line enriched"	"Detected in some"	28	"SCLC-21H: 47.6"	"Group enriched"	"Detected in some"	39	"lung cancer: 30.9;thyroid cancer: 103.2"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.4;hypothalamus: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.4;hypothalamus: 12.0"	"Group enriched"	"Detected in some"	13	"basal ganglia: 6.4;hypothalamus: 16.1"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"CAB000078: , CAB053633: AB_442138, HPA074316: "		"unprognostic (3.79e-1)"		"unprognostic (4.25e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.26e-2)"				"unprognostic (2.23e-1)"		"unprognostic (1.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.18e-1)"	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.5	0.0	0.0	51.5	0.1	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.0	122.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	47.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.1	0.2	2.5	0.0	0.1	0.1	0.4
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.2;HL-60: 12.9;HMC-1: 6.5;NB-4: 13.8;U-698: 19.9;U-937: 9.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"				Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: "	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	0.2	0.4	0.0	20.1	0.1	2.8	0.0	0.0	0.2	0.4	1.3	0.0	0.2	1.2	1.0	0.1	1.0	0.0	1.8	0.8	0.0		0.6	0.5	6.0	11.2	0.2	0.0	0.1	1.5	0.0	0.0	0.6	0.2	0.9	0.7	0.9	2.7	0.2	0.5	0.0	2.4	0.1	0.0	10.5	1.4	0.0	0.0	27.0	0.4	1.1	18.1	1.6	1.0	1.0	0.0	2.6	0.0	4.7	4.1	3.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	6.2	0.1	0.0	0.0	12.9	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	5.4	13.8	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	3.3	0.4	0.2	0.0	0.2	0.1	0.3	0.0	19.9	0.1	9.7	0.0	2.6	0.0	0.0	3.7	0.0	4.1	1.0	2.7	3.8	0.0	0.8	2.1	2.0	0.0	4.7	0.0	0.0	3.1	3.3										
NOX3	GP91-3	ENSG00000074771	"NADPH oxidase 3"	Q9HBY0	6	155395370-155455903	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"adrenal gland: 1.8"	"Cell line enriched"	"Detected in single"	9	"MCF7: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073837			Uncertain	Vesicles				Vesicles		"HPA073837: "					"unprognostic (3.42e-1)"													0.0	1.8	0.4	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.6	0.3	0.1	0.0	0.0	0.0
NPHP1	"JBTS4, NPH1, SLSN1"	ENSG00000144061	"Nephrocystin 1"	O15259	2	110122311-110205066	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"		"Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046093, HPA074071"	Approved		Uncertain	Vesicles				Vesicles		"HPA046093: , HPA074071: "	"unprognostic (2.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.66e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.93e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.64e-2)"	3.1	4.3	8.5	1.8	13.7	0.8	5.1	2.1	7.2	5.6	4.7	4.9	8.8	1.7	7.2	11.3	2.1	19.3	4.3	4.4	9.0	7.5	8.7	1.5	5.7	1.5	3.8	6.2	5.4	3.5	17.7	28.1	2.1	20.3	4.4	2.6	4.6	2.8	8.9	36.7	1.7	1.8	7.2	5.4	1.9	3.7	25.0	7.2	0.0	8.9	3.2	1.3	4.1	3.7	3.5	1.0	1.0	0.3	3.2	1.8	0.7	8.6	2.7	5.7	4.2	3.3	6.9	1.2	2.2	7.2	7.8	7.7	2.8	6.5	0.5	5.8	5.1	4.2	2.7	7.0	9.3	1.6	3.5	0.2	1.7	1.9	4.6	1.3	0.0	4.7	4.2	12.1	3.9	4.9	0.1	0.8	4.6	1.7	0.8	2.1	2.6	4.5	0.0	6.0	0.2	13.2	0.7	3.1	3.1	3.2	3.9	7.9	4.7	1.0	3.1	4.5	3.9	5.0	7.0	2.4	2.5	0.6	13.3	0.2	3.2	0.7	0.1	0.1	1.2	0.3	1.8	2.7	0.9	0.6	1.0	3.5	1.8	1.4	1.0	3.2	0.1	0.1	0.1	0.7	8.5	13.7	2.1	7.2	9.0	7.5	3.8	6.2	20.3	7.2
NRG3		ENSG00000185737	"Neuregulin 3"	P56975	10	81875314-82987179	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.6"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;HEK 293: 3.3;HUVEC TERT2: 1.6;SK-MEL-30: 7.2;U-2 OS: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA075789			Uncertain	Vesicles	"Secreted in brain"			Vesicles		"HPA075789: "	"unprognostic (6.15e-3)"		"unprognostic (2.43e-2)"	"unprognostic (1.65e-5)"	"unprognostic (1.89e-1)"	"unprognostic (7.03e-4)"	"unprognostic (1.85e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.31e-4)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.27e-4)"	0.9	1.5	15.6	1.2	8.2	0.6	2.8	1.9	30.6	0.8	0.9	4.8	0.0	0.8	0.7	0.7	0.9	8.0	5.3	0.9	14.5	6.2	1.2	1.5	1.6	0.8	4.9	8.0	0.7	0.9	0.7	1.6	1.2	6.5	0.9	0.9	3.1	5.0	1.1	0.7	0.8	0.9	0.9	5.6	0.8	0.8	3.3	6.0	0.0	0.9	0.0	0.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	8.2	1.9	12.8	14.5	6.2	4.9	8.0	6.5	6.0
NUP214	"CAIN, CAN, D9S46E, N214"	ENSG00000126883	"Nucleoporin 214"	P35658	9	131125561-131234670	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 131.5"	"Cell line enhanced"	"Detected in all"		"K-562: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 43.7;neutrophil: 131.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 131.5;monocytes: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048789			Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"			100000	Nucleoplasm	"Vesicles, Focal adhesion sites"	"HPA048789: "	"unprognostic (1.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.95e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.39e-5)"	"unprognostic (5.49e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	16.9	10.3	11.5	13.8	13.9	29.4	12.9	13.0	14.4	10.2	11.4	19.8	10.4	9.0	15.0	13.7	16.1	12.1	10.2	9.7	9.5	8.1	19.0	15.1	11.7	13.3	13.2	8.8	14.2	17.0	16.7	16.9	13.0	11.3	11.1	10.8	15.3	13.0	11.1	15.5	17.5	11.7	11.1	14.3	35.8	12.3	63.7	13.3	27.4	11.8	7.6	16.8	10.7	11.2	1.2	16.8	131.5	43.7	1.2	0.8	17.9	6.7	9.6	8.2	4.9	6.6	6.4	8.6	6.0	6.2	7.8	6.3	7.8	4.9	10.9	4.8	8.2	15.4	11.0	7.8	7.6	7.9	5.4	6.8	13.7	15.2	5.8	10.6	7.3	7.0	7.2	10.0	8.1	8.0	71.4	6.3	8.0	12.5	13.9	16.0	8.9	8.5	4.8	10.3	10.9	9.0	6.2	7.0	7.2	10.0	9.2	5.2	12.1	26.4	6.8	13.8	7.8	9.0	9.6	5.5	10.7	10.5	6.7	6.4	8.3	3.5	43.7	17.3	0.7	18.4	0.8	1.2	0.7	0.6	16.8	1.1	0.7	0.7	131.5	1.2	15.0	1.5	0.4	17.9	11.5	13.9	13.0	14.4	9.5	8.1	13.2	8.8	11.3	13.3
NUP98	NUP96	ENSG00000110713	"Nucleoporin 98"	P52948	11	3671083-3797792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074810			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA074810: "	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.71e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.08e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	20.2	13.5	8.7	23.5	11.7	40.8	23.5	14.2	13.2	18.0	15.3	14.6	17.8	11.2	19.2	17.5	18.6	17.3	17.1	18.2	7.8	8.0	12.8	20.1	20.7	17.4	11.4	8.7	25.5	19.0	25.7	23.6	20.7	12.7	18.6	15.2	17.8	17.4	25.0	35.2	18.5	15.7	20.8	10.4	18.3	16.0	57.0	10.6	27.5	20.9	15.0	26.6	22.6	19.3	8.9	9.9	24.9	10.0	6.1	13.2	8.7	29.8	23.4	19.3	21.3	21.4	17.6	17.0	21.3	24.9	29.3	26.4	25.7	37.1	29.2	10.1	25.5	32.2	33.9	21.0	40.0	20.7	24.5	31.3	19.2	17.6	18.0	39.9	26.4	20.0	14.5	16.1	29.4	22.7	38.9	23.5	31.1	12.2	40.1	13.0	24.4	18.0	24.5	23.5	14.0	16.7	23.6	17.8	11.9	30.9	25.1	14.2	15.4	15.7	16.6	23.5	20.4	25.6	19.4	14.2	24.2	31.0	15.9	17.2	24.7	19.1	7.9	15.5	11.0	10.0	11.0	8.9	10.7	9.7	9.9	7.8	12.2	10.5	24.9	6.1	6.3	2.7	13.2	8.7	8.7	11.7	14.2	13.2	7.8	8.0	11.4	8.7	12.7	10.6
OLFM3	NOE3	ENSG00000118733	"Olfactomedin 3"	Q96PB7	1	101802574-101997030	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 30.0"	"Group enriched"	"Detected in some"	11	"AF22: 9.3;HAP1: 6.4;HEL: 5.7;SCLC-21H: 3.7;SH-SY5Y: 3.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050297			Uncertain	Vesicles	"Secreted in brain"			Vesicles		"HPA050297: "			"unprognostic (4.19e-1)"	"unprognostic (4.19e-4)"	"unprognostic (1.26e-1)"				"unprognostic (4.61e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.47e-2)"			"unprognostic (3.58e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.68e-2)"		0.7	3.2	5.0	1.4	13.7	0.7	0.8	24.2	30.0	0.9	1.8	0.4	0.0	1.0	0.9	1.2	0.7	0.8	0.8	0.7	4.8	7.4	1.5	0.8	0.7	0.7	6.0	11.9	0.8	0.7	0.7	2.4	0.8	16.6	0.7	1.7	0.3	0.8	0.7	0.7	0.7	2.1	1.3	1.5	0.9	1.0	0.9	0.7	0.0	1.2	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	3.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	13.7	24.2	26.7	4.8	7.4	6.0	11.9	16.6	0.7
P4HTM	"EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4"	ENSG00000178467	"Prolyl 4-hydroxylase, transmembrane"	Q9NXG6	3	48989886-49007154	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007199	Supported		Uncertain	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA007199: AB_1855272"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.47e-2)"	"prognostic favourable (8.18e-4)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-2)"	"prognostic favourable (3.28e-5)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.65e-3)"	7.4	25.5	22.1	6.4	28.5	4.7	8.9	17.6	32.9	13.5	10.8	15.9	13.8	10.4	9.7	18.9	5.4	34.7	13.0	18.6	23.0	26.5	14.1	5.4	10.6	5.6	18.7	20.3	11.4	29.9	20.8	35.7	9.6	15.7	15.5	6.7	14.1	16.0	16.5	10.0	4.3	7.8	7.0	14.3	6.3	15.7	11.7	16.4	3.4	21.5	3.3	6.7	7.5	6.1	9.8	7.8	6.7	7.6	4.9	14.4	4.8	3.8	10.5	2.0	0.0	5.9	7.0	0.1	6.9	9.1	5.2	5.6	2.3	20.7	3.3	7.2	8.4	2.0	4.4	2.3	1.5	12.3	7.8	0.0	15.6	0.0	15.7	3.2	0.1	4.0	2.3	5.2	0.4	5.8	0.0	14.3	2.5	16.4	0.4	0.4	2.8	12.4	0.0	0.0	19.2	9.2	5.9	8.2	0.1	7.7	8.3	0.0	7.3	5.3	4.0	3.1	2.7	7.7	5.4	20.4	11.2	0.0	23.0	0.3	3.2	6.7	7.6	4.8	6.4	2.7	8.7	7.0	11.6	10.3	7.8	9.8	12.0	8.3	0.8	4.9	3.6	1.4	14.4	4.8	22.1	28.5	17.6	32.9	23.0	26.5	18.7	20.3	15.7	16.4
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 33.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	5.2	4.2	7.9	1.6	11.4	1.2	2.7	2.4	33.7	3.6	2.9	9.8	1.2	2.4	3.0	2.4	4.3	3.6	3.7	2.3	9.1	4.4	2.0	6.5	3.5	1.7	5.1	7.2	3.6	1.9	1.4	2.4	7.4	5.3	3.6	2.6	4.9	4.1	4.6	2.0	4.7	2.9	3.1	6.7	2.5	4.7	2.0	6.5	0.0	4.9	1.5	3.3	2.5	3.5	0.9	1.1	1.5	0.7	0.8	1.0	0.2	0.0	0.0	12.0	6.1	5.3	2.3	5.7	2.0	0.1	2.9	4.7	0.2	0.7	0.6	7.9	2.9	0.3	2.8	1.9	2.3	0.7	0.0	0.0	0.3	0.0	2.1	1.2	0.2	13.5	0.3	2.0	0.8	1.1	0.0	0.1	7.3	0.0	0.1	0.3	1.1	0.1	0.1	1.0	0.0	2.0	0.0	1.6	0.6	0.3	0.0	0.3	16.0	1.5	2.6	5.5	0.3	9.4	0.1	0.2	0.9	0.1	2.8	0.0	0.3	1.5	0.3	0.3	1.0	0.4	1.0	0.6	0.4	0.6	0.1	0.9	0.4	0.9	0.9	0.8	0.7	1.1	0.3	0.2	7.9	11.4	2.4	8.5	9.1	4.4	5.1	7.2	5.3	6.5
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.9;ASC TERT1: 16.1;HSkMC: 11.5;REH: 9.6;SK-MEL-30: 12.4;WM-115: 25.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	3.4	2.5	7.4	2.8	9.4	0.5	2.1	4.1	8.5	2.4	2.5	8.5	0.0	1.2	2.6	1.7	3.1	2.1	2.1	3.4	11.6	1.9	1.9	1.2	2.3	1.8	4.5	5.2	3.8	2.3	1.3	1.9	8.3	5.0	2.5	1.5	3.3	2.8	3.4	2.8	6.6	1.2	3.3	4.9	1.6	1.8	2.2	7.1	0.1	3.4	0.6	1.7	1.7	2.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.4	14.9	16.1	0.5	3.2	6.2	2.5	4.0	0.0	0.1	0.3	5.4	3.2	2.1	0.1	0.3	4.0	0.1	1.4	0.0	0.0	0.0	2.5	0.2	0.0	11.5	0.1	4.4	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	9.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.3	1.8	4.5	0.5	0.1	0.4	0.0	0.0	0.2	0.0	0.1	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	7.4	9.4	4.1	8.5	11.6	1.9	4.5	5.2	5.0	7.1
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 28.5;TIME: 14.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	7	"NK-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	2.4	2.2	2.4	0.7	4.2	0.0	1.2	1.8	2.1	2.6	1.4			0.2	3.2	3.5	1.1	2.1	0.8	2.8	2.3	4.1	2.9	3.3	2.1	0.0	1.8		5.1	1.9	3.0	2.5	6.2		2.6	0.7		3.0	3.1	1.2	3.4	0.3	1.9	2.0	0.6	0.4	0.9			3.6		0.2	1.6	2.0	0.0	0.2	0.0	0.0	1.6	0.2	0.2	0.0	0.7	7.0	0.0	4.6	5.9	0.8	6.8	28.5	2.8	1.9	0.0	0.0	0.2	5.5	0.2	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	1.6	1.8	0.0	0.0	5.7	0.0	2.7	0.0	4.3	0.2	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.6	2.6	14.3	3.8	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2										
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.2;ASC TERT1: 24.3;BJ hTERT+ SV40 Large T+: 13.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.1	1.9	0.8	0.3	3.2	0.0	3.6	2.0	4.3	1.4	0.4	2.5	1.9	0.0	2.1	2.5	1.1	2.1	0.8	1.9	0.0		1.6	3.1	6.8	2.6	0.9	1.5	4.9	2.8	11.2	2.1	9.5	1.5	2.2	0.2	3.7	3.2	3.2	1.4	2.6	0.0	1.9	3.0	0.5	0.7	1.0	2.2	0.8	3.5	0.0	0.7	1.9	1.4	0.5	0.2	0.0	0.3	0.0	1.9	0.1	0.0	1.1	0.1	0.0	32.2	24.3	0.6	8.5	0.0	13.9	15.6	1.3	4.6	4.8	11.1	9.4	6.4	0.0	3.5	7.8	0.0	1.4	0.0	0.0	0.0	3.3	0.0	3.1	8.5	0.7	0.8	4.5	4.2	0.1	0.0	0.4	3.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.0	9.0	0.0	4.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.3	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1										
PCDHGB6	PCDH-GAMMA-B6	ENSG00000253305	"Protocadherin gamma subfamily B, 6"	Q9Y5F9	5	141408021-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 26.6"	"Cell line enhanced"	"Detected in some"		"AF22: 18.2;EFO-21: 6.2;HSkMC: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.71e-4)"	6.7	7.2	8.8	2.6	9.9	1.6	4.4	6.1	26.6	5.8	4.1	10.1	0.3	1.8	7.2	5.7	3.0	5.1	4.4	4.6	8.9	5.7	3.2	9.4	4.4	2.2	6.9	4.4	13.3	5.2	16.1	4.7	6.8	5.9	4.0	2.3	9.0	5.3	5.9	5.7	4.7	2.2	4.8	4.1	4.0	2.5	2.1	6.7	0.3	6.1	1.9	2.1	4.2	5.1	0.8	0.5	3.2	0.4	0.5	0.9	0.2	0.0	0.1	18.2	0.1	0.6	0.7	0.9	1.6	0.0	0.4	1.0	0.2	0.2	1.5	6.2	1.0	0.3	0.0	0.3	1.2	0.0	0.3	0.0	0.2	0.1	1.5	0.1	0.1	4.2	2.0	0.9	0.1	0.6	0.1	0.3	0.1	0.3	0.1	1.2	0.8	0.0	0.2	0.1	0.1	2.9	0.2	0.2	0.3	0.0	0.1	0.1	1.4	0.4	2.9	0.1	0.3	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.8	1.1	0.4	0.2	0.9	0.3	0.2	0.6	0.4	0.2	0.1	0.8	0.4	0.3	3.2	0.5	0.3	0.5	0.2	0.2	8.8	9.9	6.1	7.9	8.9	5.7	6.9	4.4	5.9	6.7
PCDHGB7	"ME6, PCDH-GAMMA-B7"	ENSG00000254122	"Protocadherin gamma subfamily B, 7"	Q9Y5F8	5	141417645-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AN3-CA: 42.5;HSkMC: 13.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.22e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-2)"	10.1	9.8	12.6	3.8	13.5	0.8	8.0	19.1	12.9	10.2	7.0	16.1	1.2	2.3	11.6	5.0	6.8	7.8	9.2	8.5	14.5	7.9	5.4	3.5	11.6	2.6	10.4	7.3	17.3	5.5	9.5	5.3	11.0	9.4	8.3	3.8	15.5	7.1	12.0	5.6	6.8	3.2	10.5	20.1	5.3	4.5	4.2	14.3	0.6	8.4	3.0	2.3	4.6	6.9	0.2	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	42.5	1.0	0.2	0.4	2.8	0.3	1.0	2.1	0.0	2.6	0.3	2.3	5.6	0.7	0.1	0.5	1.0	0.0	0.3	0.0	0.0	0.0	3.2	0.2	0.0	13.5	0.3	0.8	0.4	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	4.7	0.9	0.0	0.1	0.0	4.6	6.3	0.1	0.0	0.0	0.4	0.4	5.5	5.1	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.6	13.5	19.1	12.9	14.5	7.9	10.4	7.3	9.4	14.3
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 23.6"	"Cell line enhanced"	"Detected in some"		"REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.7	2.9	5.7	0.7	9.5	0.5	0.8	23.6	21.9	1.0	1.1	2.3	0.0	0.6	0.9	1.2	0.8	1.0	1.0	1.3	4.1	10.1	0.6	0.6	1.0	0.9	3.3	4.5	0.8	1.2	0.8	1.3	0.8	8.6	0.8	0.8	1.9	1.0	0.7	1.2	1.5	0.7	0.9	2.3	0.8	0.7	1.5	0.8	0.0	0.7	0.0	1.0	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.2	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.3	0.9	0.9	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.0	1.5	0.0	9.7	0.6	0.0	0.0	0.1	8.2	15.9	0.1	0.0	0.2	0.1	0.3	0.1	0.9	0.1	0.2	0.7	0.2	0.0	0.2	0.6	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.5	23.6	15.6	4.1	10.1	3.3	4.5	8.6	0.8
PDCD11	"ALG-4, KIAA0185, RRP5"	ENSG00000148843	"Programmed cell death 11"	Q14690	10	103396648-103446292	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017924, CAB026472"	Approved		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"CAB026472: , HPA017924: AB_10601045"	"unprognostic (1.34e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.94e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.59e-2)"	11.3	11.8	11.6	13.9	12.5	9.6	13.8	12.6	12.0	11.0	10.4	10.6	8.9	8.5	17.3	10.6	17.3	14.3	9.9	10.3	10.5	7.0	11.0	14.0	11.3	14.7	9.9	8.6	16.5	17.2	17.7	14.4	10.9	10.5	12.1	12.0	9.2	11.3	13.0	42.8	22.3	11.1	13.6	9.5	14.7	10.8	22.8	12.4	20.7	10.9	13.8	17.0	11.2	16.8	5.6	5.4	1.4	4.4	3.4	9.1	3.5	10.1	15.1	10.5	29.6	9.2	8.3	11.8	11.2	7.9	11.3	9.3	20.5	10.0	28.0	8.0	8.0	18.2	27.0	14.1	12.8	12.9	18.2	16.3	9.6	16.4	11.0	32.4	11.2	8.6	13.0	17.4	39.8	12.1	26.1	12.6	10.9	11.5	16.2	18.5	21.6	14.6	16.4	15.1	12.7	7.1	10.0	7.1	13.3	7.5	8.9	12.4	8.8	9.2	13.1	8.4	10.6	11.2	20.9	16.1	22.4	26.6	7.4	31.4	6.2	0.1	4.4	1.4	5.7	4.3	9.1	5.6	5.4	4.6	4.7	4.1	4.8	5.6	0.6	3.4	3.6	5.4	3.8	3.5	11.6	12.5	12.6	12.0	10.5	7.0	9.9	8.6	10.5	12.4
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 260.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 6.4;NB-4: 6.8;NTERA-2: 11.8;REH: 13.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 29.7;NK-cell: 57.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 29.7;NK-cells: 57.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles				Vesicles		"HPA045118: "	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	0.9	1.3	0.4	2.9	0.5	4.7	0.7	0.5	0.6	0.4	0.8	0.5	0.4	0.0	0.4	0.5	0.6	0.3	1.6	0.5	0.5	0.7	3.8	2.6	2.0	13.8	0.6	0.5	0.5	0.4	0.0	0.5	8.6	0.5	0.5	0.5	260.3	0.5	0.4	0.6	0.8	2.8	0.4	0.8	17.9	0.7	2.2	0.5	2.5	0.6	0.4	4.6	2.1	0.4	1.3	8.6	29.7	7.7	57.8	2.4	3.7	0.2	0.3	0.5	0.0	0.3	0.0	0.0	0.3	1.2	1.2	1.3	0.1	0.8	0.6	0.2	0.7	0.1	0.2	0.2	2.9	0.2	0.0	0.9	0.1	6.4	1.0	0.1	0.2	0.0	0.2	1.2	0.0	3.3	0.1	0.3	1.3	0.8	0.1	6.8	11.8	0.4	13.7	0.1	2.1	0.0	0.0	0.1	0.3	0.0	0.3	0.5	0.1	0.8	1.3	0.4	0.1	0.2	0.3	0.1	0.6	1.0	1.6	2.7	0.2	29.7	5.1	8.6	1.2	7.7	0.4	0.8	0.3	0.6	8.6	1.3	0.7	2.4	0.7	57.8	4.2	0.8	0.0	3.7	0.4	0.5	0.5	0.6	0.5	0.7	0.6	0.5	0.5	0.5
PDE6H		ENSG00000139053	"Phosphodiesterase 6H"	Q13956	12	14973022-14981865	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"retina: 67.4"	"Group enriched"	"Detected in some"	4	"AN3-CA: 4.2;MOLT-4: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles				Vesicles		"HPA045118: "					"unprognostic (1.47e-3)"										"unprognostic (1.07e-2)"			0.1	1.3	1.2	0.2	1.5	9.4	0.1	0.1	4.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	1.0	2.1	0.1	0.1	0.2	0.2	2.2	0.1	0.1	0.1	0.0	0.1	2.5	0.7	0.1	0.1	67.4	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.8	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.6	0.7	0.0	0.0	1.4	0.2	0.0	0.8	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	1.2	1.5	0.1	4.2	1.0	2.1	2.2	0.1	0.7	0.1
PIGG	"FLJ20265, GPI7, LAS21"	ENSG00000174227	"Phosphatidylinositol glycan anchor biosynthesis class G"	Q5H8A4	4	499210-540196	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015997	Uncertain		Uncertain	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA015997: AB_2164679"	"unprognostic (3.87e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.48e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.61e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.97e-2)"	16.2	22.0	12.8	19.8	19.7	11.3	17.1	21.3	23.2	13.3	15.6	23.2	21.5	18.8	23.2	28.7	16.7	15.6	17.4	11.5	13.6	12.5	15.5	13.0	15.5	16.5	20.3	16.0	22.1	18.6	31.1	22.9	16.7	17.2	16.9	16.5	19.5	20.9	19.1	10.7	26.6	17.5	19.3	21.8	17.7	17.5	19.9	17.6	16.2	21.9	9.6	15.1	19.5	15.0	4.2	9.2	16.4	7.5	8.1	9.0	4.5	11.0	12.3	11.2	9.4	20.5	14.8	17.6	14.7	17.7	15.7	18.7	12.5	26.3	4.5	10.7	18.5	14.8	10.6	14.3	14.4	4.3	11.3	11.5	15.0	9.7	14.4	15.8	17.3	16.5	24.0	14.5	8.0	11.9	12.6	10.6	13.9	6.7	8.8	13.7	17.9	16.8	9.8	6.9	6.9	14.9	15.3	11.1	14.2	10.6	11.1	10.2	17.8	14.3	18.3	16.3	7.6	8.0	22.6	8.5	11.1	7.3	13.8	11.7	19.9	16.4	5.9	4.7	7.2	7.5	8.3	4.2	5.7	6.9	9.2	3.6	6.2	5.0	4.3	8.1	5.3	8.0	9.0	4.5	12.8	19.7	21.3	23.2	13.6	12.5	20.3	16.0	17.2	17.6
PIGZ	"FLJ12768, MGC52163, SMP3"	ENSG00000119227	"Phosphatidylinositol glycan anchor biosynthesis class Z"	Q86VD9	3	196946343-196969060	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058599, HPA059920"	Approved		Uncertain	Vesicles				Vesicles		"HPA058599: , HPA059920: "	"unprognostic (1.46e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.25e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (5.60e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.02e-3)"	6.6	3.1	5.7	5.3	8.6	1.9	3.4	18.5	16.3	3.3	26.5	3.2	2.0	2.9	2.3	1.7	3.2	2.8	4.5	6.4	5.3	7.5	1.6	1.6	3.1	2.0	4.4	6.4	0.8	5.9	2.7	2.9	2.1	10.8	4.6	24.5	4.3	4.7	4.6	10.0	4.5	7.4	5.3	2.8	1.8	3.1	1.4	3.0	3.2	1.7	2.8	2.1	9.9	2.9	0.1	1.6	1.4	3.3	0.0	0.2	0.3	2.0	1.4	0.8	3.3	9.1	4.4	0.8	3.0	8.5	2.3	1.9	1.9	1.7	0.3	6.0	6.7	3.4	0.2	0.4	0.6	0.6	0.4	0.9	0.7	7.3	4.3	0.0	3.4	4.4	6.5	0.3	1.1	2.8	0.2	2.6	2.2	3.6	0.3	1.7	0.1	1.1	0.5	0.1	0.6	3.5	3.8	1.3	1.5	4.2	0.3	1.6	8.4	2.9	6.9	1.9	0.5	5.5	1.0	1.2	0.2	0.1	0.4	1.2	0.7	0.0	1.1	0.8	0.2	3.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	1.4	0.0	1.4	0.3	0.0	0.3	5.7	8.6	18.5	16.3	5.3	7.5	4.4	6.4	10.8	3.0
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 95.0"	"Cell line enhanced"	"Detected in many"		"AF22: 35.0;RH-30: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"				"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: "	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (4.94e-6)"	"prognostic unfavourable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	14.6	28.5	2.3	14.8	4.3	7.7	12.3	2.0	7.6	12.9	8.9	4.6	10.0	3.9	19.5	16.3	12.4	7.7	13.0	9.0	5.1	1.5	6.8	1.5	12.1	8.2	2.6	2.2	16.0	11.2	5.2	45.6	95.0	3.6	12.6	8.6	19.3	11.7	7.3	4.5	23.1	7.9	16.8	3.8	6.8	10.9	6.8	2.0	3.9	5.6	24.2	12.0	14.2	18.4	4.1	10.3	16.4	8.1	1.7	1.4	2.3	0.0	1.5	35.0	0.0	13.9	28.6	0.1	12.0	7.7	6.0	12.5	0.1	1.9	0.8	5.9	10.4	0.0	0.2	4.2	11.8	0.9	1.6	14.9	17.5	0.2	4.6	13.3	3.0	21.5	1.5	5.2	4.6	11.8	1.4	0.2	7.1	2.0	5.5	6.2	5.8	1.1	6.7	35.6	0.0	11.2	0.3	3.1	3.4	17.3	0.0	0.0	0.0	16.5	6.8	0.0	12.8	27.7	12.9	3.1	3.0	0.1	9.2	5.5	0.6	3.4	8.1	16.4	1.0	6.2	1.0	2.7	0.9	1.4	10.3	4.1	0.7	1.2	14.8	1.7	1.9	4.6	1.3	2.3	2.3	4.3	2.0	7.6	5.1	1.5	2.6	2.2	3.6	2.0
PLEK2		ENSG00000100558	"Pleckstrin 2"	Q9NYT0	14	67386983-67412200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 26.4;CAPAN-2: 28.2;HBEC3-KT: 52.6;PC-3: 19.2;TIME: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.0;naive CD4 T-cell: 6.5"	"Lineage enriched"	"Detected in single"	8	"T-cells: 6.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA001208	Enhanced		Uncertain	Vesicles,Cytosol				Vesicles	Cytosol	"HPA001208: AB_1079631"	"unprognostic (4.41e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (8.26e-5)"	"unprognostic (1.06e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.59e-2)"	1.7	28.8	0.5	7.6	1.1	4.1	1.5	0.5	0.8	2.4	14.9	1.4	1.6	12.4	1.1	14.9	9.7	0.4	7.4	0.5	0.5	0.2	6.0	29.1	1.9	0.5	0.5	0.5	1.0	16.5	2.5	0.9	2.6	0.7	5.1	12.7	0.9	6.9	2.3	1.4	12.1	28.1	1.2	0.7	0.6	8.5	2.4	0.5	13.9	28.6	6.5	6.5	4.8	4.4	0.0	0.8	0.0	0.1	0.0	6.5	1.2	26.4	4.0	0.0	0.0	0.0	0.3	2.6	5.3	0.8	1.2	1.5	14.4	28.2	0.0	5.2	0.7	12.6	0.0	52.6	3.0	0.0	0.2	0.0	6.1	0.1	1.1	0.0	0.0	0.6	3.8	1.4	16.9	4.4	0.1	0.1	0.9	8.4	0.0	0.0	0.1	19.2	0.0	0.0	4.1	9.0	0.7	0.2	0.0	5.0	2.3	1.5	3.5	0.2	20.5	0.0	16.5	0.1	0.1	0.0	0.0	0.1	3.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.7	0.8	0.0	6.5	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.5	1.1	0.5	0.8	0.5	0.2	0.5	0.5	0.7	0.5
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"		2700000	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (2.43e-4)"	29.0	19.5	14.9	16.8	24.0	7.1	32.1	12.1	17.6	35.8	21.7	17.0	17.7	19.1	34.2	21.1	16.5	24.7	21.3	31.2	17.6	14.8	27.5	51.3	22.2	19.7	24.5	9.9	31.8	30.3	18.2	16.3	41.5	20.8	21.1	12.0	25.1	39.3	22.0	18.3	13.3	20.8	39.0	13.2	21.1	18.6	10.0	22.4	1.7	34.8	11.1	8.2	19.5	69.7	1.6	16.3	17.7	19.4	2.6	9.1	9.3	17.6	15.1	8.3	38.9	56.9	31.9	6.7	52.5	69.7	27.7	47.1	17.2	11.6	10.2	55.5	57.9	14.9	12.1	18.3	19.1	10.6	12.9	5.5	24.3	21.8	35.3	3.4	26.8	38.7	9.6	33.4	13.4	49.0	15.4	5.0	28.8	11.4	0.8	9.2	3.7	22.5	4.1	16.9	22.1	15.9	4.0	3.2	13.2	22.9	15.7	26.4	7.9	8.8	48.4	31.7	23.8	39.6	25.7	11.7	19.1	6.1	70.2	12.1	51.6	0.0	19.4	0.9	9.1	17.2	1.6	1.0	1.6	4.4	16.3	1.6	0.6	3.4	17.7	2.6	15.0	2.4	1.0	9.3	14.9	24.0	12.1	17.6	17.6	14.8	24.5	9.9	20.8	22.4
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Cell line enhanced"	"Detected in all"		"HMC-1: 79.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 73.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011616, HPA049104"	Enhanced		Uncertain	Vesicles				Vesicles		"CAB011616: AB_731977, HPA049104: "	"unprognostic (1.67e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.77e-1)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.22e-2)"	"prognostic favourable (5.65e-4)"	5.5	8.6	10.1	9.5	10.7	21.9	13.5	73.6	16.6	7.0	5.5	5.8	6.0	4.9	6.2	11.2	12.4	6.3	11.3	16.3	9.8	9.6	7.2	15.8	9.1	11.8	8.4	10.3	10.3	7.7	10.3	11.6	5.0	10.9	11.4	6.3	6.8	22.1	6.9	36.6	10.8	4.9	6.6	10.0	8.1	6.4	29.5	5.4	9.7	7.7	17.2	10.1	11.5	9.2	4.9	33.8	25.1	9.4	7.9	7.2	4.2	10.8	6.5	11.3	22.5	6.3	6.0	9.5	6.9	8.0	11.5	10.6	9.1	12.7	9.8	8.8	4.4	5.5	9.4	8.1	14.2	6.4	10.2	7.1	5.4	12.3	9.7	5.0	79.7	5.3	9.6	8.5	10.0	8.7	15.5	6.3	11.1	6.4	20.7	14.2	15.2	7.5	11.9	11.4	8.4	21.6	8.8	6.4	11.7	8.2	5.5	20.9	14.7	8.6	4.8	5.5	7.7	13.7	6.7	9.2	15.3	13.9	5.5	10.7	14.3	12.5	5.9	17.3	4.9	7.2	5.5	4.9	5.2	5.3	6.1	4.5	5.8	5.4	25.1	7.9	9.4	33.8	7.2	4.2	10.1	10.7	73.6	16.6	9.8	9.6	8.4	10.3	10.9	5.4
PPFIA3	"KIAA0654, LPNA3, MGC126567, MGC126569"	ENSG00000177380	"PTPRF interacting protein alpha 3"	O75145	19	49119389-49151026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 22.1;pituitary gland: 14.9;skin 1: 25.3"	"Cell line enhanced"	"Detected in many"		"PC-3: 23.0;SK-BR-3: 18.8;U-266/70: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043567, HPA050340"	Enhanced		Uncertain	"Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center, Vesicles"		"HPA043567: , HPA050340: "	"prognostic unfavourable (3.09e-4)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-3)"	"prognostic favourable (8.65e-4)"	"unprognostic (3.46e-1)"	"prognostic favourable (6.46e-7)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (1.27e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.41e-3)"	"unprognostic (5.21e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-1)"	1.6	3.9	13.9	1.6	9.3	0.9	2.2	22.1	20.8	1.2	4.3	1.6	1.7	5.1	1.6	1.1	4.4	1.3	1.4	1.4	12.8	12.2	1.1	1.6	1.8	1.6	7.4	13.7	1.0	4.9	4.1	14.9	1.1	7.3	3.4	2.0	1.6	2.7	1.6	1.7	25.3	4.6	1.2	2.4	1.3	2.3	2.1	1.8	0.0	1.8	1.2	2.2	1.1	1.9	0.0	0.0	0.0	0.0	0.2	1.1	0.3	1.9	2.0	2.0	5.1	0.0	0.0	3.9	0.2	0.2	1.0	1.4	1.4	0.8	4.5	2.7	0.2	1.0	3.1	0.4	0.2	4.8	6.8	2.8	1.8	1.0	0.2	1.1	7.3	0.2	1.1	0.6	0.3	0.0	5.4	7.1	0.1	8.7	1.4	1.9	0.9	23.0	4.6	4.0	2.2	0.3	1.0	4.2	5.8	0.8	18.8	2.0	10.4	2.7	0.4	1.1	4.0	0.7	0.1	13.3	10.9	3.3	1.1	4.5	2.6	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.4	0.0	0.0	1.1	0.2	0.0	0.2	0.0	0.0	0.0	0.3	13.9	9.3	22.1	19.8	12.8	12.2	7.4	13.7	7.3	1.8
PPP1R15A	GADD34	ENSG00000087074	"Protein phosphatase 1 regulatory subunit 15A"	O75807	19	48872392-48876057	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 156.9"	"Cell line enhanced"	"Detected in all"		"HHSteC: 54.6;hTERT-HME1: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 69.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.8;granulocytes: 69.8"					"Low region specificity"	"Detected in all"			"CAB018395, HPA020240"	Approved		Uncertain	Vesicles				Vesicles		"CAB018395: AB_2237473, HPA020240: AB_1849404"	"unprognostic (2.43e-3)"	"unprognostic (3.21e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.43e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.94e-2)"	39.8	29.1	16.2	33.6	12.9	156.9	56.3	12.1	12.8	26.3	19.7	13.6	12.0	12.0	37.8	19.5	28.2	34.0	32.3	42.0	14.6	13.9	18.6	18.6	56.5	10.6	29.5	6.3	24.5	10.9	9.8	16.2	44.7	31.5	28.2	15.6	12.4	9.2	23.6	35.2	40.0	16.0	36.2	17.7	13.3	19.8	14.5	17.8	3.4	18.6	46.7	19.0	41.1	114.7	8.1	23.8	69.8	10.3	2.5	6.1	6.6	9.9	4.3	4.7	3.8	13.7	7.8	7.4	17.5	27.5	20.1	18.2	6.6	5.1	3.4	4.7	12.6	7.2	1.7	9.1	15.2	1.9	2.6	15.6	2.5	3.2	54.6	3.6	22.5	10.6	25.5	27.7	94.1	10.4	20.9	29.1	12.9	1.1	1.9	5.0	1.1	7.9	2.2	4.3	1.1	4.1	11.7	2.6	4.6	9.0	6.2	39.6	2.2	6.5	11.1	24.0	6.0	16.8	10.7	15.7	12.4	3.3	8.8	2.5	28.7	27.4	10.3	17.7	4.9	6.3	4.3	8.1	4.8	4.0	7.3	5.5	2.7	2.4	69.8	2.5	7.1	23.8	6.1	6.6	16.2	12.9	12.1	12.8	14.6	13.9	29.5	6.3	31.5	17.8
PRPS2		ENSG00000101911	"Phosphoribosyl pyrophosphate synthetase 2"	P11908	X	12791355-12824222	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.1;testis: 109.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067599, CAB070417"	Enhanced		Uncertain	Vesicles				Vesicles		"CAB070417: AB_11152035, HPA067599: "	"unprognostic (7.50e-2)"	"prognostic favourable (1.90e-4)"	"unprognostic (2.09e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.64e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	5.4	20.8	4.0	10.2	8.7	6.1	6.1	3.7	11.5	18.7	13.3	5.7	44.4	4.1	17.0	21.7	9.6	9.6	13.2	3.3	4.0	3.5	10.8	9.0	5.4	10.7	2.7	7.7	75.3	19.9	20.1	2.4	3.2	2.9	14.9	10.2	4.4	11.1	138.1	1.5	10.3	6.3	12.2	3.9	7.6	14.3	109.7	3.1	26.2	7.8	5.5	10.9	15.1	10.2	21.9	17.7	10.5	12.5	15.0	22.7	16.7	31.0	20.6	7.2	13.0	8.9	10.5	4.0	15.5	8.5	17.2	16.7	14.6	25.0	9.1	7.0	7.4	23.6	13.8	16.9	20.3	24.5	29.8	11.2	17.0	13.5	8.2	22.1	11.5	10.1	11.4	12.7	17.0	7.0	8.3	12.7	14.5	21.4	33.7	10.2	15.3	27.8	18.0	30.8	23.3	10.3	25.8	13.9	9.4	18.7	0.7	11.7	18.6	10.0	6.5	13.5	9.8	49.5	16.5	30.0	11.0	21.7	14.2	11.2	21.2	10.5	12.5	5.6	11.7	12.4	13.6	18.0	17.0	11.1	17.7	21.9	22.7	15.3	5.5	15.0	7.7	12.6	14.0	16.7	4.0	8.7	3.7	11.5	4.0	3.5	2.7	7.7	2.9	3.1
PRR15		ENSG00000176532	"Proline rich 15"	Q8IV56	7	29563811-29567295	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.2;CAPAN-2: 17.2;HaCaT: 19.9;RT4: 15.2;SK-BR-3: 33.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040996, HPA048121"	Enhanced		Uncertain	"Vesicles,Cell Junctions"				Vesicles	"Cell Junctions"	"HPA040996: , HPA048121: "	"unprognostic (5.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"prognostic favourable (6.37e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.25e-1)"	"prognostic favourable (1.83e-6)"	"unprognostic (1.30e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.58e-2)"	3.8	0.5	0.7	14.4	0.4	0.0	3.1	0.4	0.8	22.8	58.9	0.8	2.6	24.8	6.8	13.3	0.7	2.9	12.1	1.0	0.6	0.5	12.7	0.5	3.7	0.6	0.4	0.4	4.0	2.0	0.0	2.7	19.0	0.5	2.7	18.5	0.3	4.6	0.9	0.5	0.3	66.1	1.1	1.1	0.4	16.6	1.4	0.4	0.3	1.0	1.0	1.9	7.0	1.9	1.6	0.0	0.0	0.5	0.0	0.0	0.6	7.2	10.3	0.0	0.0	4.0	5.0	13.2	0.3	0.5	0.2	0.1	9.0	17.2	0.0	1.9	2.4	19.9	2.2	0.0	0.0	0.0	1.4	0.5	1.9	9.8	1.3	0.0	0.0	0.0	3.3	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.2	1.4	1.6	8.2	0.0	0.0	9.1	11.9	15.2	0.2	0.1	1.0	33.5	0.0	2.4	0.0	8.8	0.2	0.0	0.0	0.4	0.8	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.4	0.8	0.6	0.5	0.4	0.4	0.5	0.4
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 98.3"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 14.3;HMC-1: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 98.3;monocytes: 28.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"				"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	5.6	2.3	2.4	16.2	1.9	20.3	2.4	0.6	2.0	6.9	3.4	1.6	3.5	1.8	2.8	1.4	16.8	2.8	7.5	3.5	2.1	2.3	6.4	1.8	9.2	6.1	4.1	1.0	1.5	2.7	0.9	0.7	3.5	1.8	2.6	3.4	0.6	3.4	2.6	1.1	2.8	5.0	3.8	5.1	15.4	2.3	2.2	1.1	2.3	1.4	22.2	21.7	5.9	3.6	1.5	13.2	98.3	28.2	0.0	0.1	10.1	7.5	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	2.1	0.5	0.0	0.0	5.2	0.2	14.3	0.3	0.1	0.2	2.8	0.0	0.3	0.0	0.7	52.4	0.0	2.3	0.1	0.1	0.0	0.2	0.2	0.0	0.5	0.0	7.1	0.2	0.1	0.1	0.0	0.0	3.5	0.8	0.1	0.0	0.0	7.1	0.0	0.1	2.0	0.0	0.1	0.3	0.0	0.0	0.5	0.4	2.1	0.0	0.9	0.2	5.9	28.2	98.3	0.0	8.9	0.1	1.5	0.0	0.0	13.2	0.7	0.0	0.0	85.7	0.0	3.5	0.1	0.1	10.1	2.4	1.9	0.6	2.0	2.1	2.3	4.1	1.0	1.8	1.1
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 32.9;HL-60: 13.0;U-266/70: 14.2;U-698: 17.6;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	32.9	0.0	0.1	0.0	0.0	0.0	0.2	3.1	0.0	4.6	0.0	0.0	0.1	13.0	10.3	2.9	0.0	1.4	0.1	5.1	0.0	7.5	5.0	0.1	9.2	7.4	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	2.3	7.8	0.1	0.1	0.2	14.2	3.0	17.6	5.4	13.4	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase, receptor type C"		1	198638457-198757476	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	4	"blood: 116.9;lymphoid tissue: 172.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 51.0;HEL: 28.8;HL-60: 26.0;MOLT-4: 38.5;THP-1: 21.4;U-266/70: 23.9;U-266/84: 21.6;U-698: 30.6;U-937: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"			"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: , CAB068221: , HPA000440: AB_1078468"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	9.8	2.9	3.4	48.0	6.2	36.1	4.3	1.3	3.5	3.1	5.6	2.8	0.5	4.9	2.9	3.9	4.8	5.6	8.8	4.9	3.9	4.5	4.4	5.2	27.5	93.2	7.9	1.3	2.9	2.1	0.3	2.5	4.5	5.3	4.2	5.8	3.3	10.7	1.0	1.7	2.5	22.2	4.5	13.2	89.3	6.5	2.3	5.3	172.5	4.6	3.9	53.2	13.1	3.7	28.5	42.8	94.7	103.8	53.7	76.1	116.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	51.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	28.8	0.0	0.0	0.0	26.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.8	0.0	0.0	38.5	15.7	0.1	0.1	1.1	0.1	0.1	0.0	0.0	0.3	0.4	0.0	0.1	0.1	0.0	21.4	0.3	0.0	0.2	0.1	0.1	23.9	21.6	30.6	0.0	23.3	0.1	20.8	52.0	56.3	76.1	99.7	64.5	28.5	52.9	72.7	42.8	26.8	60.2	60.3	94.7	53.7	103.8	6.4	54.6	116.9	3.4	6.2	1.3	3.5	3.9	4.5	7.9	1.3	5.3	5.3
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase, receptor type K"	Q15262	6	127968779-128520674	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 4.8;T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"			13000000	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: , HPA054822: "	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favourable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	12.0	5.2	18.6	10.7	20.3	1.2	20.9	4.7	24.4	12.2	21.9	25.6	11.2	25.7	12.1	10.3	9.1	13.2	29.6	11.4	17.2	12.6	13.3	23.6	17.4	5.7	20.5	19.3	15.6	25.7	11.4	12.2	17.4	14.9	16.3	23.4	3.9	18.3	17.5	9.1	13.5	27.4	14.6	17.1	6.4	24.6	2.7	23.7	15.3	10.1	6.5	7.6	18.4	15.1	4.8	0.0	0.0	0.0	0.4	1.6	0.2	4.4	4.8	2.9	0.2	6.1	8.2	2.9	12.1	23.5	5.0	4.6	8.0	3.7	0.0	3.7	11.1	12.7	3.0	9.6	7.1	13.4	4.9	0.1	7.4	11.1	7.5	0.0	0.4	6.0	8.9	10.5	14.4	13.7	0.0	0.2	12.3	9.0	6.8	0.0	3.0	6.2	24.5	6.2	0.8	12.4	9.2	15.3	0.0	12.5	14.0	0.7	3.8	0.3	23.1	7.9	5.5	15.3	10.9	0.1	1.6	0.0	10.1	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	4.8	0.4	1.6	0.0	0.4	0.0	0.0	0.1	0.2	18.6	20.3	4.7	24.4	17.2	12.6	20.5	19.3	14.9	23.7
RAB26		ENSG00000167964	"RAB26, member RAS oncogene family"	Q9ULW5	16	2140803-2154165	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7"	"Cell line enhanced"	"Detected in many"		"A549: 13.6;HeLa: 14.9;MCF7: 8.9;SCLC-21H: 18.9;SK-BR-3: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075624			Uncertain	"Vesicles,Plasma membrane,Centrosome"	"Intracellular and membrane"			"Vesicles, Plasma membrane"	Centrosome	"HPA075624: "	"unprognostic (1.01e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (7.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.92e-3)"	0.6	1.0	13.6	0.4	19.9	0.5	0.9	30.5	13.5	2.0	4.1	0.5	1.5	5.7	0.4	2.3	1.2	0.9	1.1	1.2	18.0	6.2	0.7	21.9	0.6	0.6	5.6	9.1	0.6	24.6	3.1	9.2	0.3	2.5	2.2	5.4	0.7	17.7	1.6	1.1	1.2	6.0	0.4	1.9	0.6	5.3	0.6	3.2	0.0	1.2	0.0	1.1	0.9	0.0	0.8	0.2	0.0	0.1	0.0	1.1	0.7	1.1	13.6	0.0	3.5	0.2	0.1	0.1	0.6	1.1	0.5	0.9	0.4	2.7	0.2	0.9	0.8	2.2	0.7	0.2	0.0	1.5	1.4	0.5	14.9	1.2	0.6	0.0	0.4	0.5	0.1	0.1	0.2	0.3	0.3	0.0	1.6	8.9	0.0	0.6	0.8	1.2	1.1	1.1	2.3	5.2	0.9	18.9	3.7	0.3	17.1	0.6	5.6	0.2	0.6	0.0	2.5	0.2	0.2	2.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.7	13.6	19.9	30.5	13.5	18.0	6.2	5.6	9.1	2.5	3.2
RAB33A	RabS10	ENSG00000134594	"RAB33A, member RAS oncogene family"	Q14088	X	130171649-130184870	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.3;brain: 32.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 31.6;Karpas-707: 35.9;U-266/70: 26.3;U-937: 14.9"	"Group enriched"	"Detected in many"	6	"glioma: 10.7;melanoma: 2.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059737	Uncertain		Uncertain	Vesicles				Vesicles		"HPA059737: "	"unprognostic (5.40e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.00e-6)"	"unprognostic (2.51e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.61e-1)"	1.8	2.3	12.5	4.9	11.6	6.8	1.6	15.8	32.4	2.0	1.7	20.8	0.0	1.6	2.1	1.4	1.4	2.2	3.5	10.3	15.9	9.9	1.1	1.5	1.9	11.9	13.0	12.6	2.5	0.8	3.2	1.6	2.3	10.1	1.1	1.9	0.6	1.5	1.0	0.8	1.0	1.9	1.6	21.5	3.3	2.3	1.5	17.3	1.2	1.0	0.0	13.1	3.3	0.6	7.1	3.3	27.3	1.7	5.7	22.9	5.9	0.0	0.0	2.1	0.0	0.9	0.2	0.0	0.2	0.6	0.5	0.9	0.0	0.2	1.6	0.0	0.1	0.0	2.5	0.0	0.5	8.2	0.0	9.4	0.0	0.0	8.8	7.6	31.6	0.3	0.0	0.1	0.3	0.2	0.0	35.9	0.0	0.0	3.5	2.7	0.3	0.3	0.0	0.0	0.4	0.0	0.0	6.9	5.7	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.1	0.0	26.3	7.8	0.0	1.1	14.9	0.0	9.4	0.4	27.3	11.2	0.2	7.0	7.1	10.1	11.1	3.3	2.6	9.8	13.9	1.3	5.7	1.7	0.3	22.9	5.9	12.5	11.6	15.8	18.5	15.9	9.9	13.0	12.6	10.1	17.3
RAB40A	"Rar-2, RAR2A"	ENSG00000172476	"RAB40A, member RAS oncogene family"	Q8WXH6	X	103499130-103519489	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 34.0"	"Cell line enhanced"	"Detected in many"		"AF22: 6.4;NTERA-2: 7.1"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.2"									HPA076172			Uncertain	Vesicles				Vesicles		"HPA076172: "	"unprognostic (3.49e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.49e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.43e-1)"	"unprognostic (7.36e-4)"	"unprognostic (7.85e-3)"	"unprognostic (9.39e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.11e-3)"	2.0	1.4	0.6	0.6	4.2	0.0	0.8	0.6	1.1	2.8	0.8	0.6	11.9	0.5	5.5	34.0	10.6	2.6	2.9	0.6	0.6	0.9	1.3	0.6	2.0	1.7	0.6	0.6	5.4	0.6	0.6	2.4	0.8	0.8	5.5	0.4	0.6	0.6	6.2	0.6	0.7	0.9	1.3	0.6	0.8	0.5	7.8	0.6	0.6	0.6	0.6	0.6	1.5	2.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	1.7	6.4	0.2	1.4	1.9	3.1	1.9	0.4	0.3	0.5	1.3	0.9	1.6	2.4	0.3	0.1	0.4	0.1	0.3	0.0	3.7	0.5	2.9	0.3	0.6	0.1	0.2	1.5	0.3	0.6	0.4	0.3	2.3	1.0	0.6	0.4	0.4	0.2	7.1	1.0	0.0	0.5	0.1	0.1	0.6	2.7	3.3	0.6	0.1	1.3	0.0	0.2	3.2	2.6	1.5	4.0	1.8	1.1	0.7	1.2	2.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.6	4.2	0.6	0.6	0.6	0.9	0.6	0.6	0.8	0.6
RAB40AL	"RAR2, RLGP"	ENSG00000102128	"RAB40A like"	P0C0E4	X	102937272-102938300	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;HEK 293: 1.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"											HPA076172			Uncertain	Vesicles				Vesicles		"HPA076172: "	"unprognostic (1.99e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.90e-10)"	"unprognostic (4.74e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.64e-2)"	0.3	1.0	0.2	0.2	0.3	0.7	0.4	2.1	0.4	0.3	0.4			1.0	0.8	2.9	0.2	0.3	0.7	0.3	0.3	0.3	0.2	0.5	0.5	0.0	0.2		1.0	0.2	0.0	0.9	0.6		0.8	0.1		0.2	0.5	0.0	0.2	0.1	0.6	0.4	0.2	0.1	0.3			0.8		0.2	0.0	0.5	0.0	1.2	0.0	0.3	0.0	0.7	0.0	0.5	0.6	0.8	0.2	0.0	0.0	2.3	0.0	0.2	0.0	0.5	0.0	0.5	0.0	0.6	0.0	0.0	1.2	0.0	0.6	0.2	1.9	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.3	0.3	0.4	0.3	0.3	0.0	0.0	1.4	0.6	0.9	0.6	1.6	0.0	0.3	0.0	0.2	1.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.3	1.4	0.5	0.4	0.3	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0										
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616757	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 58.0"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 27.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043010	Uncertain		Uncertain	Vesicles				Vesicles		"HPA043010: "	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	5.5	2.3	4.2	2.5	2.6	1.6	4.4	2.7	4.7	4.9	4.0			3.6	6.3	1.8	1.9	3.6	1.9	1.5	3.6	3.0	3.3	0.2	2.7	3.6	1.9		4.1	2.1	6.8	3.7	4.0		3.3	1.6		2.0	5.6	58.0	5.4	4.3	3.2	1.2	4.1	2.2	0.6			2.2		2.4	3.9	4.7	3.6	11.3	2.2	9.4	1.5	3.7	3.1	0.7	1.2	9.1	1.8	1.6	4.7	0.3	9.3	4.7	3.1	3.3	3.7	2.7	7.1	6.9	14.1	9.1	0.4	0.1	2.3	1.3	2.4	2.0	3.6	0.9	1.8	1.3	2.7	4.3	1.1	0.8	0.4	1.6	3.1	10.5	0.7	3.6	7.1	4.9	0.7	4.7	9.7	2.0	10.2	0.3	3.4	8.9	18.6	1.7	2.1	1.2	1.8	3.6	2.3	27.3	13.3	3.1	2.3	16.6	10.2	6.1	3.4	3.0	3.3	0.4	8.4	0.3	1.9	9.4	3.7	2.8	3.2	2.2	11.3	3.6	3.4	2.4	2.2	1.5	1.2	9.8	3.5	3.1										
RASA4B		ENSG00000170667	"RAS p21 protein activator 4B"	C9J798	7	102482445-102517781	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 47.4"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 6.2;monocytes: 3.7"									HPA043010	Uncertain		Uncertain	"Vesicles,Cell Junctions"				"Cell Junctions"	Vesicles	"HPA043010: "	"unprognostic (1.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.10e-1)"	2.9	1.1	2.3	1.4	1.2	0.0	2.1	0.5	4.4	3.2	2.4			2.5	4.1	0.0	0.6	1.5	1.3	0.5	1.8	2.0	0.9	0.1	0.8	1.3	1.1		2.2	0.9	0.0	1.1	1.7		1.5	0.0		0.7	3.7	47.4	1.8	3.0	0.5	0.5	1.9	0.8	0.2			0.3		0.2	1.4	2.3	0.1	6.2	0.0	3.7	0.0	0.2	1.8	0.2	0.9	3.2	0.2	0.5	1.9	0.1	5.7	3.0	1.2	2.9	0.2	0.4	2.2	6.4	6.5	7.6	0.0	0.0	0.0	0.2	0.7	0.3	1.7	0.5	0.0	0.0	0.2	2.1	0.3	0.0	0.0	0.8	0.6	8.1	0.7	2.1	0.0	1.1	0.0	0.9	2.3	1.1	3.6	0.0	0.8	2.2	11.8	0.9	0.2	0.2	0.2	1.5	1.0	16.5	14.1	1.3	0.5	2.7	1.8	0.2	1.9	0.4	2.6	0.0	3.7	0.0	0.2	3.7	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.6	3.9	0.0	1.8										
RELL2	"C5orf16, FLJ90583"	ENSG00000164620	"RELT like 2"	Q8NC24	5	141636950-141641077	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;parathyroid gland: 27.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077928			Uncertain	Vesicles				Vesicles		"HPA077928: "	"unprognostic (3.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.76e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.85e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.31e-2)"	"unprognostic (6.58e-2)"	2.0	4.5	6.9	2.4	12.3	2.2	2.3	12.5	27.6	1.4	2.3	2.3	0.0	2.5	1.3	1.8	2.7	1.2	2.4	1.6	10.8	14.5	3.3	1.8	2.7	4.7	17.8	8.4	1.1	2.2	27.6	9.4	7.4	24.9	2.2	2.1	1.7	3.7	1.8	1.0	4.2	1.8	2.2	3.8	5.4	2.3	4.6	2.5	4.6	2.8	1.7	5.0	2.9	0.9	2.5	7.8	1.2	3.5	0.1	5.4	1.9	0.9	3.0	3.0	5.7	2.4	0.7	1.4	2.6	4.8	8.4	12.5	11.3	1.1	0.1	1.2	3.9	4.6	2.8	10.9	2.2	2.7	1.8	6.9	6.5	5.6	3.9	2.2	20.0	1.6	6.8	7.8	5.7	2.3	2.4	3.6	1.9	1.4	4.0	0.8	3.5	1.5	0.2	0.6	4.7	2.7	2.7	5.0	5.5	2.3	11.0	1.8	3.8	5.2	2.0	6.5	2.9	5.1	4.4	2.1	5.7	16.2	3.5	9.6	4.1	0.0	1.4	0.0	3.0	3.5	1.1	2.5	3.2	3.0	2.3	1.5	2.9	1.6	1.2	0.1	2.5	7.8	5.4	1.9	6.9	12.3	12.5	27.6	10.8	14.5	17.8	8.4	24.9	2.5
RGPD4	"DKFZp686P0288, RGP4"	ENSG00000196862	"RANBP2-like and GRIP domain containing 4"	Q7Z3J3	2	107826937-107890841	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"testis: 8.6"	"Cell line enriched"	"Detected in single"	12	"U-266/70: 4.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.5"									"HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"HPA049497: , HPA051675: , HPA067564: "	"unprognostic (4.96e-2)"	"unprognostic (3.04e-1)"			"unprognostic (4.38e-1)"	"unprognostic (1.31e-1)"		"unprognostic (2.46e-1)"		"unprognostic (1.29e-1)"	"unprognostic (3.05e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.69e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6			0.0		0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.3	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.4	0.2	0.1	0.1	0.2	0.0	1.5	0.1										
RGPD5	"BS-63, DKFZp686I1842, RGP5"	ENSG00000015568	"RANBP2-like and GRIP domain containing 5"	Q99666	2	109792758-109857695	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 10.5;PC-3: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"HPA045704: , HPA049497: , HPA051675: , HPA067564: "	"unprognostic (2.50e-2)"				"unprognostic (1.55e-1)"			"unprognostic (3.49e-1)"		"unprognostic (2.23e-1)"		"unprognostic (4.23e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.19e-3)"		"unprognostic (3.19e-1)"		4.9	5.0	5.2	2.5	11.7	11.4	9.4	8.2	6.3	6.4	5.2	7.5	6.0	12.3	6.8	6.1	2.6	4.0	3.4	4.4	4.7	4.8	5.3	5.1	5.6	3.0	5.1	4.9	6.0	11.9	3.8	15.1	4.9	5.6	6.4	2.0	8.3	8.5	4.9	7.4	5.2	5.8	6.9	4.9	3.7	8.7	15.7	3.7	1.0	6.8	3.2	2.6	6.3	15.3	6.9	4.3	9.2	3.5	2.8	6.7	0.9	8.3	4.7	1.7	1.8	0.4	0.1	1.6	4.2	1.3	1.6	2.4	9.0	1.0	0.6	5.3	0.7	3.4	1.4	0.3	0.3	1.9	10.5	3.7	3.6	0.2	0.2	0.6	0.5	0.7	2.3	0.9	0.6	0.9	2.3	2.1	0.7	2.3	0.4	1.2	2.4	11.0	3.6	5.8	0.0	0.5	3.0	5.7	3.2	5.0	0.0	1.4	0.1	0.9	5.8	1.8	6.4	0.4	2.3	4.0	0.3	0.6	3.2	0.1	0.7	6.8	3.5	4.1	4.1	1.6	6.7	4.0	3.8	4.0	2.3	6.9	4.9	3.7	9.2	2.8	3.0	4.3	2.9	0.9	5.2	11.7	8.2	6.3	4.7	4.8	5.1	4.9	5.6	3.7
RGPD6	RGP6	ENSG00000183054	"RANBP2-like and GRIP domain containing 6"	Q99666	2	110513812-110577185	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"HPA045704: , HPA049497: , HPA051675: , HPA067564: "	"unprognostic (1.11e-2)"				"unprognostic (6.38e-2)"			"unprognostic (1.18e-1)"		"unprognostic (3.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.14e-4)"		"unprognostic (2.04e-1)"		5.6	4.1	3.2	2.4	4.9	6.9	5.5	5.6	8.1	4.5	3.8			2.1	4.9	10.1	2.3	3.8	3.4	4.7	3.8	4.4	3.3	4.7	5.1	2.8	3.4		6.4	6.9	8.5	9.5	5.3		6.0	3.5		3.3	4.4	5.2	6.2	4.1	3.5	2.6	3.2	4.0	19.9			7.5		2.4	3.8	3.7	5.7	3.8	8.1	2.6	2.9	4.1	0.3	13.8	3.4	16.6	12.5	5.0	6.1	1.7	10.1	9.2	8.3	5.9	11.3	5.1	0.3	7.4	8.7	6.1	10.2	5.6	11.0	3.3	5.8	14.6	1.2	7.7	6.2	1.9	1.9	5.5	5.7	10.6	10.9	5.3	6.2	3.4	6.9	4.0	4.4	0.4	11.1	4.3	2.1	8.4	0.1	8.2	7.4	23.5	4.2	5.2	1.1	9.7	0.6	5.6	7.7	9.1	12.2	2.3	10.9	7.7	0.3	0.3	7.2	0.8	3.9	6.8	2.6	3.2	2.4	1.3	4.1	2.5	3.1	2.7	1.7	5.7	3.1	2.5	8.1	2.9	1.6	3.8	0.9	0.3										
RGPD8	"RanBP2alpha, RANBP2L1"	ENSG00000169629	"RANBP2-like and GRIP domain containing 8"	O14715	2	112370092-112434488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.0"	"Cell line enhanced"	"Detected in many"		"HEL: 14.4;hTEC/SVTERT24-B: 12.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"HPA045704: , HPA049497: , HPA051675: , HPA067564: "	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-3)"	"unprognostic (3.17e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-2)"	2.4	0.9	0.5	1.3	0.9	6.2	2.3	2.6	2.7	1.7	1.5			0.4	1.9	2.1	1.1	1.6	1.4	1.7	0.6	0.8	1.3	2.8	2.4	0.9	0.6		2.2	2.3	2.0	2.8	2.0		1.4	1.0		1.3	1.6	1.5	2.4	1.3	1.5	0.8	1.3	1.2	14.0			2.1		1.4	1.9	1.5	2.9	2.1	3.1	2.4	1.4	5.1	1.2	6.1	2.9	4.5	2.7	1.4	3.0	0.1	2.9	2.2	2.2	1.6	5.2	0.4	0.0	1.9	3.4	2.7	10.7	1.5	2.3	7.5	3.5	14.4	3.8	2.8	1.7	0.1	0.2	0.5	2.0	12.1	3.0	2.0	7.3	0.4	3.3	2.2	6.5	0.8	2.8	3.2	0.0	0.7	0.0	1.0	2.7	2.9	0.6	7.1	0.1	1.6	0.7	3.1	8.5	1.5	2.2	4.8	4.2	0.1	0.0	0.0	0.4	1.7	0.3	3.1	1.3	1.3	3.5	1.0	5.1	1.7	2.3	2.9	1.4	2.9	3.2	2.2	1.0	1.4	2.4	2.1	1.3	1.2										
RGS6		ENSG00000182732	"Regulator of G protein signaling 6"	P49758	14	71932439-72566529	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.8"	"Group enriched"	"Detected in some"	7	"HEL: 8.1;Karpas-707: 29.3"	"Group enriched"	"Detected in some"	7	"glioma: 3.1;thyroid cancer: 1.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.6;T-reg: 1.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003067	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA003067: AB_1079807"	"unprognostic (7.18e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.24e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.68e-2)"	6.9	0.8	8.6	1.1	11.1	2.0	4.9	4.0	18.0	7.9	1.8	2.8	0.3	0.8	2.7	4.2	1.0	3.6	1.9	15.7	3.7	7.5	3.3	0.6	1.7	0.5	15.4	9.3	2.3	0.6	10.9	2.6	4.6	20.8	0.7	1.8	1.3	1.3	2.5	1.7	1.4	1.4	2.2	5.2	1.5	0.8	13.9	2.4	0.0	8.5	0.3	1.0	1.1	1.3	0.5	0.4	1.6	0.2	0.6	1.2	4.1	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	29.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.6	0.0	0.4	1.2	4.1	8.6	11.1	4.0	18.0	3.7	7.5	15.4	9.3	20.8	2.4
RHBDF1	"C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1"	ENSG00000007384	"Rhomboid 5 homolog 1"	Q96CC6	16	58059-76355	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077399			Uncertain	Vesicles				Vesicles		"HPA077399: "	"unprognostic (2.62e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.54e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (2.49e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.22e-2)"	12.7	3.7	6.2	11.5	9.3	0.3	17.7	3.5	6.2	21.8	10.8	6.1	6.7	5.6	13.0	10.4	17.5	10.6	17.2	15.9	7.0	2.8	8.2	3.8	17.8	4.1	6.9	4.9	18.8	9.6	9.8	4.3	26.5	7.3	19.6	5.5	15.9	20.1	13.5	13.4	22.4	7.5	14.6	5.8	6.1	9.2	7.1	3.1	1.2	11.2	15.7	10.1	16.0	19.4	0.0	0.5	0.0	1.7	0.0	0.4	0.0	4.2	6.9	4.0	9.2	15.7	19.5	13.2	11.8	22.2	8.3	8.0	9.4	15.0	0.2	4.9	12.5	13.6	1.9	7.9	1.4	0.1	2.1	0.1	6.9	2.6	17.6	0.1	7.6	16.2	8.3	21.5	3.6	12.6	1.6	0.2	13.1	23.9	0.0	1.3	3.6	5.9	0.1	4.7	0.3	9.3	4.4	0.1	0.9	3.4	13.1	7.3	20.1	1.5	13.2	13.2	9.3	10.2	3.2	0.1	0.2	0.1	9.2	0.2	20.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.2	9.3	3.5	6.2	7.0	2.8	6.9	4.9	7.3	3.1
RHOBTB3	KIAA0878	ENSG00000164292	"Rho related BTB domain containing 3"	O94955	5	95713522-95824383	"Predicted intracellular proteins"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 86.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 51.2;HaCaT: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 10.1;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA000265			Uncertain	Vesicles				Vesicles		"HPA000265: "	"unprognostic (1.68e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.39e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.00e-3)"	"unprognostic (9.29e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.01e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.23e-1)"	"unprognostic (8.21e-2)"	38.7	21.4	27.0	6.4	25.8	4.0	12.8	11.8	23.1	16.4	12.0	26.9	11.8	8.2	7.5	15.5	9.8	7.8	11.0	17.6	26.2	12.8	16.4	11.5	9.5	3.6	20.1	21.3	46.6	59.2	24.1	11.0	86.0	13.0	16.4	11.7	21.7	21.0	12.2	15.3	7.4	9.0	11.2	18.2	6.0	12.1	12.4	21.3	1.8	11.1	4.1	1.6	10.9	12.8	0.8	1.2	10.1	1.5	0.5	2.9	0.9	10.3	4.2	10.3	11.0	38.9	22.6	0.1	18.0	17.2	7.0	11.0	20.0	1.9	0.0	51.2	9.2	65.0	5.5	1.3	12.1	0.4	7.1	3.6	39.6	5.7	30.7	0.8	5.1	36.5	1.0	10.5	0.1	5.4	14.1	2.7	27.8	2.9	1.1	2.8	3.9	6.5	1.5	20.3	1.2	5.9	7.4	18.3	23.7	14.2	6.2	16.7	4.7	5.2	8.6	9.4	40.6	6.3	6.8	2.7	5.3	0.4	2.9	0.2	15.4	0.1	0.9	10.1	2.9	0.5	1.2	0.8	2.1	2.5	0.2	0.2	2.9	0.6	0.7	0.5	1.5	1.2	1.1	0.9	27.0	25.8	11.8	18.6	26.2	12.8	20.1	21.3	13.0	21.3
RIMBP3	"KIAA1666, RIMBP3.1, RIMBP3A"	ENSG00000275793	"RIMS binding protein 3"	Q9UFD9	22	18605815-18611919	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 22.0"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 5.9;THP-1: 6.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA001183	Supported		Uncertain	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA001183: AB_1079205"	"unprognostic (1.55e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	"unprognostic (6.06e-3)"	"unprognostic (9.58e-2)"	"unprognostic (8.49e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.69e-3)"	"unprognostic (7.95e-2)"	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.4			0.0	0.0	0.5		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.3	0.0	22.0			0.1		0.2	0.0		0.7	1.1	0.9	1.0	1.7	2.5	1.1	0.8	2.8	1.1	0.9	1.6	0.8	0.1	1.0	3.1	1.4	1.5	0.1	0.0	0.7	1.2	0.3	0.7	0.6	0.0	0.3	2.8	0.9	1.2	0.7	1.1	0.1	3.9	0.1	0.3	0.1	0.6	0.0	0.0	0.5	0.7	1.2	1.3	5.9	3.1	1.2	0.3	2.4	3.5	0.4	0.4	0.2	1.6	0.3	2.5	0.0	0.5	0.3	6.4	0.2	2.1	1.4	1.1	0.5	0.2	0.8	0.6	1.1	1.3	2.3	0.0	1.0	0.9	1.0	0.6	2.5	0.7	1.4	1.4	1.1	0.6	1.8	0.9	0.3	1.7	0.4	0.1	1.2	1.1										
RIMBP3B		ENSG00000274600	"RIMS binding protein 3B"	A6NNM3	22	21383374-21389478	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 11.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.8;RH-30: 3.4;THP-1: 4.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA001183	Supported		Uncertain	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA001183: AB_1079205"	"unprognostic (3.78e-1)"	"unprognostic (3.54e-2)"			"unprognostic (1.53e-2)"			"unprognostic (1.51e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.35e-2)"		"unprognostic (4.37e-1)"	"unprognostic (3.61e-4)"	"unprognostic (1.69e-2)"		"unprognostic (7.11e-2)"		0.0	0.0		0.3		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.4		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	11.6			0.0		0.2	0.0		0.3	0.4	0.4	0.9	1.0	1.5	0.4	0.1	1.7	0.2	0.4	1.1	0.7	0.3	0.5	1.2	0.5	0.9	0.2	0.3	0.3	1.0	0.2	0.0	0.7	0.0	0.1	1.7	1.1	0.6	0.3	0.2	0.0	0.5	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.3	0.6	0.2	2.0	2.8	0.4	0.4	1.9	3.4	0.0	0.1	0.0	0.5	0.0	1.5	0.0	0.5	0.1	4.8	0.0	0.4	0.4	0.4	0.2	0.1	0.1	0.0	0.9	0.4	1.5	0.0	0.5	0.4	1.1	0.2	1.4	0.1	0.7	1.5	0.4	0.3	1.1	0.7	0.1	1.0	0.9	0.1	1.2	0.4										
RIMBP3C		ENSG00000183246	"RIMS binding protein 3C"	A6NJZ7	22	21545357-21551461	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"testis: 16.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 3.2;THP-1: 3.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA001183	Supported		Uncertain	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA001183: AB_1079205"	"unprognostic (1.74e-1)"	"unprognostic (4.05e-2)"			"unprognostic (3.49e-2)"	"unprognostic (2.18e-1)"		"unprognostic (8.30e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.17e-6)"	"unprognostic (3.04e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.76e-6)"	"unprognostic (1.66e-2)"	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0		0.0	0.1	0.0	0.0	0.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	16.6			0.0		0.3	0.1	0.0	0.5	1.3	0.9	0.8	1.4	1.7	1.0	0.2	0.0	0.5	0.1	0.1	0.0	0.2	0.1	0.8	0.7	0.3	0.1	0.3	0.0	1.5	0.6	0.5	0.7	0.2	0.1	0.7	0.5	0.5	0.0	0.3	0.2	1.5	0.6	0.0	0.2	0.5	0.1	0.3	0.1	0.0	0.1	0.7	1.7	3.2	0.3	0.2	1.4	0.9	0.1	0.1	0.1	0.7	0.2	0.5	0.4	0.2	0.0	3.5	0.0	1.3	0.6	0.7	0.2	0.5	0.4	0.2	1.3	1.1	1.7	0.9	0.8	0.8	0.5	0.5	1.4	0.5	0.9	0.7	1.3	0.4	1.7	0.6	0.8	1.4	0.7	0.1	0.9	1.0										
SARS2	"FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS"	ENSG00000104835	"Seryl-tRNA synthetase 2, mitochondrial"	Q9NP81	19	38915266-38930896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA052730, HPA056957"	Approved		Uncertain	Nucleoplasm,Vesicles,Mitochondria				"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: , HPA056957: "	"unprognostic (3.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.62e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.69e-2)"	5.8	16.5	9.9	7.2	12.8	11.1	7.4	10.7	20.4	8.0	9.2	11.3	11.4	12.3	9.0	9.4	12.9	11.5	8.2	12.3	8.3	8.6	13.4	20.6	6.3	11.0	10.9	7.8	9.5	14.4	11.2	11.4	10.7	15.0	11.0	8.5	11.8	13.6	9.9	15.5	15.6	9.9	8.1	7.2	11.3	11.1	8.8	11.5	11.4	13.8	9.5	12.6	11.0	8.3	6.3	12.7	0.4	7.2	6.5	8.0	4.3	5.6	17.3	6.9	4.1	2.9	6.0	9.6	4.0	5.4	9.4	7.5	14.1	7.1	6.4	5.8	5.6	5.4	7.3	11.4	2.4	5.5	9.3	12.8	7.5	12.1	6.9	11.0	12.8	9.0	6.2	6.2	4.2	6.6	11.0	6.4	4.8	12.2	8.2	10.0	7.0	3.5	11.9	6.2	7.0	10.0	13.9	11.9	7.6	5.3	14.4	3.6	7.4	7.4	4.2	5.9	6.7	4.6	3.9	4.6	2.7	5.1	3.7	7.7	4.9	0.0	4.1	0.4	8.0	7.2	6.4	6.3	5.9	8.0	12.7	5.7	4.3	4.9	0.3	6.5	6.4	5.0	6.6	4.3	9.9	12.8	10.7	20.4	8.3	8.6	10.9	7.8	15.0	11.5
SEMA4G	"FLJ20590, KIAA1619"	ENSG00000095539	"Semaphorin 4G"	Q9NTN9	10	100969518-100985871	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.0;liver: 33.9"	"Group enriched"	"Detected in many"	4	"A549: 13.7;CACO-2: 13.1;Hep G2: 47.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038362, HPA077752"	Uncertain		Uncertain	"Vesicles,Lipid droplets"	"Intracellular and membrane"		840000	"Vesicles, Lipid droplets"		"HPA038362: AB_10669524, HPA077752: "	"unprognostic (3.90e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.05e-2)"	1.2	5.0	8.2	9.2	5.6	0.2	1.9	17.8	9.0	2.5	34.3	4.9	3.2	25.9	2.1	16.6	1.8	3.1	25.9	1.6	4.9	5.0	9.5	33.9	2.9	1.2	4.2	4.6	9.2	21.3	3.7	4.4	2.2	7.8	8.6	42.3	4.8	4.3	6.1	1.2	7.1	44.0	2.5	2.5	1.8	10.4	2.5	3.7	0.1	9.8	0.5	0.5	2.3	2.4	2.4	1.0	0.4	0.4	0.0	1.3	0.0	0.0	13.7	3.5	1.5	2.2	0.7	3.0	0.5	1.5	0.7	0.7	13.1	2.2	0.2	1.8	0.6	0.9	3.4	0.6	0.6	0.3	2.1	0.7	1.1	47.9	5.7	0.5	0.4	3.7	0.8	0.7	0.4	1.9	1.3	0.1	1.1	0.8	0.2	0.5	0.5	0.8	1.3	0.3	0.6	3.2	0.4	1.1	5.5	0.5	0.9	1.4	3.8	0.6	1.3	0.4	1.6	0.4	0.1	0.4	0.2	0.2	0.4	0.4	0.4	0.0	0.4	0.4	0.3	0.0	0.2	2.4	0.4	1.3	1.0	0.6	0.4	0.2	0.0	0.0	0.2	0.3	0.1	0.0	8.2	5.6	17.8	9.0	4.9	5.0	4.2	4.6	7.8	3.7
SEMA7A	"CD108, H-Sema-L, SEMAL"	ENSG00000138623	"Semaphorin 7A (John Milton Hagen blood group)"	O75326	15	74409289-74433958	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Differentiation, Inflammatory response, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 99.7;hTEC/SVTERT24-B: 39.1;U-251 MG: 57.5;U-87 MG: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 8.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008210, HPA042273"	Uncertain		Uncertain	Vesicles			29000000	Vesicles		"HPA008210: , HPA042273: AB_10806234"	"unprognostic (2.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (2.45e-11)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.57e-2)"	2.2	1.9	5.4	10.4	13.8	12.8	1.4	22.9	27.3	1.3	1.8	19.9	1.4	2.7	4.3	1.8	3.2	1.2	3.3	1.4	10.8	5.7	1.4	1.5	4.4	19.0	28.5	5.7	5.9	0.9	6.4	1.9	54.0	28.6	1.4	1.8	7.8	1.7	3.5	1.4	4.7	6.0	2.0	36.4	34.7	3.7	23.6	15.4	9.0	1.1	0.4	19.7	4.6	1.7	1.4	1.8	8.9	0.0	0.8	0.2	0.0	5.7	0.0	1.7	0.5	2.2	7.4	14.3	26.5	10.7	5.6	8.6	2.2	9.4	0.0	1.5	12.0	1.7	0.5	1.7	5.8	0.4	0.3	10.3	0.0	2.8	0.5	0.3	99.7	5.2	0.0	39.1	2.2	0.0	5.9	3.6	18.1	0.4	1.4	3.4	1.8	4.0	0.2	1.1	1.5	2.3	2.4	0.1	0.1	0.2	4.8	2.1	0.3	2.1	1.0	10.5	7.0	5.0	57.5	0.6	0.4	0.1	33.6	1.2	0.5	3.9	0.0	8.9	0.2	0.0	0.2	1.4	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.8	0.0	1.8	0.0	0.0	5.4	13.8	22.9	27.3	10.8	5.7	28.5	5.7	28.6	15.4
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256079	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.6;RT4: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: "	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	6.9	21.1	9.0	7.8	11.2	3.0	6.7	5.3	15.6	10.2	16.3	28.8	11.2	5.1	6.9	12.9	9.7	9.6	8.4	4.1	9.5	7.3	5.3	26.3	8.0	9.3	13.4	7.0	9.8	7.8	4.2	5.3	24.7	12.1	20.3	17.5	3.6	9.8	8.4	3.1	10.9	9.5	4.4	9.7	8.3	9.7	18.9	15.0	7.8	5.2	6.7	12.3	9.3	7.7	0.8	4.0	6.2	6.9	0.4	17.5	4.7	5.1	9.2	3.1	2.0	4.3	4.6	9.3	4.2	2.8	1.8	1.9	18.5	26.6	0.8	4.3	5.4	14.9	4.2	11.1	2.7	0.7	2.2	0.6	1.1	9.9	1.6	0.6	1.9	5.2	6.2	4.8	12.6	3.4	1.6	4.4	4.9	8.8	10.3	2.5	4.3	3.2	12.3	2.7	1.4	5.5	25.4	0.2	3.0	3.7	8.7	16.3	3.8	3.2	3.7	5.4	1.5	5.4	5.2	5.7	1.6	13.3	10.2	1.8	22.0	6.2	6.9	4.4	1.6	3.4	1.2	0.5	13.9	4.2	4.0	0.8	17.5	10.5	3.6	0.4	1.0	0.9	4.5	4.7	9.0	11.2	5.3	10.9	9.5	7.3	13.4	7.0	12.1	15.0
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1563521-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 137.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 24.7;NB-4: 32.8;THP-1: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 137.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 137.6;monocytes: 43.6"									HPA047463	Uncertain		Uncertain	Vesicles			33000000	Vesicles		"HPA047463: "	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	23.7	1.8	2.3	18.7	5.4	31.9	1.8	2.7	3.2	1.1	1.4	1.9	0.1	1.0	1.0	0.5	0.9	2.5	7.6	7.2	2.3	1.6	1.5	7.5	19.4	19.5	6.6	0.7	1.9	0.9	0.1	1.5	3.8	3.7	1.2	1.2	1.7	1.8	0.6	0.9	0.9	2.6	2.1	7.2	28.7	1.2	1.2	3.9	2.5	0.9	0.4	2.9	4.1	1.9	0.2	15.2	137.6	43.6	0.7	1.0	19.2	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	24.7	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	32.8	0.1	1.5	0.0	0.0	0.0	4.9	0.1	0.0	0.1	0.1	0.0	0.2	0.0	25.4	0.7	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.5	6.0	0.1	0.5	43.6	72.5	0.6	36.3	0.9	0.2	0.6	0.5	15.2	0.2	0.8	0.5	137.6	0.7	29.5	14.5	1.0	19.2	2.3	5.4	2.7	3.2	2.3	1.6	6.6	0.7	3.7	3.9
SLC23A2	"KIAA0238, SLC23A1, SVCT2, YSPL2"	ENSG00000089057	"Solute carrier family 23 member 2"	Q9UGH3	20	4852356-5010293	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052825, HPA059314"	Approved		Uncertain	"Golgi apparatus,Vesicles"				Vesicles	"Golgi apparatus"	"HPA052825: , HPA059314: "	"unprognostic (3.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.09e-1)"	"prognostic favourable (3.35e-4)"	"unprognostic (6.22e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.36e-3)"	"prognostic favourable (7.14e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (6.08e-5)"	6.6	55.6	14.7	6.1	17.5	5.4	6.3	15.9	27.2	8.6	4.6	19.3	4.0	5.0	9.5	7.1	4.6	12.4	7.8	5.4	14.4	14.5	6.0	27.7	7.4	7.2	14.9	16.6	29.4	7.5	15.1	12.5	25.1	16.4	9.0	5.0	22.1	4.2	8.4	2.6	8.5	6.3	7.8	17.5	11.7	7.1	8.5	11.4	5.3	18.6	2.2	7.4	18.7	6.4	4.2	6.0	3.1	2.5	0.8	2.8	2.0	10.5	12.4	16.8	6.3	11.8	6.7	21.3	4.5	6.2	5.4	5.0	6.4	12.1	4.8	4.9	6.2	10.3	4.6	12.3	10.2	3.0	8.3	6.7	2.1	24.0	6.7	9.3	4.0	5.6	7.2	13.4	8.1	7.8	4.5	4.1	7.1	3.9	10.2	5.2	5.9	7.7	9.4	11.1	7.2	2.9	17.3	5.6	6.3	8.7	9.2	32.2	5.1	5.5	6.7	12.1	5.6	14.4	8.7	5.8	10.8	13.0	4.3	5.6	18.9	0.0	2.5	0.2	2.8	1.8	2.6	4.2	2.2	2.0	3.6	2.9	2.1	2.1	3.1	0.8	2.1	6.0	1.3	2.0	14.7	17.5	15.9	25.3	14.4	14.5	14.9	16.6	16.4	11.4
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 34.4;thyroid gland: 42.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 35.2;Hep G2: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favourable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favourable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	0.8	3.1	3.3	0.8	4.9	0.3	2.4	2.1	2.8	8.6	0.2	1.3	0.8	0.1	0.9	2.0	7.5	1.1	2.2	0.5	3.0	0.6	11.4	0.1	1.3	0.9	1.4	1.1	0.6	0.1	0.4	2.4	0.3	1.8	2.2	0.3	1.1	34.4	5.8	3.5	5.3	0.3	0.2	1.4	0.3	1.9	3.2	1.2	0.2	42.7	3.3	5.1	2.6	2.1	0.0	0.7	0.0	1.4	0.0	1.1	0.4	5.3	7.6	0.9	4.0	2.6	0.7	10.9	2.7	1.7	1.4	0.8	0.5	7.0	0.0	3.1	0.9	35.2	4.2	8.3	0.2	0.0	1.7	0.3	3.3	20.6	1.6	1.9	6.9	0.3	3.4	1.7	1.6	3.5	0.7	4.9	1.4	3.4	0.2	0.2	6.1	10.3	1.2	5.2	1.7	8.5	15.0	0.4	2.5	1.4	8.8	0.2	3.4	3.3	5.9	1.0	3.6	0.2	1.3	0.2	0.3	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	0.3	0.0	0.0	0.0	1.4	0.0	1.1	0.4	3.3	4.9	2.1	2.8	3.0	0.6	1.4	1.1	1.8	1.2
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816200-10940733	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;esophagus: 10.5;skin 1: 11.5"	"Cell line enhanced"	"Detected in some"		"A-431: 4.6;HaCaT: 12.4;Hep G2: 14.3;hTCEpi: 11.2;NTERA-2: 6.3;T-47d: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.8	0.8	11.5	0.7	14.1	0.8	2.9	3.1	23.0	0.9	0.8	5.0	0.0	0.7	1.7	1.1	10.5	1.8	0.7	0.8	8.4	24.5	0.7	0.9	0.8	0.7	37.0	5.9	0.8	1.0	0.7	0.2	1.6	35.4	2.3	0.8	0.4	1.1	0.7	1.0	11.5	0.8	1.0	10.4	1.5	0.7	3.4	9.2	0.0	0.8	0.2	1.1	1.3	0.7	0.5	0.3	1.2	0.4	0.2	0.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	2.0	0.0	0.0	0.2	0.2	0.0	14.3	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	2.8	1.8	4.3	3.6	0.1	0.0	4.7	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.5	0.2	0.2	1.2	0.2	0.4	0.3	0.3	0.0	11.5	14.1	3.1	14.7	8.4	24.5	37.0	5.9	35.4	9.2
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"				"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favourable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	23.6	29.6	38.8	21.3	43.6	40.7	30.1	41.6	44.0	23.8	17.3	20.0	38.4	10.3	26.4	30.1	20.4	29.4	22.8	21.2	30.2	30.8	23.4	28.9	20.2	29.5	25.9	32.4	85.0	18.5	104.1	35.0	23.2	24.7	23.2	15.9	22.8	26.1	44.8	41.3	27.0	18.3	26.6	19.7	23.9	15.8	26.5	23.4	20.6	28.0	24.8	27.1	23.7	22.0	9.9	11.3	20.4	8.3	8.6	12.5	4.2	5.2	3.9	2.9	4.2	6.0	7.2	8.8	6.7	5.3	3.1	2.3	0.0	2.1	9.1	2.7	6.1	2.3	1.6	5.6	2.2	176.7	2.5	24.6	10.9	1.9	2.3	10.3	14.5	4.7	2.1	3.1	5.8	4.9	0.8	31.3	5.2	2.1	2.5	8.6	2.9	1.5	11.6	3.7	8.2	7.1	4.8	1.9	1.7	4.3	1.0	1.8	1.9	6.7	5.8	5.0	2.4	3.2	3.2	2.9	3.6	4.1	5.4	3.9	1.3	20.4	4.6	13.1	10.3	6.2	9.9	9.9	9.9	10.5	5.6	8.0	12.5	10.0	13.5	8.6	8.3	11.3	10.4	4.2	38.8	43.6	41.6	44.0	30.2	30.8	25.9	32.4	24.7	23.4
SOHLH2	"bHLHe81, FLJ20449, SPATA28, TEB1"	ENSG00000120669	"Spermatogenesis and oogenesis specific basic helix-loop-helix 2"	Q9NX45	13	36168208-36214615	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 23.6"	"Cell line enhanced"	"Detected in some"		"A-431: 7.1;HL-60: 9.3;Karpas-707: 10.6;NB-4: 13.6;U-266/84: 13.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA029182			Uncertain	Vesicles				Vesicles		"HPA029182: AB_10602409"	"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"		"unprognostic (1.99e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-2)"		"unprognostic (3.01e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.10e-1)"	"unprognostic (8.56e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.93e-2)"	0.3	0.3	0.9	0.3	2.1	0.5	0.4	0.3	3.5	0.3	1.8	0.3	0.3	0.2	0.3	2.0	0.3	0.2	0.3	0.9	1.2	1.2	0.6	0.3	0.3	0.3	1.2	0.3	0.3	0.3	0.2	0.3	3.5	0.3	1.8	0.0	0.3	0.3	1.2	0.4	0.2	0.3	0.4	0.6	0.3	0.1	23.6	0.3	0.3	0.4	0.3	0.3	1.3	0.3	1.0	0.3	0.5	0.3	0.0	0.5	0.0	7.1	0.2	0.7	0.0	0.6	1.1	4.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.1	9.3	0.0	2.0	0.6	0.0	0.0	0.9	0.3	10.6	2.1	0.1	0.0	13.6	0.2	0.0	0.2	0.2	0.8	1.0	0.7	0.1	1.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.8	0.5	0.5	1.4	13.6	0.2	0.8	5.0	0.5	0.0	0.3	0.5	0.2	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.9	2.1	0.3	3.5	1.2	1.2	1.2	0.3	0.3	0.3
SPTAN1		ENSG00000197694	"Spectrin alpha, non-erythrocytic 1"	Q13813	9	128552558-128633662	"Disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004581, HPA007927"	Enhanced		Approved	Vesicles,Microtubules			270000	"Vesicles, Microtubules"		"CAB004581: AB_671135, HPA007927: AB_1857435"	"unprognostic (1.46e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"prognostic favourable (1.84e-12)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.19e-3)"	27.8	18.0	46.4	21.3	54.0	14.7	18.0	80.9	74.7	21.1	22.3	33.3	17.0	14.5	27.5	20.5	22.2	33.1	19.4	37.2	42.6	46.2	19.5	13.8	32.1	20.6	41.8	59.8	32.4	14.2	47.2	18.2	33.1	75.1	20.2	22.0	26.9	16.7	29.3	12.7	40.1	17.9	35.1	31.8	24.2	18.2	26.1	29.9	18.0	22.2	11.4	21.7	19.6	27.5	5.5	2.5	3.2	1.2	5.7	12.8	4.2	23.2	25.8	17.0	18.7	24.9	28.3	13.9	20.0	16.8	22.5	17.0	36.6	16.6	20.4	17.9	30.2	42.9	18.0	20.1	14.0	11.5	10.7	3.4	70.0	20.5	14.1	15.1	11.6	13.5	16.2	37.7	12.8	30.1	1.9	24.2	22.0	16.1	29.1	6.4	21.7	16.2	19.7	20.4	12.9	18.3	20.1	13.2	20.7	65.6	9.1	9.5	15.7	4.3	51.5	15.7	23.2	22.6	15.5	14.8	17.4	11.6	19.1	6.9	14.7	2.5	1.2	3.2	8.9	1.1	12.2	5.5	11.2	8.2	1.9	5.3	7.0	7.2	1.3	5.7	0.9	2.5	12.8	4.2	46.4	54.0	80.9	74.1	42.6	46.2	41.8	59.8	75.1	29.9
SQLE		ENSG00000104549	"Squalene epoxidase"	Q14534	8	124998497-125022283	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018038, HPA020762"	Enhanced		Uncertain	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA018038: , HPA020762: "	"unprognostic (1.37e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.12e-2)"	"unprognostic (9.51e-3)"	"unprognostic (4.63e-1)"	"prognostic unfavourable (7.42e-4)"	"unprognostic (4.76e-3)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (3.45e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavourable (5.70e-4)"	"unprognostic (9.71e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.74e-3)"	4.6	15.7	11.1	9.9	13.9	10.4	12.1	8.9	19.9	15.1	11.5	28.8	4.4	15.8	8.9	5.1	40.3	10.0	6.3	4.2	15.4	14.5	7.8	38.1	16.0	8.6	10.8	9.7	17.5	6.3	16.5	9.5	24.7	28.5	13.8	10.1	9.3	10.4	4.7	1.3	23.8	8.7	6.6	36.0	5.6	11.5	29.3	18.7	9.8	5.7	24.2	15.0	5.3	21.6	15.1	12.4	1.2	9.7	9.5	9.0	6.1	25.5	9.9	59.4	17.0	18.5	31.4	6.0	6.7	20.7	9.2	16.9	13.4	37.3	17.6	9.7	8.3	19.5	24.7	37.2	10.7	14.5	52.3	50.2	6.7	34.2	27.2	5.9	14.8	21.4	39.8	27.4	22.6	10.0	28.6	34.3	7.4	42.1	20.3	7.4	24.6	6.8	8.9	10.9	23.9	64.7	29.4	18.6	9.4	13.8	44.4	13.8	11.8	15.4	9.8	3.8	13.4	4.5	6.0	6.2	12.6	24.1	6.4	17.9	6.5	1.2	5.1	0.5	9.0	8.5	4.4	13.6	5.4	8.3	12.4	15.1	7.5	7.8	0.1	9.5	9.7	8.8	5.6	6.1	11.1	13.9	8.9	16.4	15.4	14.5	10.8	9.7	28.5	18.7
SRGAP3	"ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP"	ENSG00000196220	"SLIT-ROBO Rho GTPase activating protein 3"	O43295	3	8980591-9363053	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;HBEC3-KT: 8.2;hTCEpi: 8.2;RT4: 10.9;T-47d: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036959, HPA044074, HPA078079"	Enhanced		Uncertain	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: "	"unprognostic (3.63e-3)"	"unprognostic (1.12e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.39e-3)"	1.8	6.1	10.6	1.7	20.4	1.2	3.2	32.4	34.9	9.7	2.1	10.5	0.0	1.9	4.4	3.4	2.6	18.5	2.3	2.7	10.0	11.2	4.9	1.4	2.2	2.3	7.5	9.8	7.2	2.4	2.7	5.7	1.9	15.5	4.7	2.5	4.8	5.7	3.2	2.5	4.0	1.7	2.0	6.1	1.7	2.9	4.4	4.8	0.4	3.3	0.6	2.1	6.7	1.4	0.0	1.9	1.9	0.4	1.0	1.3	0.1	0.5	0.5	9.5	0.4	0.6	1.3	1.3	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.5	0.0	4.8	0.2	8.2	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	5.1	0.8	8.2	0.7	0.8	0.0	0.0	0.0	0.0	0.1	0.2	2.0	0.9	0.7	1.1	0.0	0.0	4.1	10.9	1.1	1.2	0.2	2.9	0.1	10.6	0.0	0.0	0.0	0.4	0.1	0.1	2.8	0.1	0.0	0.8	1.7	0.3	1.2	0.4	1.9	0.0	0.1	0.0	0.0	0.2	0.0	1.9	0.0	0.2	0.0	0.0	1.0	0.1	0.5	1.3	0.1	10.6	20.4	32.4	34.9	10.0	11.2	7.5	9.8	15.5	4.8
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558728-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4"	"Group enriched"	"Detected in some"	5	"Daudi: 62.1;U-698: 27.8"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 3.2"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.1;naive B-cell: 36.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.7	0.3	0.4	27.8	0.3	2.9	0.6	0.3	0.4	0.7	2.1	0.0	12.3	0.8	0.6	1.2	2.4	0.4	0.7	0.4	3.2	0.3	20.0	0.5	2.7	23.9	0.4	0.0	0.3	0.6	0.0	0.4	0.1	0.2	1.0	1.3	0.3	2.6	5.1	0.4	0.5	9.3	0.1	0.4	26.5	1.1	2.1	0.0	5.9	0.7	0.7	30.4	4.6	0.6	36.8	1.7	7.7	0.0	12.6	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	7.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	8.9	0.0	1.2	0.0	7.7	0.3	0.0	0.7	28.1	0.7	0.3	0.4	36.8	2.9	0.1	0.3	12.6	0.0	1.7	0.1	1.7	0.4	0.3	0.3	0.4	3.2	0.3	0.4	0.0	0.2	0.0
STMN4	RB3	ENSG00000015592	"Stathmin 4"	Q9H169	8	27235323-27258420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 132.2"	"Cell line enriched"	"Detected in some"	26	"SCLC-21H: 44.0"	"Cancer enriched"	"Detected in some"	27	"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027765			Uncertain	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA027765: AB_1857607"	"unprognostic (1.52e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.19e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.31e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.63e-2)"	1.5	7.9	30.8	1.5	23.4	1.5	1.5	22.2	132.2	1.5	2.3	37.3	0.0	1.8	1.5	2.0	1.5	1.5	1.6	1.4	36.3	27.9	1.5	1.4	1.5	1.5	34.9	37.2	1.4	1.4	1.5	0.0	1.4	21.4	1.5	2.3	0.0	1.5	1.5	1.4	1.5	2.2	1.8	71.8	1.4	1.5	1.6	6.6	0.0	1.4	0.0	1.4	1.5	0.0	1.0	0.9	0.3	0.2	0.1	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.2	0.4	0.1	1.0	0.7	0.2	0.3	0.1	0.2	0.9	0.4	0.0	30.8	23.4	22.2	34.4	36.3	27.9	34.9	37.2	21.4	6.6
STPG3	"C9orf173, FLJ40246"	ENSG00000197768	"Sperm-tail PG-rich repeat containing 3"	Q8N7X2	9	137251261-137253483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 55.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;RPMI-8226: 3.0;SK-BR-3: 2.9;T-47d: 4.5;U-266/70: 2.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044352			Uncertain	Vesicles				Vesicles		"HPA044352: AB_10965328"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.72e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.95e-2)"	0.8	0.4	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0.3	0.2	0.2	0.2	4.4	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.0	1.1	1.7	0.2	0.2	0.2	0.2	0.2	1.4	0.0	1.1	0.2	0.2	0.2	0.0	0.2	1.5	0.2	0.2	0.5	3.2	0.2	0.2	0.2	0.5	55.3	0.2	0.2	1.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.6	2.0	1.2	0.3	0.0	1.0	0.0	0.0	0.0	7.1	0.0	0.1	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	1.3	1.1	0.0	1.7	0.0	0.2	0.0	0.4	0.0	0.0	3.0	0.0	0.0	0.9	0.6	0.4	2.9	0.0	4.5	0.0	0.0	0.8	1.4	0.2	0.0	2.8	1.5	1.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3A, catalytic subunit of the oligosaccharyltransferase complex"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 202.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	20.6	20.5	8.3	13.1	11.7	8.3	16.9	10.7	13.9	27.8	19.3	17.7	39.6	12.0	30.5	41.4	19.6	20.8	15.1	19.5	8.3	9.1	26.2	67.1	18.7	14.9	9.3	7.7	30.1	59.0	202.3	27.5	35.9	11.6	22.2	17.4	20.8	50.7	41.4	9.5	12.9	19.8	17.1	12.3	21.8	17.7	17.1	6.7	19.2	38.6	13.6	20.8	19.5	18.0	15.0	53.2	27.0	15.5	17.2	27.5	13.4	20.7	18.9	24.2	33.2	45.6	35.4	26.0	38.0	45.4	31.0	38.8	57.5	56.2	27.1	46.2	55.9	38.4	33.5	33.3	41.2	21.1	17.8	63.8	13.1	39.7	50.5	38.1	29.9	27.3	24.2	42.8	83.7	34.5	26.8	40.6	39.0	15.3	15.3	12.2	15.5	20.6	18.2	20.6	40.7	33.8	32.3	15.1	13.0	26.9	44.0	13.5	51.5	27.5	30.8	44.6	16.1	18.8	29.8	12.8	14.9	20.9	17.2	38.6	35.4	27.0	15.5	11.6	19.7	14.8	27.5	15.0	19.1	18.2	21.6	11.6	13.8	16.0	5.4	17.2	13.0	53.2	14.1	13.4	8.3	11.7	10.7	13.9	8.3	9.1	9.3	7.7	11.6	6.7
SUMF2	DKFZp566I1024	ENSG00000129103	"Sulfatase modifying factor 2"	Q8NBJ7	7	56064002-56080670	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024040, CAB025743, HPA074892"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"		730000	"Vesicles, Plasma membrane"		"CAB025743: , HPA024040: AB_1857651, HPA074892: "	"unprognostic (2.93e-1)"	"prognostic unfavourable (6.58e-6)"	"unprognostic (2.42e-2)"	"prognostic favourable (3.96e-4)"	"unprognostic (3.87e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavourable (7.71e-4)"	26.8	38.3	13.0	17.7	17.0	15.4	26.2	10.9	28.2	35.0	31.9	24.8	35.4	31.1	32.2	32.3	23.8	37.8	51.2	16.8	12.8	11.6	36.0	40.4	30.2	25.9	19.8	18.0	28.6	91.0	34.7	18.3	37.5	20.7	29.5	25.0	25.0	39.7	37.1	14.0	23.6	35.1	27.2	19.6	27.0	32.9	16.2	17.6	29.8	33.3	15.1	25.1	29.1	23.1	21.0	43.1	17.1	28.5	15.7	33.4	28.5	63.9	19.4	8.4	39.1	41.8	28.9	13.1	21.0	29.4	17.7	22.0	10.5	52.0	10.1	18.2	30.0	32.5	5.1	24.3	11.8	16.4	8.1	6.5	12.7	9.8	27.1	15.7	20.7	22.9	23.8	15.9	27.7	26.0	20.4	45.1	28.4	14.1	13.4	18.5	11.6	9.9	10.8	8.6	64.5	24.1	7.1	10.0	12.2	26.3	55.8	25.7	55.9	26.3	21.4	16.4	23.5	40.1	17.9	30.7	23.3	15.0	26.9	29.9	52.3	17.1	21.0	7.5	26.2	27.4	33.4	21.0	25.6	26.2	24.8	18.7	28.5	27.7	1.3	15.7	28.5	43.1	26.8	28.5	13.0	17.0	10.9	28.2	12.8	11.6	19.8	18.0	20.7	17.6
SUSD5	KIAA0527	ENSG00000173705	"Sushi domain containing 5"	O60279	3	33150042-33219215	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 14.5;HUVEC TERT2: 36.0;LHCN-M2: 13.9;TIME: 14.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.9;neutrophil: 1.5"	"Group enriched"	"Detected in many"	9	"B-cells: 1.9;granulocytes: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052788	Uncertain		Uncertain	"Golgi apparatus,Vesicles"			4300000	"Golgi apparatus, Vesicles"		"HPA052788: "	"unprognostic (1.81e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.45e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.89e-2)"	7.6	2.5	7.0	1.5	6.1	0.4	2.5	2.0	13.2	11.0	2.6	4.6	2.3	1.5	7.0	6.5	2.3	7.9	13.1	5.7	6.4	8.1	2.6	1.1	3.0	4.4	6.9	6.9	6.4	1.2	1.0	1.3	0.5	6.3	1.9	2.2	3.7	1.3	10.7	2.2	2.8	2.7	7.7	4.6	3.9	3.3	4.7	3.3	0.0	5.3	2.9	8.1	3.0	3.5	1.9	0.1	1.5	0.1	0.1	0.1	0.1	0.0	0.5	0.6	0.3	0.8	0.1	0.0	4.4	1.5	14.5	4.9	0.0	0.0	0.0	4.1	1.1	0.0	6.3	2.0	6.0	0.1	7.0	0.0	1.0	0.0	0.1	0.0	0.0	0.6	1.1	9.3	1.8	36.0	0.0	0.0	13.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	1.1	0.8	0.8	14.2	0.0	6.9	0.5	2.1	0.0	0.3	0.0	0.1	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	0.1	0.1	1.5	0.1	0.0	0.1	0.0	0.1	7.0	6.1	2.0	13.2	6.4	8.1	6.9	6.9	6.3	3.3
SYCE1	"bA108K14.6, C10orf94, CT76"	ENSG00000171772	"Synaptonemal complex central element protein 1"	Q8N0S2	10	133553901-133569835	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 75.4"	"Group enriched"	"Detected in some"	8	"K-562: 17.0;U-2 OS: 15.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040208	Enhanced		Uncertain	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA040208: AB_10796450"	"unprognostic (5.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"		"unprognostic (1.85e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.75e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	1.8	1.8	4.9	0.7	5.4	0.3	1.3	8.1	8.2	0.4	0.7	0.9	0.0	0.4	0.8	0.5	0.6	1.4	1.6	0.7	4.0	3.3	0.9	3.9	0.5	1.1	1.5	6.7	1.1	1.5	0.2	0.3	8.6	3.5	1.8	0.6	0.2	0.4	0.6	0.9	0.3	0.5	0.7	1.7	0.8	0.5	75.4	0.0	0.1	1.4	0.1	0.7	0.4	0.0	1.3	2.0	0.3	2.6	0.2	3.2	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.7	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.1	0.0	0.5	0.3	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.2	0.1	0.1	0.1	15.8	0.2	0.3	0.2	0.3	0.4	0.0	0.1	0.0	0.0	1.7	0.3	3.2	1.8	3.0	0.9	2.4	0.8	1.2	1.3	1.4	2.7	0.0	0.2	2.6	2.0	2.2	1.8	4.9	5.4	8.1	8.2	4.0	3.3	1.5	6.7	3.5	0.0
TACC3	ERIC1	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1721490-1745176	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.8"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: , HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	3.8	2.7	1.1	39.1	1.1	26.0	3.4	2.1	1.4	1.9	4.4	1.1	0.8	4.5	1.8	2.7	8.8	1.6	3.5	2.0	1.4	1.3	2.5	2.4	4.3	20.1	1.3	0.7	1.6	1.0	0.5	1.8	5.7	1.1	1.6	4.9	1.6	3.0	1.2	2.0	2.6	7.7	2.5	1.8	15.6	3.4	58.1	0.9	64.3	1.6	7.3	27.9	3.2	3.0	4.0	10.4	54.8	19.9	3.8	17.9	16.1	25.2	21.0	32.2	18.5	1.7	3.6	18.2	28.6	15.3	32.9	21.8	23.2	30.5	32.2	12.2	15.6	17.1	34.0	20.8	33.5	14.1	18.4	27.3	17.4	21.4	1.6	36.9	23.2	1.5	1.4	20.7	12.0	24.9	24.6	25.5	31.2	20.6	48.6	52.8	34.8	27.6	34.4	22.8	12.9	18.7	38.2	25.1	15.8	17.2	10.9	8.0	21.4	21.4	14.6	19.2	23.0	17.3	43.1	17.9	23.6	51.6	11.1	35.7	27.1	24.7	19.9	17.9	5.5	9.0	6.0	4.0	12.3	7.6	10.4	3.8	17.9	9.8	54.8	3.8	5.5	3.1	17.5	16.1	1.1	1.1	2.1	1.4	1.4	1.3	1.3	0.7	1.1	0.9
TBC1D3	"DKFZp434P2235, PRC17, TBC1D3A"	ENSG00000274611	"TBC1 domain family member 3"	Q8IZP1	17	38181659-38192541	"Predicted membrane proteins"		"GTPase activation"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 3.4;intestine: 5.5;lymphoid tissue: 3.5;testis: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.0;REH: 5.6;U-138 MG: 7.8;U-266/70: 12.1;U-266/84: 4.7;U-698: 6.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "																		0.0	0.0		0.0		0.0	0.0		0.0	1.5	0.5			0.0	3.4	0.0	0.0	0.0	1.5	0.0			0.1	0.0	0.0	1.7			0.0	0.0	0.0		0.0		2.9	1.9		0.0	0.0	0.0	0.2	5.5	0.0		0.0	0.0	5.5			0.0		3.5	0.0		0.0	0.0	2.2	0.0	0.0	0.9	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	12.1	4.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0										
TBC1D3B	"PRC17, TBC1D3I"	ENSG00000274808	"TBC1 domain family member 3B"	A6NDS4	17	36165681-36176636	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 6.6;testis: 3.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.3;HeLa: 9.7;T-47d: 7.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.15e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.34e-1)"	0.0	0.1		1.0		0.4	0.4		0.1	0.0	0.1			1.2	0.0	0.0	1.0	0.4	0.2	0.0			0.0	0.0	0.2	0.6			0.1	1.3	0.0		0.0		0.2	0.0		0.8	0.8	1.2	6.6	0.5	0.0		2.0	1.9	3.5			0.0		0.1	0.4		0.0	0.0	0.7	0.0	1.0	0.4	0.1	1.4	2.4	1.4	1.8	1.5	1.8	4.8	1.2	0.7	1.3	2.1	0.5	11.3	0.2	0.9	0.7	4.9	0.7	1.1	0.5	2.0	3.8	0.8	9.7	0.7	0.9	0.3	1.4	1.5	2.2	1.5	0.2	0.9	0.7	1.1	0.4	0.1	1.0	4.3	0.5	0.5	1.5	0.4	0.1	1.5	1.4	0.9	1.3	1.1	0.7	0.9	7.9	1.0	2.7	0.5	0.4	3.9	0.5	1.6	1.2	0.5	1.4	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1										
TBC1D3C	MGC44903	ENSG00000278299	"TBC1 domain family member 3C"	Q6IPX1	17	38057693-38068592	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.3;skin 1: 3.5;testis: 3.4"	"Cell line enriched"	"Detected in some"	5	"CAPAN-2: 26.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "																		0.0	0.0		0.6		3.3	0.0		0.0	0.0	0.0			0.9	0.2	0.0	0.0	0.5	1.2	0.5			0.1	0.0	1.8	1.0			0.7	0.0	0.0		0.0		0.0	0.0		0.8	0.0	1.3	3.5	0.0	0.1		0.0	1.5	3.4			0.0		0.9	0.0		0.0	0.0	0.8	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.2	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.5	0.2	0.0	1.0	0.0	0.0	5.4	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0										
TBC1D3D		ENSG00000274419	"TBC1 domain family member 3D"	A0A087WVF3	17	38003976-38014902	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 7.9;skin 1: 4.2"	"Cell line enhanced"	"Detected in some"		"AF22: 3.8;CAPAN-2: 11.3;HaCaT: 8.2;HeLa: 9.2;RPMI-8226: 4.9;RT4: 5.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "																		0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0			2.0	1.1	0.0	0.0	0.0	0.0	0.9			0.0	0.0	0.4	0.2			0.0	0.0	0.0		0.8		1.5	0.8		0.0	0.0	0.8	4.2	7.9	0.0		0.0	0.0	2.6			0.0		0.5	0.0		0.0	0.0	0.7	0.2	0.0	0.3	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	2.1	9.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	4.9	0.0	5.5	0.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.9	1.0	0.0	3.4	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
TBC1D3E		ENSG00000278599	"TBC1 domain family member 3E"	A0A087X179	17	38127951-38138862	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.9;gallbladder: 3.0;pancreas: 4.3;testis: 4.1"	"Cell line enriched"	"Detected in some"	4	"HHSteC: 9.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "	"unprognostic (1.18e-1)"	"unprognostic (3.35e-1)"			"unprognostic (3.51e-1)"					"unprognostic (4.22e-2)"	"unprognostic (6.28e-2)"		"unprognostic (1.87e-2)"	"unprognostic (5.07e-3)"			"unprognostic (1.32e-3)"	0.0	0.0		0.0		3.9	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.0	0.0			0.0	0.0	0.0	1.7			0.0	4.3	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.1			0.0		0.0	0.0		0.0	0.5	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	9.5	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0										
TBC1D3F		ENSG00000275954	"TBC1 domain family member 3F"		17	36428618-36439566	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in single"	6	"testis: 4.8"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046969			Uncertain	Vesicles				Vesicles		"HPA046969: "																		0.0	0.0		0.0		0.8	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	4.8			0.0		0.0	0.0		0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0										
TBC1D3I		ENSG00000274933	"TBC1 domain family member 3I"	A0A087WXS9	17	36253456-36264553	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"skin 1: 1.3;testis: 3.0"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 10.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "																		0.0	0.0		0.0		0.1	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.7			0.0	0.0	0.4		0.0		0.2	0.0		0.9	0.5	0.0	1.3	0.9	0.0		0.3	0.1	3.0			0.0		0.1	0.2		0.1	0.2	0.7	0.2	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.6	0.0	0.1	0.1	0.2	0.1	10.9	0.1	0.6	0.0	1.6	0.0	0.1	0.0	0.1	0.7	0.7	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.2	0.1	0.9	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.2	0.7	0.0										
TBC1D3K		ENSG00000273513	"TBC1 domain family member 3K"	A0A087X1G2	17	37924415-37935365	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.3;skeletal muscle: 1.1;testis: 4.2"	"Group enriched"	"Detected in some"	5	"SiHa: 2.2;T-47d: 5.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "																		0.0	0.0		0.0		0.5	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	1.3			0.6	0.0	0.1		0.0		0.0	0.0		0.0	0.0	1.1	0.0	0.0	0.0		0.0	0.0	4.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
TBC1D3L		ENSG00000274512	"TBC1 domain family member 3L"	B9A6J9	17	37977972-37989048	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 10.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.9;NB-4: 22.1"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in many"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "	"unprognostic (5.14e-2)"	"unprognostic (8.71e-2)"	"unprognostic (8.44e-2)"		"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.63e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-3)"	0.5	2.4		1.8		0.6	1.8		1.3	0.2	1.2			2.4	0.0	2.9	2.4	1.2	0.8	0.0			0.0	0.6	1.0	1.8			0.5	0.3	0.1		0.3		1.4	1.1		3.3	1.3	4.1	10.8	1.0	0.2		2.7	1.8	0.9			0.0		0.3	1.2		0.6	0.3	3.8	0.8	1.0	1.0	0.4	7.4	9.8	4.0	6.0	7.5	6.9	23.9	3.4	2.3	3.1	3.6	5.4	0.1	2.5	0.1	4.3	12.2	3.6	3.2	2.0	7.3	9.3	0.0	15.9	2.3	5.4	1.0	9.3	5.8	8.0	4.0	2.3	4.1	1.9	8.8	5.0	4.0	4.4	22.1	3.8	2.2	2.9	4.6	0.0	9.7	10.2	5.5	7.6	0.0	4.0	4.4	5.8	1.5	9.4	0.0	5.4	4.1	4.6	6.2	2.7	0.0	6.2	3.1	3.5	0.0	0.8	0.9	0.3	0.6	0.0	0.1	0.3	0.9	0.1	0.6	0.6	1.0	3.8	1.0	0.8	0.3	0.3	0.4										
TCTE1	"D6S46, DRC5, FAP155, MGC33600"	ENSG00000146221	"T-complex-associated-testis-expressed 1"	Q5JU00	6	44278743-44297688	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 17.3;testis: 48.6"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.6;Karpas-707: 3.8;SCLC-21H: 3.1;U-266/70: 1.7;U-266/84: 3.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031739			Uncertain	Vesicles				Vesicles		"HPA031739: AB_10601269"	"unprognostic (3.27e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.23e-5)"	"unprognostic (7.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.68e-1)"	0.2	0.2	2.2	0.2	2.2	1.1	0.2	5.8	1.8	0.7	0.2	1.1	0.0	0.2	0.6	3.0	0.2	17.3	0.3	0.2	2.8	2.0	0.2	0.2	2.1	0.2	0.8	1.0	2.2	0.3	0.2	0.2	0.2	3.2	0.4	0.2	0.0	0.4	0.4	0.2	0.6	0.3	0.3	0.6	0.3	0.2	48.6	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.9	0.0	0.1	0.0	0.2	0.1	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.1	0.2	0.1	0.6	0.3	0.0	0.0	2.6	0.0	0.1	3.8	0.0	0.3	0.2	0.5	0.2	0.0	0.9	0.4	0.0	0.0	0.1	3.1	1.0	0.0	0.2	1.2	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.7	3.2	0.3	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.1	0.2	0.0	2.2	2.2	5.8	1.8	2.8	2.0	0.8	1.0	3.2	0.3
TDGF1	"CR, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582463	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 45.5"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 6.4;testis cancer: 27.1"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 12.5;pons and medulla: 9.1"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"			Vesicles	Cytosol	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.6	3.9	0.6	0.6	0.8	0.0	0.6	0.6	0.6	0.6	2.1	0.6	0.6	0.2	0.7	1.3	0.6	0.0	0.6	0.6	1.0	0.6	9.9	0.8	0.6	0.6	0.9	0.6	9.7	0.6	0.0	0.6	0.6	0.6	0.6	4.3	1.1	0.6	0.6	1.0	0.0	0.6	0.8	1.0	16.7	2.4	0.6	0.6	5.2	2.1	0.6	0.6	0.6	0.6	1.0	0.7	3.7	0.6	1.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	10.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.6	0.5	0.5	0.3	0.3	0.6	0.4	0.3	0.1	1.0	0.6	0.4	3.7	1.5	0.4	0.7	0.2	0.1	0.6	0.8	0.6	0.6	1.0	0.6	0.9	0.6	0.6	0.6
TMEM131	"CC28, KIAA0257, PRO1048, RW1, YR-23"	ENSG00000075568	"Transmembrane protein 131"	Q92545	2	97756333-97995891	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017678, HPA017682"	Approved		Uncertain	"Vesicles,Intermediate filaments"				"Vesicles, Intermediate filaments"		"HPA017678: AB_1858086, HPA017682: AB_1858087"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.58e-2)"	"unprognostic (4.18e-2)"	"unprognostic (7.59e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.10e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.77e-1)"	16.6	19.4	13.7	33.6	19.2	15.8	15.6	18.5	19.4	21.0	25.5	19.1	14.5	18.6	21.8	15.7	19.9	17.3	20.1	17.3	11.7	12.1	14.6	15.8	15.7	24.0	14.1	14.0	21.2	22.0	31.4	27.8	30.9	15.0	17.7	24.1	14.6	18.6	12.7	31.4	24.2	23.6	21.1	13.2	22.5	26.3	14.4	15.3	23.2	14.7	16.8	27.6	20.5	16.7	4.5	5.2	7.3	3.5	5.4	5.4	2.2	13.3	8.2	15.5	11.2	16.3	19.8	16.9	19.9	19.5	10.2	12.3	10.6	19.4	21.4	11.0	20.5	9.7	16.2	26.6	15.2	15.1	10.5	15.5	5.8	15.2	18.4	14.4	20.9	18.9	10.9	18.1	18.9	12.5	9.2	22.9	31.0	8.0	10.4	9.2	8.5	17.8	15.3	9.9	9.4	10.5	16.0	17.5	8.5	12.9	8.9	12.2	7.5	13.4	14.8	26.7	12.3	12.8	7.6	9.8	13.4	10.8	20.9	12.7	18.0	7.3	2.8	7.3	4.0	3.5	4.6	4.5	3.4	4.0	3.7	4.2	4.2	5.4	1.9	5.4	3.2	5.2	2.1	2.2	13.7	19.2	18.5	19.4	11.7	12.1	14.1	14.0	15.0	15.3
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.7;brain: 11.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.3;EFO-21: 5.6;hTCEpi: 3.8;SH-SY5Y: 4.8"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	1.2	11.7	6.7	0.7	2.9	0.0	0.5	2.7	7.0	0.8	0.9	2.3	0.4	0.6	0.8	1.2	2.2	1.0	0.4	1.0	5.9	11.4	1.4	0.9	1.8	1.2	5.8	4.8	2.8	0.4	0.0	8.1	0.7	3.8	0.9	0.6	1.1	0.8	1.8	5.8	1.3	0.6	0.7	5.2	1.2	0.3	1.6	1.0	0.4	0.8	1.7	1.3	0.8	0.4	0.0	0.3	0.0	0.1	0.0	6.1	1.2	2.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.0	6.3	0.0	5.6	0.0	0.2	0.4	0.5	0.0	0.0	0.0	1.6	0.1	0.0	1.8	0.0	0.0	0.0	3.8	0.0	2.5	1.0	0.0	0.5	0.0	0.3	0.1	0.0	0.4	0.3	2.4	0.0	0.5	0.2	0.1	0.7	4.8	0.7	0.8	0.1	0.2	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.0	1.8	1.0	0.3	0.0	6.1	0.9	0.0	0.0	0.0	0.0	1.0	1.2	6.7	2.9	2.7	7.0	5.9	11.4	5.8	4.8	3.8	1.0
TSLP		ENSG00000145777	"Thymic stromal lymphopoietin"	Q969D9	5	111070062-111078024	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.0;HHSteC: 13.6;hTCEpi: 8.1;hTEC/SVTERT24-B: 17.2;hTERT-HME1: 9.8;U-87 MG: 11.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"									HPA056350			Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	38400		"Golgi apparatus, Vesicles"		"HPA056350: "	"unprognostic (6.47e-4)"	"unprognostic (3.26e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.74e-3)"	5.1	1.7	0.7	2.0	1.1	0.2	19.1	0.5	0.8	5.4	4.6	1.4	6.6	1.5	4.2	0.7	14.1	1.1	14.1	18.7	1.4	0.8	1.6	17.3	4.6	1.8	1.2	1.7	1.1	0.8	0.2	1.5	0.4	2.3	16.4	1.7	1.0	3.5	6.8	2.3	1.7	2.7	12.6	4.6	1.0	2.6	7.9	1.1	0.3	4.1	3.2	2.3	10.0	6.0	0.0	0.0	0.0	0.5	0.0	2.1	0.3	0.0	0.0	0.0	1.4	1.8	12.0	0.0	0.0	1.7	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.6	0.0	1.8	2.1	0.1	0.0	13.6	0.3	0.0	0.3	8.1	17.2	9.8	0.0	0.2	0.0	2.4	0.0	1.8	0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	3.2	0.0	0.0	11.1	0.2	0.5	0.0	0.5	0.0	0.9	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.1	0.5	0.8	1.4	0.8	1.2	1.7	2.3	1.1
TSPO	"BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS"	ENSG00000100300	"Translocator protein"	"B1AH88, P30536"	22	43151514-43163242	"Cancer-related genes, FDA approved drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 139.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011232, HPA046260"	Uncertain		Approved	Vesicles,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Vesicles	"CAB011232: , HPA046260: "	"unprognostic (5.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-3)"	33.9	21.2	9.8	17.8	11.0	117.3	48.7	2.7	8.1	24.9	23.9	12.3	10.3	20.5	12.3	13.6	83.2	14.3	36.8	32.1	8.0	5.4	18.0	22.0	39.8	40.0	15.4	5.2	13.3	13.2	4.0	6.7	15.5	9.7	23.1	9.7	16.4	34.6	9.2	13.2	46.6	23.0	12.7	11.4	27.2	39.0	10.5	10.0	9.4	17.9	44.3	50.0	19.1	41.3	22.9	99.9	91.4	139.5	28.5	43.8	104.8	47.1	23.4	1.6	22.2	8.9	29.6	1.7	35.3	17.3	17.8	18.9	4.5	36.1	0.0	24.4	27.3	39.1	4.4	27.3	2.3	7.9	18.4	4.8	25.7	1.6	32.4	10.7	24.2	22.9	45.1	10.5	9.4	42.0	3.9	8.9	18.2	39.4	0.1	29.9	1.9	58.4	10.6	0.0	80.5	22.6	28.5	2.3	10.9	16.7	33.4	41.1	12.5	41.5	43.3	22.0	16.5	22.5	14.8	3.6	0.6	0.4	28.6	34.8	28.2	43.8	139.5	75.3	28.4	86.3	22.2	16.3	39.5	27.8	99.9	22.9	30.4	24.5	91.4	28.5	57.1	17.7	43.8	104.8	9.8	11.0	2.7	8.1	8.0	5.4	15.4	5.2	9.7	10.0
UBA5	"FLJ23251, UBE1DC1"	ENSG00000081307	"Ubiquitin like modifier activating enzyme 5"	Q9GZZ9	3	132654446-132678097	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017235	Uncertain		Enhanced	Vesicles,Cytosol				Cytosol	Vesicles	"HPA017235: AB_1858507"	"unprognostic (4.34e-3)"	"unprognostic (6.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	14.8	30.3	17.8	12.3	19.8	13.2	17.4	17.9	26.2	14.5	15.0	10.5	27.8	16.2	13.4	24.2	15.1	13.3	12.7	21.2	15.3	16.3	22.7	29.8	13.7	14.8	16.0	25.0	15.1	41.4	29.3	32.7	18.1	21.2	18.8	16.7	11.7	37.8	33.5	32.5	15.7	17.9	14.6	13.6	18.9	18.5	15.3	12.7	17.9	23.5	17.5	17.4	15.1	12.5	11.1	14.1	5.0	6.6	18.9	15.0	7.9	27.0	10.1	17.8	14.6	12.6	14.4	18.7	23.4	24.2	14.7	17.1	18.3	10.1	21.6	17.2	16.9	16.5	17.6	18.4	21.9	20.5	7.5	26.2	16.3	20.5	12.5	32.1	15.4	12.5	10.9	14.0	21.1	16.5	16.3	32.0	16.4	24.0	17.7	12.1	16.2	9.7	15.5	15.6	40.9	13.5	21.0	17.2	15.5	13.7	13.8	19.8	16.6	16.3	14.8	15.6	15.3	7.5	12.2	30.3	20.3	40.0	17.8	11.7	13.9	4.1	5.1	5.0	9.6	5.8	11.6	11.1	10.8	15.0	11.8	6.9	12.9	12.8	1.1	18.9	6.6	14.1	10.7	7.9	17.8	19.8	17.9	26.2	15.3	16.3	16.0	25.0	21.2	12.7
ULBP3	RAET1N	ENSG00000131019	"UL16 binding protein 3"	Q9BZM4	6	150063150-150069095	"Predicted intracellular proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.7"									"HPA056541, HPA063007"	Approved		Uncertain	"Vesicles,Centriolar satellite"	"Intracellular and membrane"			Vesicles	"Centriolar satellite"	"HPA056541: , HPA063007: "	"unprognostic (4.87e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.16e-2)"	8.0	3.6	1.0	0.4	1.2	0.2	8.2	0.3	2.0	1.9	2.8	0.4	1.1	1.4	1.1	2.1	3.6	3.6	4.4	1.2	1.3	2.3	5.5	2.6	3.1	0.3	0.7	0.6	2.0	1.1	1.9	0.7	1.4	0.8	1.3	1.1	1.7	1.2	0.4	0.7	1.0	1.0	0.8	0.5	0.5	2.9	24.3	0.3	0.3	8.2	5.3	2.1	1.8	3.1	0.3	0.0	0.0	0.0	0.0	2.7	0.5	3.8	1.6	4.6	5.1	1.5	8.7	1.4	4.1	1.9	5.3	5.9	8.3	3.6	0.0	9.3	6.8	6.4	13.7	15.0	5.3	3.4	6.9	0.1	2.3	0.4	2.1	0.0	0.6	7.7	2.9	11.3	6.0	7.0	0.2	0.0	4.7	5.6	0.0	0.0	2.1	12.2	4.4	4.7	0.2	10.6	8.9	0.8	0.1	9.7	6.1	2.1	1.8	1.0	3.7	0.9	7.0	13.8	9.6	0.0	0.0	2.7	7.4	2.0	3.8	0.0	0.0	0.0	1.5	0.0	2.0	0.3	2.0	1.1	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.0	2.7	0.5	1.0	1.2	0.3	2.0	1.3	2.3	0.7	0.6	0.8	0.3
USP6	"HRP1, Tre-2, TRE17, Tre2, TRESMCR"	ENSG00000129204	"Ubiquitin specific peptidase 6"	P35125	17	5116438-5175034	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Calmodulin-binding, Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"skeletal muscle: 18.2;testis: 29.0"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA046969			Uncertain	Vesicles				Vesicles		"HPA046969: "	"unprognostic (3.89e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.91e-4)"	"unprognostic (6.28e-3)"	"unprognostic (3.24e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.09e-4)"	0.3	0.3	0.3	0.3	0.6	0.2	0.4	0.5	0.5	0.3	0.5	0.3	1.2	0.0	0.6	0.6	0.3	0.5	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.3	2.6	0.3	0.0	0.4	0.4	0.3	0.4	0.1	0.3	0.3	0.3	18.2	0.6	0.7	0.9	0.3	0.3	0.0	29.0	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.9	1.2	1.9	1.0	0.2	0.4	0.1	2.2	1.0	2.2	1.7	0.4	0.2	2.3	1.9	0.1	0.6	0.4	0.8	1.1	2.2	1.7	1.3	1.0	0.7	0.8	0.5	1.6	1.3	1.7	1.3	0.9	1.2	0.5	2.9	1.1	0.5	0.1	0.2	0.3	0.5	0.3	0.5	2.5	1.9	0.7	1.6	0.1	1.4	2.0	0.2	0.5	0.7	0.9	2.2	1.0	0.1	3.3	2.2	2.2	1.2	1.0	3.3	2.1	1.4	2.0	1.7	1.5	0.0	0.1	2.7	0.1	0.4	0.9	0.4	0.3	0.2	0.6	0.3	0.3	0.3	0.9	0.3	0.4	1.9	0.2	1.0	1.2	0.1	0.1	0.3	0.6	0.5	0.3	0.3	0.1	0.3	0.3	0.3	0.3
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9, X-linked"	Q93008	X	41085635-41236579	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles				Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	18.0	21.8	17.7	14.0	15.9	15.5	16.8	16.6	16.7	18.4	20.6	11.4	25.4	13.2	19.6	19.0	17.3	17.0	17.1	20.9	14.2	14.2	18.5	34.2	16.7	23.1	15.2	15.4	15.7	16.5	45.8	17.0	41.1	12.9	13.4	14.4	13.9	14.2	25.2	42.8	14.8	22.0	17.3	14.0	16.7	16.9	16.9	14.0	21.1	20.3	17.6	16.5	20.3	19.9	6.4	5.5	13.0	5.0	4.9	7.8	3.1	19.0	22.6	20.1	20.5	16.9	17.7	4.6	11.0	14.8	12.5	14.6	10.4	8.9	12.8	6.2	25.0	12.9	34.5	20.0	21.1	16.1	24.8	14.9	21.9	9.3	14.3	12.9	10.9	15.3	9.0	30.0	28.5	19.3	18.0	10.5	19.3	14.0	9.2	5.1	21.2	12.5	10.1	27.5	8.3	11.9	15.8	11.4	10.7	46.2	12.8	12.6	12.4	7.2	20.6	19.2	14.8	18.1	11.8	9.6	11.2	16.4	13.7	5.8	9.5	3.3	4.7	6.0	5.6	4.2	7.8	6.4	6.6	6.2	5.5	4.7	6.7	6.0	13.0	4.9	5.0	4.2	5.6	3.1	17.7	15.9	16.6	16.7	14.2	14.2	15.2	15.4	12.9	14.0
USP9Y	DFFRY	ENSG00000114374	"Ubiquitin specific peptidase 9, Y-linked"	O00507	Y	12701231-12860839	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 16.0;RT4: 8.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.7"					"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 2.0;T-cells: 2.7"	"Not detected"	"Not detected"							HPA057687			Uncertain	Vesicles				Vesicles		"HPA057687: "			"unprognostic (2.63e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.10e-5)"	"unprognostic (8.46e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.42e-1)"	1.2	2.2	1.4	0.9	3.1	1.7	1.1	9.6	4.0	0.0	1.6			1.4	0.0	8.6	4.4	0.0	3.8	2.4	1.8	3.4	2.9	2.2	2.2	1.4	2.1		0.0	2.7	0.0	4.8	1.7		9.3	4.8		2.3	7.6	2.8	2.0	1.8	0.0	1.5	2.2	1.5	2.9			2.8		4.5	3.2	0.0	2.4	2.0	0.1	0.2	0.5	2.7	0.2	0.0	2.2	0.0	0.0	0.0	0.0	2.4	7.1	7.1	3.6	3.9	0.0	0.0	4.0	0.0	5.9	0.0	0.0	0.0	3.2	2.2	0.0	2.5	0.0	7.0	4.0	0.0	0.0	5.9	5.2	0.0	0.0	0.0	0.0	0.0	6.4	0.0	4.0	0.0	1.5	0.0	0.0	2.0	0.8	16.0	8.6	2.8	0.0	0.0	0.0	2.1	0.0	0.0	5.5	4.4	0.0	0.0	3.2	0.0	3.7	7.0	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.2	2.7	1.2	2.2	1.5	0.3	2.4	2.2	1.3	0.1	0.5	0.0	2.0	1.6	0.2										
VDAC1	"MGC111064, PORIN"	ENSG00000213585	"Voltage dependent anion channel 1"	P21796	5	133971915-134005133	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 189.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005885, HPA030780, CAB072343"	Supported		Uncertain	Vesicles			4800000	Vesicles		"CAB005885: AB_2214787, CAB072343: , HPA030780: "	"prognostic unfavourable (5.30e-4)"	"unprognostic (7.63e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.11e-3)"	"prognostic unfavourable (4.90e-4)"	"prognostic unfavourable (8.49e-4)"	"prognostic unfavourable (2.87e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	22.4	27.0	32.2	18.9	36.6	9.8	22.6	24.4	46.4	13.8	31.3	15.6	20.4	54.0	12.1	42.8	35.2	13.3	25.8	79.0	31.0	32.3	44.9	52.5	16.3	17.3	30.6	29.5	14.6	27.5	31.6	14.1	22.8	41.8	17.9	35.3	23.3	26.6	17.9	189.4	21.9	39.9	18.9	20.7	18.3	32.5	8.3	14.7	16.3	17.3	66.6	25.5	18.9	21.3	18.9	44.7	9.2	36.5	26.5	23.3	20.0	55.7	49.6	45.5	47.1	45.7	64.0	64.2	62.8	46.5	62.5	64.4	101.4	44.9	77.1	47.3	65.5	44.0	64.1	110.6	78.5	45.5	52.8	44.4	53.1	81.1	46.6	40.7	44.1	58.2	59.4	48.5	54.2	60.5	39.5	31.6	81.5	62.2	49.5	40.6	31.8	42.1	45.7	45.5	73.3	97.1	70.6	50.9	28.8	40.0	48.9	62.6	23.5	40.0	49.0	58.9	39.3	53.9	82.1	42.4	41.9	48.4	87.4	54.7	66.9	6.4	26.2	9.2	18.5	36.5	20.4	18.9	19.1	19.3	44.7	13.4	13.7	15.1	2.2	26.5	31.2	13.1	23.3	20.0	32.2	36.6	24.4	46.4	31.0	32.3	30.6	29.5	41.8	14.7
VN1R1	"V1RL1, VNR19I1, ZVNH1, ZVNR1"	ENSG00000178201	"Vomeronasal 1 receptor 1"	Q9GZP7	19	57454790-57457142	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 6.1;U-266/70: 5.5;U-266/84: 6.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"											HPA062209			Uncertain	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA062209: "	"unprognostic (7.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.59e-5)"	0.1	1.4	2.0	0.3	2.9	0.3	1.5	9.2	3.5	0.2	0.7			0.0	0.5	5.3	0.9	0.8	0.6	1.9	1.9	2.0	0.8	0.9	0.9	0.7	1.5		1.6	0.4	3.6	3.5	1.1		2.0	0.4		0.8	1.3	3.6	4.0	0.5	0.5	1.5	1.1	0.9	1.4			2.7		0.4	0.5	0.3	2.3	0.3	0.5	0.3	0.6	0.4	0.1	0.5	0.1	1.8	1.9	0.1	0.5	0.9	0.4	0.7	0.4	1.8	0.0	0.2	0.2	0.9	0.2	0.0	0.4	0.2	0.7	0.0	6.1	0.9	0.0	0.6	0.3	0.4	1.2	0.7	0.6	0.1	0.4	0.2	0.3	0.9	0.9	0.3	0.4	2.0	0.5	0.6	0.4	1.2	0.9	0.6	1.0	3.3	1.4	0.0	0.5	0.1	0.9	0.6	0.1	1.5	0.2	0.4	0.6	5.5	6.5	0.5	0.5	0.1	1.1	0.5	0.3	0.3	0.4	0.0	0.2	1.3	0.3	0.3	0.2	2.3	0.4	0.3	0.5	0.6	0.2	0.3	0.0	0.1										
WBP4	"FBP21, MGC117310"	ENSG00000120688	"WW domain binding protein 4"	O75554	13	41061274-41084006	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038965, HPA058738"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	"Vesicles, Plasma membrane"	"HPA038965: AB_10672836, HPA058738: "	"unprognostic (2.56e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.65e-3)"	"prognostic favourable (2.89e-4)"	"unprognostic (2.52e-1)"	14.0	14.2	17.2	7.9	22.1	11.4	11.5	15.8	17.2	12.0	10.7	8.6	8.9	9.6	16.6	14.1	10.9	10.1	8.0	18.8	14.7	15.8	10.5	13.4	8.7	9.0	14.7	19.0	11.8	7.5	8.8	11.3	15.9	15.9	12.5	8.0	4.8	7.2	13.2	76.2	9.4	9.6	14.7	15.0	7.9	8.1	10.0	12.8	12.7	9.6	12.6	9.3	13.3	11.1	10.9	15.2	22.7	16.2	9.7	12.9	5.0	8.8	5.9	16.5	10.6	10.8	16.5	10.1	20.2	14.3	15.9	12.3	9.3	9.5	12.7	8.1	14.1	12.6	6.2	10.0	20.5	13.1	8.7	17.9	5.7	9.4	16.6	11.1	11.7	13.5	15.4	11.6	16.5	13.4	9.5	5.6	16.6	7.5	16.0	12.2	10.0	4.9	15.0	10.2	5.0	14.5	8.8	3.8	9.1	6.4	7.0	9.5	5.7	17.5	11.7	10.0	9.2	13.7	11.6	3.7	4.1	8.9	12.3	8.2	13.6	13.0	11.0	9.7	9.3	9.6	8.5	10.9	11.8	9.9	8.9	10.6	12.9	12.6	22.7	9.7	16.2	15.2	11.3	5.0	17.2	22.1	15.8	17.2	14.7	15.8	14.7	19.0	15.9	12.8
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type containing 20"	Q5W0Z9	13	21372573-21459370	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	7.5	7.0	8.3	9.4	33.6	14.9	11.3	6.4	15.3	10.3	10.9	21.0	7.6	10.8	9.3	5.6	18.4	7.1	10.0	5.4	12.7	11.8	3.8	7.6	10.6	12.3	47.4	4.9	6.5	6.1	4.0	5.3	10.8	26.1	9.2	9.6	3.1	10.4	9.9	5.5	12.2	15.4	8.9	45.0	8.6	23.1	22.0	35.8	10.4	10.0	5.1	10.9	16.2	9.6	4.6	7.8	8.8	15.2	10.1	10.2	11.1	13.5	7.8	11.4	7.2	10.6	11.2	27.9	14.8	14.9	9.9	8.9	14.2	41.5	14.4	8.0	18.1	22.0	13.1	11.4	18.8	15.7	8.3	25.3	4.9	7.8	6.0	17.1	11.0	10.2	8.0	9.8	6.9	15.3	7.0	6.1	14.7	11.4	23.9	6.5	9.3	7.7	19.2	20.5	5.0	11.8	25.2	10.9	5.0	19.5	12.2	8.0	11.2	8.7	26.6	10.5	10.0	17.6	11.0	6.3	7.7	15.0	7.5	9.9	29.5	8.8	15.2	3.4	10.2	14.2	9.4	4.6	8.8	8.7	7.8	3.7	8.3	8.5	2.7	10.1	12.0	3.9	9.3	11.1	8.3	33.6	6.4	15.3	12.7	11.8	47.4	4.9	26.1	35.8
ZIC5		ENSG00000139800	"Zic family member 5"	Q96T25	13	99962964-99971909	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 48.9"	"Cell line enhanced"	"Detected in some"		"AF22: 10.9;HEK 293: 6.3;NTERA-2: 7.5;SCLC-21H: 42.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	24	"cerebellum: 48.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7"	"Region enriched"	"Detected in many"	6	"cerebellum: 53.2"	HPA074045			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA074045: "	"unprognostic (2.78e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.38e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.87e-2)"		"unprognostic (1.13e-1)"	"unprognostic (3.12e-2)"		"unprognostic (4.94e-2)"	0.1	0.0	1.2	0.0	0.5	0.0	0.1	48.9	4.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.5	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.9	0.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	1.6	0.0	0.0	2.2	0.0	0.0	1.9	6.3	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	1.5	0.0	0.0	0.8	0.0	0.8	7.5	0.1	0.9	0.4	0.0	0.0	0.0	42.8	0.0	1.1	1.0	0.0	0.0	1.3	0.0	0.6	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.5	48.9	1.3	1.5	0.5	0.4	0.3	2.0	0.0
ZNF644	"BM-005, KIAA1221, MGC60165, MGC70410"	ENSG00000122482	"Zinc finger protein 644"	Q9H582	1	90915298-91022272	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057795	Uncertain		Uncertain	Vesicles				Vesicles		"HPA057795: "	"unprognostic (8.20e-2)"	"unprognostic (5.86e-3)"	"prognostic favourable (4.27e-4)"	"prognostic unfavourable (8.39e-4)"	"unprognostic (3.19e-3)"	"unprognostic (4.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-1)"	22.2	14.1	20.7	19.0	20.0	19.4	23.9	34.9	25.1	24.7	17.6	17.8	17.1	11.2	23.8	16.7	17.6	14.4	14.2	14.9	21.7	16.6	15.2	26.2	15.1	19.5	23.7	18.9	21.3	14.4	22.4	24.2	18.2	23.3	18.3	18.7	12.0	20.6	15.3	20.3	14.4	19.1	19.2	25.3	21.6	14.6	17.1	26.5	35.3	26.1	14.9	19.7	19.9	18.3	8.1	7.0	5.0	4.8	12.5	8.6	3.2	12.8	6.2	18.1	10.0	8.5	10.0	10.4	11.2	12.0	12.9	13.8	8.2	4.7	15.8	12.5	8.6	10.2	18.1	13.1	19.1	11.2	10.2	20.4	12.2	11.7	12.1	18.5	6.8	9.4	15.4	12.7	17.4	13.4	14.2	18.2	13.4	4.6	15.0	16.4	16.4	11.6	14.9	29.7	8.8	13.4	11.9	14.9	11.6	13.9	10.9	28.8	7.1	18.7	10.5	14.2	11.8	11.5	17.3	13.0	8.8	21.1	5.8	14.2	7.3	5.0	4.5	5.0	6.2	4.8	7.0	8.1	7.0	7.0	5.8	7.2	8.6	7.5	1.3	12.5	4.7	7.0	5.5	3.2	20.7	20.0	34.9	25.1	21.7	16.6	23.7	18.9	23.3	26.5